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ABSTRACT 
Objectives: To determine whether skin microvascular perfusion and reactivity in critical limb 
ischaemia (CLI) is more enhanced following surgical, compared to endovascular treatment 
and if this is supplemented with concomitant improvement in clinical and haemodynamic 
parameters. 
 
Design: Prospective observational study of forty CLI patients with multi-level atherosclerotic 
arterial disease requiring infra-inguinal revascularisation. 
 
Methods: Clinical assignment to surgical (n=30) or endovascular (n=10) treatment with six-
week follow-up. Laser Doppler fluxmetry (LDF) was used to assess the time to peak (Tp), 
basal flux and vasoconstrictor mechanisms.  Outcomes were compared with clinical 
improvement and pressure changes at the ankle and toe.  Anthropometric measures and tissue 
tension were assessed for evidence of reactive lower limb oedema. 
 
Results: The surgical group showed a significant decrease in Tp (100±4 to 59±7, p<0.001) 
and some restoration of autoregulation, notably vasoconstriction in the foot on sitting 
(72.4±6.8 to 52.2±2.3, p0.05).   Improvement in the anatomical severity of disease correlated 
with concomitant rise in toe pressures (p<0.001) but not with pressures at the ankle.  Reactive 
oedema was more evident post-surgery, with associated increases in lower-limb tissue 
tension.  Endovascular intervention ameliorates symptoms in the short-term but did not 
provide the same microvascular restoration.   
 
Conclusions: Microvascular perfusion and reactivity is greatly improved at six-weeks after 
surgical revascularisation but not after endovascular intervention. 
 
 
 
 
 
 
 
 
 
 
 
 
“Wonder is the beginning of wisdom” 
Socrates 
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ABBREVIATIONS 
 
 
  
ABS Arterial Bypass Surgery  L-NMMA NG monomethyl-L-arginine 
ABP Ankle Blood Pressure  MAP Mean Arterial Pressure 
ABPI Ankle-Brachial Pressure Index  MRA Magnetic Resonance 
Angiography 
Ach Acetylcholine  MTH Metatarsal Head 
APU Arbitrary Perfusion Units  NO Nitric Oxide 
AT Anterior Tibial  NSBI Nicolson-Simms-Brown Index 
AU Arbitrary Units  PA Popliteal Artery 
AV Arterio-venous  PAOD Peripheral Arterial Occlusive 
Disease 
CAD Coronary Artery Disease  PG Prostaglandin 
CBV Capillary Blood Velocity  PN Peroneal 
CFA Common Femoral Artery  PORH Post Occlusive Reactive 
Hyperaemia 
CFC Capillary Filtration Coefficient  PT Posterior Tibial 
CGRP Calcitonin Gene Related Peptide  PTA Percutaneous Transluminal 
Angioplasty 
CIA Common Iliac Artery  PTFE Polytetrafluoroethylene 
CLI Critical Limb Ischaemia  PU Perfusion Units 
CT/A Computed Tomography/ 
Angiography 
 PVD Peripheral Vascular Disease 
CVD Cerebrovascular Disease  RBC Red Blood Cell 
DAP Digital Artery Pressure  RH Reactive Hyperaemia 
DM Diabetes Mellitus  SFA Superficial Femoral Artery 
DP Dorsalis Pedis  SNP Sodium Nitroprusside 
DPN Diabetic Peripheral Neuropathy  SPP Skin Perfusion Pressure 
DSA Digital Subtraction Angiography  SWM Semmes-Weinstein Monofilament 
DVT Deep Vein Thrombosis  TASC Trans-Atlantic Inter-Society 
Consensus 
EDRF Endothelial Derived Relaxation 
Factor 
 TBP Toe Blood Pressure 
EIA External Iliac Artery  TBPI Toe-Brachial Pressure Index 
ESVS European Society Vascular 
Surgery 
 TcP02 Transcutaneous Oxygen Pressure 
FFT Fast Fourier Transformation  Tp Time to peak 
HHD Hand-Held Doppler  VAR Veno-Arteriolar Reflex 
IC Intermittent Claudication   VDT Vibration Detection Threshold 
IIA Internal Iliac Artery  VPT Vibration Perception Threshold 
LDF Laser Doppler Fluxmetry  Xe133 Xenon isotope 
INTRODUCTION 
1.1!Peripheral!Vascular!Disease!
All mammalian species depend on the circulation of blood, propelled by the heart through a 
vascular network, in order to supply tissues with oxygen and nutrients and remove 
metabolites.  Cardiac output, balanced by variable arteriolar tone in the periphery, creates 
pulsatile pressure in the arteries and enables tissue perfusion to be varied to meet local 
metabolic demands.  The relatively higher pulse pressures and flow velocities applied to 
arteries, as distinct from veins, create shear stress, which is an important factor in the 
development of the degenerative process of atherosclerosis.  Atherosclerosis is characterized 
by the progressive accumulation of lipoprotein plaques in the sub-endothelial layers of large 
arteries, particularly at points of branching where shear forces tend to be concentrated.  The 
particular susceptibility of man to atherosclerosis is probably related to longevity as well as 
exposure to toxins and nutritional imbalance.  As atherosclerotic plaques extend they tend to 
produce loss of arterial wall compliance and reduction of luminal diameter resulting in 
stenosis and later occlusion with restriction in nutritional blood flow to the tissues served, 
known clinically as Peripheral Arterial Occlusive disease (PAOD). 
 
In its early stages PAOD is silent but as arterial stenosis develops the ability to up-regulate 
blood flow distal to the stenosis in order to fuel increased tissue activity is lost.  In the case of 
skeletal muscle in limbs this functional ischaemia manifests as “intermittent claudication” 
(IC), where exercising muscles receiving insufficient blood flow develop oxygen debt, 
leading to acidosis perceived as local pain and fatigue.   IC is commonly associated with 
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arterial stenosis/occlusion at a single anatomical level in the limb.  Beyond this point of 
occlusion there is usually a measurable fall in systolic arterial pressure compared to an 
uninvolved limb (usually an arm), allowing calculation of the “ankle/brachial pressure index” 
(ABPI), usually less than 0.9 and showing a further fall when the affected limb is exercised 
sufficiently to produce IC.  Compensatory increase of flow in branch networks having the 
effect of redirecting blood around the axial occlusion is known as collateral development.   
 
In its later stages PAOD impairs nutritive blood flow to the extent that the basal metabolic 
requirements of tissues are not met, producing sensorimotor dysfunction and failure of growth 
and repair. In the limbs this combination of pain and trophic changes is known as “critical 
limb ischaemia” (CLI) and its development usually implies arterial occlusion involving two or 
more anatomical levels.  ABPI may be 0.5 or considerably lower and sustained CLI, if not 
corrected or not compensated by collateral development can progress to gangrene and 
amputation (Figure 1).  Whilst only 5% of patients with IC require any vascular intervention, 
the risk of amputation in uncorrected CLI is 40% at six months (Falluji and Mukherjee, 2012, 
Norgren et al., 2007).  
 
Therapeutic interventions in PAOD, either by surgical reconstruction or endovascular 
recanalization, are designed to relieve claudication or prevent amputation and their efficacy 
may be judged by their clinical success in achieving these objectives.  However the impacts of 
these forms of intervention on circulatory pathophysiology are subtly different and change 
over time.  This work was undertaken to see whether scientific measurement of the peripheral 
circulation in a spectrum of limbs with CLI before and after different forms of treatment 
could analyse their impact and possibly inform their selection. 
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Figure 1: Photographic illustration of distal limb ischaemia, with wet gangrene of the forefoot and toes, with soft tissue 
swelling  (Grey et al., 2006). 
 
CLI is most commonly caused by obstructive atherosclerotic arterial disease but rarely may 
follow vasculitis, thromboangiitis obliterans, cystic adventitial disease, popliteal entrapment 
or trauma.  These mechanisms will not be considered further in this study due to their 
infrequency (Gresele et al., 2011). 
 
Aetiology 
 
The aetiology of atherosclerotic CLI corresponds to the risk factors for the development of 
atherosclerosis in other vascular beds.  Figure 2 demonstrates the independent risk factors for 
CLI, which tend to act independently and are additive. 
 
 
Figure 2: Independent risk factors for the development of CLI, with approximate magnitude of their effect on the 
development of CLI in parentheses (Norgren et al., 2007). 
 
Diabetes!(x4)! Age!>65yrs!(x2)!
Lipid!abnormality!
(x2)! Smoker!(x3)!
RISK!OF!
DEVELOPING!CLI!
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Other than increasing age, many of these risk factors are modifiable.  Approximately 55% of 
patients with PAOD also suffer with hypertension (Clair et al., 2012).  Diabetes confers 
around a four-fold increased risk for developing CLI, giving rise to predominantly diffuse, 
poorly collateralised, infra-geniculate disease.  Smoking contributes significantly and the risk 
rises proportionately with cigarette consumption (Becker et al., 2011, Lepantalo et al., 2011, 
Norgren et al., 2007).  Furthermore, the risk of developing CLI is significantly greater with a 
lower ABPI particularly <0.5 (Norgren et al., 2007).  The increasing prevalence of these risk 
factors continues to fuel the increasing public health burden of PAOD. 
 
Some other conditions, not primarily related to atherosclerosis, can lead to or cause 
progression to CLI without being actual risk factors.  These include congenital or acquired 
hypercoagulable states, embolic disease (cardioembolic/popliteal aneurysms) and vasculitic 
conditions. 
 
Disease Assessment 
 
CLI is defined on the basis of specific assessment criteria made by clinical, haemodynamic 
and anatomical evaluation as follows. 
!
Clinical! %
Assessment of vascular compromise can be made by clinical history and examination. Simple 
objective bedside tests can be employed to assess the macro- and/or microcirculation and 
together they should provide sufficient information to determine the presence, location/level 
and severity of the disease and whether revascularisation is possible or appropriate. Clinical 
signs pertinent to CLI are related to evidence of haemodynamic changes. Signs of severe rest 
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pain can be assessed by the patient’s position and their willingness to elevate the limb to a 
horizontal position (Table 1).  Ulcerations and gangrene typically occur at the extremity of the 
limb, the lateral aspect of the gaiter region and in areas of high pressure such as the heel or the 
metatarsal heads and in this context, should be due to objectively proven arterial occlusive 
disease.   
 
Degree of rest pain Limb position and relief of pain 
First Pain starts when horizontal but declines quickly 
 
Second Pain is only relieved when the limb is placed in the dependent position 
 
Third Patient has to remain in the seated position to relieve the pain 
 
 
Table 1: The three degrees of rest pain and associated positioning of the limb. (Becker et al., 2011) 
 
Trophic changes of skin, nail beds and toe pulp atrophy will be evident, together with a 
prolonged capillary refill time and poor venous refilling.  Pallor of the foot on elevation and 
rubor in dependency is typical of low perfusion pressure and vasomotor paralysis (see section 
on ‘postural vasoconstriction’ for more detail). 
!
Haemodynamic  
 
Objective haemodynamic tests are performed to quantify disease severity and aid treatment 
planning: 
Ankle-brachial Pressure Index (ABPI) 
 
Yao introduced measurement of ABPI in 1969, demonstrating an objective pressure drop 
proportional to the severity of occlusive lesions and this remains the first line of evaluation 
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today (Becker et al., 2011).  Ankle pressures non-invasively measure a drop in blood pressure 
across an area of increased arterial resistance, even in areas where flow levels can remain 
normal (Rutherford, 2000).  It tends to decrease alongside the functional and anatomical 
severity of the arterial disease.   
 
ABPI Disease 
0.91-1.3 Normal 
0.90-0.71 Mild 
0.70-0.40 Moderate 
<0.40 Severe 
 
Table 2: Pressure readings and their association with disease severity  
 
Reliably, daily variation of ankle pressure indices do not tend to exceed 0.15mmHg, making it 
a reproducible test (Wahlberg et al., 1995, Line et al., 1996).  Their ratio with upper limb 
pressure is used as a clinical outcome measure for disease severity and subsequent success of 
intervention or for follow-up. They are typically assessed with Doppler, as auscultation is 
extremely challenging in diseased vessels with low pressures. The value of ABPI varies 
slightly with the anatomical location of the lesion/s, but multi-level disease tends to produce 
the greatest reduction in indices (Rutherford, 2000). 
 
Ankle pressures can be represented in a number of formats, either as an independent ankle 
systolic pressure, as an index with the brachial systolic pressure, or as a gradient across the 
vessel (brachial systolic pressure – ankle systolic pressure).  Flow-limiting disease tends to be 
better detected using the latter two, whereas detection of critical limb ischaemia can be done 
with absolute pressures <50-70mmHg (Ouriel and Zarins, 1982). Nevertheless, clinical 
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discretion is fundamental to interpretation of results.  With resting ankle pressures alone being 
of limited sensitivity in mild disease, comparison with post-exercise pressures can identify 
more subtle pathology, through augmentation of blood flow to calf muscle to demonstrate a 
larger pressure drop (Otah et al., 2005).  In a similar way, ankle pressures have also been used 
in combination with reactive hyperaemia by measuring the systolic pressure in the ankle 
immediately after cuff occlusion and comparing it with that prior to arrest of inflow.  They 
have been shown to be as reliable as exercise tests but avert the problems associated with poor 
mobility in elderly patients or patients with co-morbidities thus reducing compliance (Wyatt 
et al., 1990, Fowkes et al., 1988).  They are, however, subject to variability, which can be 
reduced with serial measurements over time (Fowkes et al., 1988).  
 
Measurements in patients with diabetic disease, uraemia or end stage renal failure and in the 
very elderly can also be inherently unreliable as a consequence of medial calcinosis, reflecting 
arterial wall rigidity from calcification of smooth muscle cells.  Vessel incompressibility 
gives a high number of false negative readings in up to 25% of diabetics and less severe 
calcification may result in a normal ABI despite clinically significant PAOD (Lepantalo et al., 
2011, Saucy et al., 2006). 
 
Despite this, overall ankle pressures are an extremely useful and reliable indicator of disease 
in the macrocirculation in the vast majority of patients but their limitations can be exposed, 
particularly in some patient sub-groups, hence they should be used in conjunction with other 
clinical and anatomical findings and physiological parameters.  They do not, however, 
provide information on nutritive blood supply in the microcirculation, particularly in the foot, 
nor about disease distal to the cuff (Jelnes, 1986, Stalc and Poredos, 2002).  Moreover their 
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ability to predict limb survival is not good and in a study of 111 critically ischaemic limbs the 
mean ankle pressures and their associated indices did not differ significantly between patients 
who underwent amputation and those who did not (34mmHg and 0.22 vs. 43mmHg and 0.27) 
(Ubbink et al., 1999).  
  
 
Toe-brachial Pressure Index (TBPI) 
 
Toe pressure also correlates with disease severity and is a predictor of foot viability.  It should 
be used in all patients suspected of having CLI as it reflects the overall obstruction in the 
arterial tree proximal to the measured digits (Tsai et al., 2000).  Normally the toe pressure is 
about 30mmHg less than the ankle pressure (Falluji and Mukherjee, 2012).  The great 
advantage of toe pressures is that they can provide accurate information on arterial pressures 
even if larger vessels are incompressible, as arterial calcification at this level is not a common 
occurrence.  Therefore, they are a great adjunct in the assessment of diabetic patients.  Toe 
pressures can also be represented as an index of brachial systolic pressure, which is typically 
10-20mmHg below that of the arm or a gradient from the ankle of less than 60mmHg in 
healthy individuals (Rutherford, 2000).  Like ankle pressures the degree of vascular 
impairment correlates strongly with the absolute toe pressure, with critically ischaemic 
patients having an absolute toe pressure less than 30-50mmHg or a TBPI <0.25 (Rutherford, 
2000).   
 
Cuff and strain gauge or photoplethysmography techniques can be employed to indirectly 
measure systolic arterial pressure at the level of the toe (Eickhoff, 1985).  However, due to the 
requirement for specialist equipment it is not routinely used in all units. Limitations also exist, 
predominantly due to the ability of the equipment to detect the return of pressure as a 
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corollary of anatomical abnormalities like thickened nails and callus, absent toes usually from 
previous amputation, or even the presence of ulcers and gangrene can interfere with the 
readings.  In one study of diabetics with CLI, inability to perform readings was as high as 
16% (Lepantalo et al., 2011). 
 
 
Skin Perfusion Pressures (SPP) and Digital Artery Pressure (DAP) 
 
As alternatives to toe pressure measurements when these are practically unfeasible due to 
digital necrosis, skin perfusion or digital artery pressure can be determined. ‘The minimal 
external counter pressure on the underlying skin elicited by the pressure cuff, above which 
skin blood flow or digital artery flow ceases’, defines SPP and DAP respectively and both can 
be measured non-invasively (Yamada et al., 2008).  They reflect perfusion in the smaller 
vessels and can provide a quantitative assessment of disease severity and predict the ability of 
a wound to heal. 
 
The counter pressure is applied using a standard pneumatic cuff and increased above systolic 
pressure to achieve a near zero perfusion pressure.  As cuff pressure is gradually reduced, 
often 5-10mmHg at a time, arterial inflow will increase with a rise in systolic pressure in 
microvessels in the skin.  This can be detected either by laser Doppler, 
photophlethysmography or radioisotope washout techniques (Yamada et al., 2008).  If the site 
of measurement is distal to the cuff, rather than beneath the cuff, distal arterial pressure 
(DAP) is measured as opposed to SPP.  This reflects the pressure acting on the digital arteries 
serving the tip of the toe.  Whilst it has been shown to correlate with SPP (r=0.82) DAP does 
tend to provide a more consistent reading amongst individuals (Fischer et al., 1995). 
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In normal individuals there is a physiological pressure drop between the ankle and the DAP of 
around 70%.  This gradient is greater in patients with PAOD, indicating low driving pressure 
and flow since arteriolar resistance is already low, as vessels are dilated. A similar mean 
pressure drop between ankle and SPP exists in these two groups (Fischer et al., 1995).  Thus, 
restoration of microcirculation/capillary flow in a healthy individual is around 50-70mmHg.  
The value is determined by the reappearance of pulsatile flow; however in patients with 
increasing severity of disease pulsatile flux is lost and distinguishing a rise in flux can be 
quite challenging (Fischer et al., 1995). 
 
The sensitivity of SPP is increased with concurrent use of TBP but is still valuable when used 
in isolation, to assess disease severity and predict wound healing (Castronuovo et al., 1997, 
Yamada et al., 2008).  Using a laser Doppler, Castronuovo et al characterised CLI by an SPP 
reading of <30mmHg (Castronuovo et al., 1997).  Its advantage over TBP is that it can be 
used in the presence of toe ulceration, gangrene or toe amputation by assessing viable tissue.  
Furthermore, it overcomes the limitations of assessment of patients with medial calcinosis 
that ankle pressure is prone to (see section ‘ABPI’ above).  Where accurate toe and ankle 
pressures are both available they have been shown to correlate well (r=0.87). This is true in 
both diabetic and non-diabetic patients (r=0.85 and 0.93 respectively) (Tsai et al., 2000, 
Yamada et al., 2008). 
 
Whilst there are many factors to consider to achieve wound healing, patients with ulceration 
and a skin perfusion pressure of <30-40mmHg are significantly less likely to heal than those 
with perfusion pressures greater than this.  In Castronuovo’s series, 4 patients with SPP 
<30mHg did ultimately heal but it took much longer than the rest of the cohort who had all 
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healed within 6 weeks (Castronuovo et al., 1997).  Therefore SPP can accurately predict 
wound healing with a greater reliability than other measures of distal perfusion (Castronuovo 
et al., 1997, Yamada et al., 2008). 
 
There are a number of other measures of tissue perfusion, including methods such as 
transcutaneous oxygen pressure (TcPO2), which will be discussed in more detail in ‘How to 
assess skin circulation’.  By and large, these measures are not routine in clinical practice and 
tend to be reserved for research and trials. 
!
Anatomical  
 
Imaging techniques are used to assess the morphology of the disease and the inflow and 
outflow to occlusive lesions. They do not offer knowledge on the physiology and functional 
significance of the disease state but they do assist with detailed planning for revascularisation 
and the anatomical level at which re-perfusion is required.  Primary imaging is done with 
Duplex ultrasonography, which is non-invasive and offers haemodynamic evaluation as well 
as an imaging modality (Cao et al., 2011).  In experienced hands it is highly sensitive and 
specific and in infrainguinal disease there is excellent reproducibility with digital subtraction 
angiography, the gold standard (Eiberg et al., 2002).  Its use can be limited in the visualisation 
of iliac disease due to the presence of overlying bowel gas or in patients who have extensive 
ulceration and therefore cannot tolerate examination over this area.  With extremely poor 
inflow, significant oedema, obesity and/or highly calcified vessels images may be sub-
standard (Clair et al., 2012).  It is also the method of choice for surveillance following 
infrainguinal revascularisation. 
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Further multi-planar imaging with computed tomography (CT) or magnetic resonance 
imaging (MRI) and/or contrast angiography with digital subtraction (DSA) is performed 
depending on the individual, the unit and the requirement for accurate planning.  Three-
dimensional magnetic resonance angiography (MRA) is non-invasive, does not require the 
use of radiation and negates the need for intravenous contrast, which is advantageous in this 
population who are more susceptible to renal impairment.  It has a tendency to over-estimate 
the degree and length of stenotic lesions but accuracy is further improved with the use of 
gadolinium and it is not affected by arterial calcification unlike CTA, which is useful 
particularly in the diabetic population.  These non-invasive methods of imaging are now much 
more frequently used than traditional angiography, although this may be invoked if 
supplementary images or haemodynamic pressure assessments are required for treatment 
planning. 
 
Disease Classification 
 
The natural history of CLI is different from peripheral arterial disease as a whole and it is 
important to objectively distinguish this sub-group using the assessment criteria – clinical, 
haemodynamic and anatomical – as described above.  PAOD does not necessarily progress 
through a stepwise trajectory through the clinical stages e.g. with intermittent claudication 
prior to the onset of rest pain, with many sufferers progressing from asymptomatic to CLI. 
This is particularly common in patients who are limited by other comorbidities and their 
functional status.  Their clinical manifestation will depend on the extent of ischaemia and the 
time course of its development (Gresele et al., 2011).  
 
Disease can be categorised clinically using the Fontaine and/or Rutherford classifications:  
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FONTAINE RUTHERFORD 
I) Asymptomatic 
II) Claudication  
a) mild  
b) moderate to severe 
III) Ischaemic rest pain 
IV) Ulceration and/or gangrene 
0) Asymptomatic 
1) Mild claudication  
2) Moderate claudication 
3) Severe claudication 
4) Ischaemic rest pain 
5) Minor tissue loss 
6) Ulceration or gangrene 
 
Table 3: The Fontaine and Rutherford classification of peripheral vascular disease (Dormandy and Rutherford, 2000). 
 
The shortfall of these classification systems is the lack of delineation between symptoms and 
vascular status, as they do not take haemodynamic criteria into account. For example, 
ulceration may be due to arterial insufficiency or be caused by other pathologies such as 
chronic venous hypertension, peripheral sensory neuropathy and low flow states like 
congestive cardiac failure.  Furthermore, these co-morbidities can also exacerbate less severe 
arterial occlusive disease and can complicate the clinical course (Dawson and Mills, 2007).  
 
The changing definitions and inconsistent use of the term ‘CLI’ since it was first described in 
1982, has made the incidence and prevalence of CLI difficult to accurately quantify. 
Definitions from working groups like the TransAtlantic Inter-Society Consensus (TASC) 
group have evolved over time: 
 
 
‘Ischaemic rest pain with an ankle systolic pressure less 
than 50mmHg or toe systolic pressure <30mmHg; or if 
there is ulceration or gangrene and the ankle systolic 
pressure is <70mmHg or toe pressure <50mmHg.’ 
 
Figure 3: TASC II definition of critical limb ischaemia (Norgren et al., 2007). 
 
Comparable definitions by the Modified/International vascular symposium working parties 
and the First/Second European Working groups have also been produced. They are not all 
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uniform with respect to exact haemodynamic parameters but have similarly depleted ankle 
and toe pressures.  Some of the definitions of CLI from notable working groups are shown in 
the table below (Figure 4).  There should be a causal link between symptoms and the severity 
of PAOD.  In the case of CLI, one would expect failure to improve the arterial blood supply 
to result in a major amputation in the next six months to one year (Norgren et al., 2007). 
 
Definitions of Critical Limb Ischaemia 
Fontaine 
Classification 
International 
Vascular 
Symposium 
Working Party 
Definition 
Modified 
International 
Vascular 
Symposium 
Working Party 
Definition 
First European 
Working Group 
Definition 
Second European 
Consensus 
Document 
1. Stage 3 Rest Pain 
caused by arterial 
disease 
 
1. Several weeks rest 
pain requiring opiate 
analgesia for at least 
4 weeks and either 
1. Severe rest pain 
requiring opiate 
analgesia for at least 
4 weeks and either 
1. Severe rest pain 
requiring opiate 
analgesia for at least 
2 weeks or 
1. Persistently 
recurring ischaemic 
rest pain requiring 
analgesia >2 weeks 
and ankle systolic 
pressure <50mmHg 
and/or toe systolic 
<30mmHg or 
2. Stage 4 Ulceration 
and/or gangrene 
caused by arterial 
disease 
2. Ankle Pressure 
<40mmHg or 
2. Ankle Pressure 
<40mmHg or 
2. Ulceration or 
gangrene and 
2. Ulceration or 
gangrene of the foot 
or toes and ankle 
systolic pressure 
<50mmHg and/or 
toe systolic 
<30mmHg 
 3. Ankle pressure 
<60mmHg in the 
presence of tissue 
necrosis or digital 
gangrene 
3. Tissue necrosis or 
digital gangrene 
3. Ankle Pressure 
<50mmHg 
 
  
Figure 4: Definitions of critical limb ischaemia (Wolfe and Wyatt, 1997). 
 
All the definitions in use reflect the chronicity of the condition with symptoms lasting greater 
than two weeks, distinguishing it from acute limb ischaemia.  Some groups also recommend 
the use of techniques to quantify the local microcirculation such as capillary microscopy, 
transcutaneous oxygen pressure (TcPO2) or laser Doppler (1991). 
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Epidemiology 
 
Difficulty stratifying the severity of ischaemia not only complicates estimation of the 
incidence and prevalence of CLI, but also our understanding of the natural history of the 
disease and the interpretation and prediction of the outcomes of treatments.  PAOD in general 
has a reported prevalence of around 3-10% in the general population, increasing to 15-20% in 
those aged over seventy years. Estimates of PAOD incidence are currently around 50-100 per 
100 000 per annum, with approximately 5-10% progressing from asymptomatic or claudicant 
to CLI at 5yrs (Adam et al., 2005, Falluji and Mukherjee, 2012, Gresele et al., 2011, Norgren 
et al., 2007).  The prevalence of CLI is estimated at approximately 1% in the 60-90 year old 
population (Becker et al., 2011, Sigvant et al., 2007).  In PAOD, there remains a significant 
male preponderance of approximately 3:1.  In a Swedish study, this difference is reported to 
equalise when data is age-matched for CLI alone.   However, whilst equivalent definitions to 
TASC were used, only patients with rest pain and an ABPI <0.5 were included (Sigvant et al., 
2007).  Some other studies however report gender differences in CLI prevalence with a 3:1 
male preponderance similar to PAOD (Norgren et al., 2007). 
 
Tyrell and Wolfe prospectively collected follow up data on critically ischaemic patients based 
on different working definitions of CLI.  They aimed to identify patients who were likely to 
require amputation in the absence of successful reconstruction, given that a proportion of CLI 
patients will not progress to amputation without treatment (Tyrrell and Wolfe, 1993). None of 
the definitions proved sensitive or specific in predicting outcomes and indeed results were 
worse still in the diabetic population.  Four years later, Wolfe attempted to stratify severe 
ischaemia into high risk and low risk groups to be more representative of outcome (Wolfe and 
Wyatt, 1997).  He analysed 6118 patients from recent publications and grouped them as high 
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risk/critical if patients presented with tissue loss and/or ankle pressure <40mmHg and low 
risk/subcritical if they had rest pain and/or ankle pressure >40mmHg.  In the high-risk group 
only 5% of patients survived with an intact limb unless they underwent successful surgical 
intervention, compared to 27% in the lower risk group (Wolfe and Wyatt, 1997). Whilst both 
groups carry a high risk of limb loss the difference between the two groups was statistically 
significant and it suggests that revascularisation procedures are essential in the high risk 
group and other modalities of treatment such as sympathectomy or pharmacotherapy will not 
be effective in the high-risk group, but may prove to be of benefit in the subcritical group.   
 
Confounding and Associated Conditions 
 
CLI is the end-stage of arterial occlusive disease in the peripheries and therefore there is a 
high incidence of concurrent disease in other vascular territories, given that they are 
vulnerable to the same risk factors.  The incidence of associated cerebrovascular disease 
(CVD) and severe cardiovascular disease (CAD) in this population is approximately 50-75% 
and 20% respectively (Bhatt et al., 2006).  Coronary vessel assessment with angiography 
however, suggested up to 90% of patients would have some coronary disease present.  For 
each pressure drop of 0.1 at the ankle, there is a 10% increase in the risk of a major 
cardiovascular event (Fowkes et al., 1991, Norgren et al., 2007).  Intervention for CLI 
therefore carries a significant cardiovascular and cerebrovascular morbidity and mortality 
(~3%). 
 
CLI is 10-20 times more common in the diabetic population than non-diabetics and the 
severity of their symptoms correlates with the severity and duration of their diabetes (Clair et 
al., 2012).  Indeed, every 1% increase in glycosylated haemoglobin corresponds to a 25-28% 
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increase in relative risk of PAD (Lepantalo et al., 2011).  In relation to this, Fosse found that 
diabetics have a 12x higher incidence of lower limb amputation than non-diabetics in a study 
of over 17000 amputations (Fosse et al., 2009).  This risk climbs to 23-fold in those aged 65-
74yrs (Lepantalo et al., 2011).  In part this is due to the effects of diabetic vasculopathy on the 
microcirculation.  In addition, it can confound the diagnosis of CLI as sensory neuropathy 
may mask symptoms of ischaemic rest pain and cause an underestimation of disease severity 
until further complications occur and significant vessel calcification can cause an 
overestimate of pressures.  This is also true of the very elderly population who can have 
similarly rigid arteries.  Infectious complications are more common in the diabetic population, 
which can precipitate wound breakdown and poor healing (see section ‘Diabetes’).  
Furthermore, a sub-group of patients can be found to have critically low perfusion pressures 
but remain asymptomatic.  This cohort of patients tends to be sedentary and may be diabetic 
with peripheral sensory neuropathy (Norgren et al., 2007). 
 
Patient Prognosis 
 
This patient population has a very poor prognosis.   They are at exceptionally high risk of 
limb loss without some form of revascularisation procedure and approximately 25% will 
undergo amputation at first presentation.  A significant number of patients will have other 
medical conditions and will be immobile or unable to live independently.  Indeed, primary 
amputation may be preferable in these patients rather than aggressive revascularisation. At 
one-year the mortality rate is approximately 25% and the 5-year survival is 56% for class III 
and 33% for class IV patients, reflecting the underlying systemic atherosclerotic disease 
burden (Dorros et al., 2001).   
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Figure 5: Percentage of the type of treatment patients with CLI undergo and their outcomes one year later (Norgren et al., 
2007). 
 
In an American prospective study, a cohort of 142 patients with uncomplicated stable 
ischaemic ulceration who were deemed unsuitable for revascularisation were followed up 
with non-interventional methods, predominantly dedicated wound care.  Diabetes was present 
in over 70% of cases and chronic renal insufficiency featured in over a quarter of the patients.  
Patients who had complex or necrotising infections were not included and they usually 
required a revascularisation procedure.  By 12 months 23% had required limb amputation and 
those whose wounds healed often took a year (52%) or more to achieve, which involved 
significant expense and limited activity by the patients.  The study included all patients with 
ABI <0.7 however, those with an ABI <0.5 were significantly more likely to require 
amputation in keeping with CLI (15.7% vs. 30.8%, p0.02). Other measures of 
microcirculatory perfusion were not routinely assessed (Marston et al., 2006).  Figure 6 below 
details the natural history of PAOD. 
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Figure 6: The natural history of atherosclerotic lower extremity peripheral arterial disease syndromes. PAD – peripheral 
arterial disease, CLI – critical limb ischaemia, CV – cardiovascular, MI – myocardial ischaemia (Norgren et al., 2007). 
 
 
In summary, CLI is a complex disease process with attendant atherosclerosis in multiple 
vessel beds. It requires careful clinical, haemodynamic and anatomical assessment to ensure 
appropriate and timely intervention.  In particular, diabetic patients can prove difficult to 
diagnose due to associated neuropathic and microcirculatory changes.  Concomitant 
disturbance in flow in the microcirculation makes the skin most vulnerable to gangrene and 
ulceration. 
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1.2!Pathophysiology!of!Skin!Circulation!in!CLI!
Ulceration of the lower extremities is the typical manifestation of chronic ischaemic 
conditions, which is a state of low pressure and hypoperfusion.  The ensuing complex 
processes of both macrovascular and microvascular dysfunction result in rest pain, trophic 
changes and impaired wound healing, pathognomonic of CLI.  These features, representing a 
combination of anatomical deterioration and regulatory dysfunction of the skin resistance 
vessels and microcirculation, are predominantly due to inflammation, loss of sympathetic 
auto-regulatory mechanisms with oedema, altered blood composition and thrombosis, which 
culminate in further tissue damage (Abularrage et al., 2005). 
 Macrocirculation 
 
The primary cause of CLI is the development of atherosclerotic plaques, which affect large 
and medium sized vessels.  They are commonly found at arterial bifurcations where flow is 
more turbulent but they can occur anywhere in the arterial tree and can be very extensive.  In 
early disease macrophages enter the sub-endothelial layer, encouraging accumulation and 
deposition of lipids.  The adherent macrophages and the overlying endothelial cells promote 
inflammation and intimal hypertrophy through cell-signalling pathways.  This results in an 
increase in the intima-media thickness of the vessel wall.    Small areas of damage and erosion 
in the endothelium expose underlying collagen and stimulate formation of thrombus.  
Fissuring or rupture of the collagenous cap promotes further thrombus and haemorrhage into 
the plaque (Underwood, 2000).  The progressive enlargement of fibro-lipid plaques, 
complicated by haemorrhage and rupture, and smooth muscle hypertrophy causes stenosis and 
obstruction within the vessel, which presents a high resistance to flow. 
  
 
 
21 
As a consequence, circulation downstream of multi-level multi-segment stenoses or 
occlusions has a critically low perfusion pressure and a reduction in blood supply to the 
tissues.  The lack of pulsatile flow/pressure-dependent mechanical forces and shear stress on 
the vessel wall causes a respective deficiency in arterial wall remodelling and dilatation 
through endothelial mediators such as nitric oxide (NO) (Coats and Wadsworth, 2005, 
Kvernmo et al., 1999, Moncada and Higgs, 1991, Vallance et al., 1989). This causes further 
deterioration and limitation of exercise i.e. inadequate functional hyperaemia.  
 
Compensatory angiogenesis and collateral formation recompense for a period of time but it is 
not sufficient in the longer term.  Dependent positioning of the foot also increases local 
hydrostatic pressure and therefore increases nutritional blood supply to the ischaemic limb, 
but this too is of limited durability before tissue loss ensues. 
  Microcirculation%
 
The skin microcirculation is a complex and dynamic system and an intimate relationship 
exists between pressure, flow and vascular structure and function (Berardesca et al., 2002).  It 
is essential for ensuring adequate nutrition to the skin, preserving its barrier functions, and 
maintaining thermoregulatory regulation.  Its control is mediated by local, systemic and reflex 
mechanisms induced by factors such as heat, posture and stress, in addition to its own 
inherent circadian rhythm to support tissue homeostasis.   
 
The morphology of skin microcirculation has been studied in animals and humans alike and 
many similarities exist functionally and anatomically. The resistance arterial vessels – 10 - 
150µm in diameter – control flow through two horizontal plexuses, one situated 1-1.5 mm 
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below the skin surface and the other at the dermal-subcutaneous junction. Ascending 
arterioles and descending venules are paired as they connect the two plexuses. From the upper 
layer, arterial capillaries rise to form the dermal papillary loops that represent the nutritive 
component of the skin circulation. The composition of skin microcirculation varies 
significantly depending on the location and therefore skin blood flow is not homogeneous 
(Fullerton et al., 2002).  Glabrous or non-hairy skin such as that found at the tips of fingers 
and pulps of the toes contains predominantly (75%) arterio-venous (AV) shunts, giving rise to 
low resistance and high flow approximately 3-4x higher than skin without shunts (Kvernebo, 
1988).  These large-diameter dynamic microvessels are ideal for their primary function of 
thermoregulation, achieved via sympathetic modulation of vascular tone and perfusion; hence 
glabrous areas undergo wide fluctuations in flow (Abularrage et al., 2005, Fullerton et al., 
2002, Jorneskog, 2012).  On the other hand, in non-glabrous or hairy skin that does not 
possess AV shunts, nutritive flow is through capillaries supplied by resistance vessels that 
maintain a low basal flow but are responsive to autonomic sympathetic neural input, both 
vasoconstrictor and vasodilator, as well as local chemical and axon reflex influences. The 
metabolic demands of the skin only require a small fraction of the blood entering the skin 
(Rendell et al., 1998, Shepherd and O\berg, 1989).  Optimal flow is also preserved by 
vascular myogenic activity, dependent on intra-luminal pressure dynamics to maintain basal 
vascular tone and total peripheral resistance (Coats and Hillier, 2000, Coats and Wadsworth, 
2005).  
 
Resistance vessels in CLI 
 
The skin resistance arteriolar vessels that govern microcirculatory flow demonstrate structural 
and functional abnormalities in the pathogenesis of CLI long before the onset of clinical 
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symptoms (Celermajer et al., 1992).  In early ischaemia electron microscopy demonstrates 
derangement in vessel architecture, secondary to hypoxic damage. There is a thicker basal 
lamina and endothelial swelling with associated ‘gaps’ between the elongated cells 
proximally, with collapsed and degenerated cells distally (Kelsall et al., 2001, Anvar et al., 
2000c).  This is further compounded by a reduction in the adventitia:lumen and media:lumen 
ratios and cross sectional areas, giving an overall reduction in wall thickness of around 30% 
(Coats, 2003, Coats and Hillier, 2000).  This may be from atrophy, hypoplasia or remodelling 
of the cells, but regardless, this has a direct affect on the diameter/pressure relationship 
(Hillier et al., 1999).  Interestingly, the media cross-sectional area is not significantly reduced 
in CLI, suggesting no loss of smooth muscle i.e. not hypoplastic (Anvar et al., 2000c, Hillier 
et al., 1999).  The structure of a vessel wall is largely contingent on pressure-dependent 
vascular wall stress and shear stress (Coats, 2003, Coats and Wadsworth, 2005).  Equally, the 
ability of a vessel to resist pressure-dependent change via myogenic response depends on its 
structural properties.  Chronic ischaemia also leads to derangement of resistance vessel 
reactivity that has deleterious consequences for nutritive skin perfusion. Arterioles remain in a 
state of maximal vasodilatation in CLI such that their responses to the autonomic 
vasoconstrictor stimuli, adrenaline and noradrenaline, that maintain normal vascular tone are 
attenuated (Coats, 2003).  Both active (myogenic) and passive (mechanical) tone may also be 
reduced. The constant low pressure and flow within the ischaemic microcirculation interfere 
with shear-dependent endothelial synthesis and activity of substances such as nitric oxide, 
causing additional loss of vasorelaxation and contributing to a situation of vasomotor 
paralysis. Over time with progression of disease, even the compensatory processes of 
vasodilation, angiogenesis and opening of collateral vessels are not sufficient to relieve 
symptoms (Figure 7). 
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Figure 7: Postulated overview of physiological adaptations of the vasculature in critical limb ischaemia (Coats and 
Wadsworth, 2005). 
 
The consequences of these changes are evident in the disturbed distribution of blood flow to 
the nutritive microcirculation. Before examining this, it is pertinent to consider the 
methodology that is available for investigation of human skin microcirculation.  
 
Techniques for assessment of skin microcirculation in CLI 
 
There is no single standardised method for assessing and quantifying microvascular reactivity 
and the associated reflex and control mechanisms, rather an array of available modalities.  
This reflects the complexities of the microvasculature, in part due to the wide variation in skin 
blood flow on a day-to-day basis and between different sites (Sundberg, 1984).  Furthermore, 
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arterioles are not readily accessible for observation and hence most techniques use indirect 
measures. The diversity of methodology and investigative models in the literature is based on 
studies of human or animal subjects assessed in health or with pathology, which may have 
been produced artificially as in the case of many animal studies.  In early studies, indirect 
methods such as thermography, radioisotope washout or limb plethysmography were used to 
measure skin perfusion in areas such as the forearm or lower limb/hind leg that provide 
readily accessible vascular beds, following a series of interventions which elicit different 
substances suspected to have a key role in ischaemia-induced vasodilatation.  In addition, 
blood flow could be assessed after periods of exercise or occlusion at rest to assess active and 
reactive hyperaemia respectively. These methods are, however, not necessarily specific to 
cutaneous tissue and therefore confounded by ischaemic alterations in such as adipose or 
muscular tissues.  
 
More recent techniques permit direct observations of basal skin perfusion and responses to the 
different interventions that provoke specific regulatory mechanisms. These have been 
reviewed by (Roustit and Cracowski, 2012) and (Abularrage et al., 2005), the latter in relation 
to vascular disease. The following table summarises common methods employed for 
structural and functional assessment of the skin microcirculation in CLI: 
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Method Technique Assess Measure 
Laser Doppler 
Fluxmetry (LDF) 
Non-invasive, continuous measure of allowing 
detection of short-term variations.  Can be used with a 
variety of provocations / interventions including 
iontophoresis (see below) 
 
Flow Direct 
Laser Doppler 
Imager 
 
Utilises Doppler principle & directs laser with a large 
mirror to raster across skin, capturing a more sizeable 
area.  Can be used with iontophoresis. 
 
Flow Direct 
Iontophoresis Non-invasive technique delivering vasoactive 
substances (NO agonists Ach & SNP, and antagonists) 
transdermally, using an electrical potential difference.  
Can be used simultaneously with LDF. 
 
Flow Direct 
Video / Dynamic 
capillary nailfold 
microscopy 
 
Basic light microscopy looking at density and 
morphology 
Quantitative measure of capillary flow velocity in a 
small number of capillaries.  
Can also be combined with fluorescein to show flow 
patterns 
Flow Direct 
Transcutaneous 
tissue 
oxygenation 
(TcpO2) 
 
Non-invasive quantification of oxygen transfer to the 
skin after heating.  Reacts very slowly to changes in 
blood flow.  
Oxygenation Direct 
 
Table 4: Methods of assessing functional measures of skin microcirculation. NO – nitric oxide, Ach – Acetylcholine, SNP – 
sodium nitroprusside, AV – arterio-venous (Abularrage et al., 2005, Schabauer and Rooke, 1994, Kubli et al., 2000, Johnson 
et al., 1984, Winsor et al., 1987). 
 
Laser!Doppler!Fluxmetry!(LDF)!!
 
LDF is non-invasive and based on the changes in frequency of low energy laser light 
(Doppler effect) when it is scattered by moving red blood cells in the microcirculation.  It is a 
continuous dynamic measure easily performed at any skin location allowing detection of 
short-term variations in blood flow (Bircher et al., 1994).  It correlates well with other 
modalities, which all measure the microcirculation at slightly different levels of penetration 
(Kvernebo, 1988, Saumet et al., 1988).  LDF detects sub-capillary flow as well as flow in the 
nutritive capillary bed and AV anastomoses. This is of importance in conditions where blood 
supply is redistributed pathologically i.e. in diabetes (Tooke et al., 1983) (See section 
‘Diabetes’). It does not interfere with venous haemodynamics or cause injection trauma that 
 
 
27 
may alter local circulation (Orlandi et al., 1988). LDF can be used in isolation or coupled with 
microdialysis or iontophoresis in order to study perfusion and flow responses to vasoactive 
substances (Fullerton et al., 2002, Vongsavan and Matthews, 1993). 
  
 ‘Normal’ basal or resting flux values are subject to significant spatial and temporal 
variations, particularly in areas of AV shunts and are therefore referred to as arbitrary 
perfusion units (APUs) (Sundberg, 1984).  The coefficient of variation in healthy human 
volunteers has been shown to be as high as 47.6%, even within a short time frame (Orlandi et 
al., 1988).  Significant differences in basal flux have been reported between healthy subjects 
and those with structural vascular abnormalities such as PAOD, although in some instances it 
has not always shown sufficient differentiation between normal limbs and those with disease 
due to a degree of overlap (Shepherd and O\berg, 1989, Morales et al., 2005, Wahlberg et al., 
1990, Abu-Own et al., 1993, Van den Brande and Welch, 1988, Seifert et al., 1988).  On the 
other hand, it does permit real-time examination of skin perfusion during specific 
interventions that invoke vasoreactivity and as such enables characterisation of deficits in 
CLI. Furthermore, the recent development of laser Doppler imaging gives regional integrative 
data over larger areas than the conventional single or multi-probe LDF, thus compensating for 
heterogeneity of perfusion. 
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LDF KEY POINTS 
o Acceptance of the LDF technique depicted through its widespread use 
o Generally a linear relationship between LDF and blood flow 
o It is specific to superficial cutaneous vessels 
o Allows simple, continuous, non-invasive measurement 
o Heterogeneous nature of microvascular architecture does not allow absolute 
readings of blood flow to be measured 
 
Dynamic!capillaroscopy!
 
Capillaroscopy uses optical microscopy to visualise the 5-7µm diameter surface microvessels 
and their associated networks in vivo.  Capillary morphology such as number, tortuosity and 
diameter can be recorded and/or viewed on a video monitor (Wright et al., 2006).  Functional 
measurements of erythrocyte transit times within capillaries allow assessments of flow  
(capillary blood cell velocity, CBV), which may be more sensitive to early changes in disease 
processes (Chang et al., 1997).  More sophisticated software is used in dynamic 
capillaroscopy to enable measurement of flow dynamics and permeability (Abularrage et al., 
2005).  The use of fluorescein gives much clearer images and better functionally assesses the 
capillary system by progressive diffusion of dye into the interstitial medium, confirming 
perfusing capillaries (Berardesca et al., 2002). The main limitation is the relatively small 
sample area that can be studied (Tooke et al., 1983). 
 
In healthy individuals, Lamah and colleagues confirmed that the total numbers of capillaries 
were not influenced by foot position, with a maximum 4% difference in observed capillary 
numbers between different foot positions over the period of one month (Lamah et al., 2001).  
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They also demonstrated the percentage ratio of perfused to total capillaries was 54.2% 
suggesting that under physiological conditions half of the nutritive capillaries are not 
perfused, allowing recruitment of capillaries to take place on physiological demand (Lamah et 
al., 2001).  Capillaroscopy can also be used synchronously with other techniques, including 
LDF, which measures plexus and anastomotic vessels rather than just capillary flow, yielding 
complementary results particularly in conditions where blood flow may be pathologically 
redistributed such as diabetes (Tooke et al., 1983).  This group also looked at the ratio of 
perfused to total skin capillaries in the PAOD population using dynamic capillaroscopy and 
found a higher proportion of perfused capillaries in this group compared with controls, 
although this was shown to be a consequence of a decreased total number of capillaries in the 
PVD group. The microcirculation was not simultaneously measured to assess flow 
(Abularrage et al., 2005).  Furthermore, in critical limb ischaemia CBV in the supine position 
was found to be significantly lower than in claudicants or healthy subjects (0.04 vs. 0.20 vs. 
0.19mm/s respectively, p0.005), whilst capillary density and LDF did not differ. This is in 
keeping with lower ankle and toe pressures in the CLI group (de Graaff et al., 2003). 
 
TcpO2!
 
This technique is used to assess the metabolic state of the limb.  Electrodes on the skin surface 
are heated to 44oC and measure the oxygen diffusing through the skin from superficial 
vessels. This is reflective of the tissue perfusion and vascularity of the limb (Falluji and 
Mukherjee, 2012).  A normal TcpO2 value is around 60mmHg.  The diagnosis of CLI is 
confirmed with a value <30mmHg (Norgren et al., 2007).  Certainly a TcPO2 >40mmHg is 
likely to see greater than 90% of neuroischaemic ulcers heal and accordingly patients who fail 
to improve following surgical revascularisation have an associated lower TcpO2 than those 
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who improve (18.3±25.3 vs. 33.5±18.7) (Ray et al., 1997a).  Pressure measurements alone 
have a poor predictive value and do not accurately predict the outcome of intervention and are 
not reflective of Tcp02 readings. Tcp02 correlates well with other microcirculatory parameters 
such as LDF time to peak with both measures having better association with clinical 
improvement (p0.04 and p0.02 respectively, ABPI and toe pressures were not statistically 
significant) (Ray et al., 1997a).  Interestingly in percutaneous procedures Tcp02 undergoes a 
transient decrease immediately following the intervention, before improving if it has been 
successful. This is likely to be a reflection of endothelial dysfunction caused by contrast 
material and does not correlate with macrocirculatory measures such as ABPI (Stalc and 
Poredos, 2002, Wagner et al., 2003, Wildgruber et al., 2007). 
 
Whilst TcpO2 is shown to be a sensitive indicator of CLI, the disadvantage is that it is time 
consuming to perform due to the time required for the process of heating.  It is also less 
reliable in the presence of oedema (Abularrage et al., 2005).  Furthermore, assessment of 
perfusion using LDF and reactive hyperaemia has been shown to be marginally more accurate 
than TcpO2 in predicting clinical response to revascularisation in CLI (p0.02 vs. p0.04 
respectively) (Ray et al., 1997a).  For this reason, it was not used in this study and will not be 
considered further. 
 
Assessing microcirculatory reactivity in CLI 
 
The predominant mechanisms for regulation of skin microcirculation are neural, myogenic 
and endothelial. Cutaneous sympathetic neural activity induces vasoconstriction in response 
to cold or autonomic reflexes in all types of skin. In glabrous (non-hairy) skin, which is rich 
in AV shunts this is the only neurogenic mechanism but in non-glabrous (hairy) skin, there is 
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dual innervation of skin vessels with a non-adrenergic vasodilator pathway for vasodilation 
for thermoregulatory purposes (Charkoudian, 2010, Hodges and Johnson, 2009).  The 
vascular myogenic response is an inherent property of smooth muscle in the walls of small 
arteries and arterioles, allowing these principal resistance segments of the microcirculation to 
respond to changes in transmural pressure. Elevated intraluminal pressure leads to myogenic 
constriction, whereas reduced pressure leads to myogenic dilation. This mechanism plays an 
important role in the fluctuations of flow within cutaneous microvascular networks (Lossius 
& Eriksen, 1995).  The microvascular endothelium seeks to control vascular tone to maintain 
pressure, flow and distribution at an appropriate level.  Several endothelial factors play a role 
in its regulation, of which the principal regulator is nitric oxide (NO), a powerful endothelial-
derived vasodilator. NO regulates skin and other vascular beds both at rest and during periods 
of increased flow (Wong et al., 2003).  It can be inhibited by NG monomethyl-L-arginine (L-
NMMA) in vascular endothelial cells and intra-arterial administration causes a dose-
dependent decrease in skin blood flow secondary to vasoconstriction.  L-NMMA has no 
intrinsic vasoconstrictive properties itself and hence the mechanism of its inhibitory action on 
vasodilation is via NO (Meredith et al., 1996).  This can be reversed by L-arginine, the amino 
acid it is synthesised from (Figure 8) (Moncada and Higgs, 1991, Vallance et al., 1989).  
NITRIC OXIDE PATHWAY 
L-arginine 
↓ 
Endothelial-dependent relaxation factor: EDRF (NO)4 
                 NG monomethyl-L-arginine      →     ⊗  ↓               ←   Nitric oxide synthase 
                                  (L-NMMA)                                    
Nitric Oxide (NO) 
                                                  Serotonin      ⇐      ↓              ⇐   Acetylcholine (Ach) 
Decrease blood pressure 
Increased vascular conductance 
 
Figure 8: The nitric oxide pathway and its effect on blood pressure and vascular conductance. 
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Chemical stimulation with substances such as acetylcholine or substance P cause NO to 
constantly emanate from the arterial endothelium during periods of basal flow, to maintain a 
dilator tone and lower vascular resistance (Moncada and Higgs, 1991).  In synergy with 
prostacyclin, platelets also produce NO as a method of regulating platelet aggregation. 
Therefore, impairment of NO synthesis results in increased platelet aggregation and 
adherence to the vessel wall, as well as vasoconstriction. In contrast, sodium nitroprusside 
(SNP) acts directly on cGMP in vascular smooth muscle cells and can be used to test 
endothelial-independent dilator function (Kvernmo et al., 1999, Jagren et al., 2002).  The 
inherent characteristics and action of these substances make them ideal for investigating 
endothelial dysfunction and for use in iontophoresis.  
 
The impact of CLI on these mechanisms regulating skin perfusion can be investigated in a 
number of different ways, one of which is the examination of patterns of microcirculatory 
flowmotion, or oscillations, in resting tissue.  In addition, vascular tone is dependent on 
control by a number of variables including the autonomic nervous system, emotional and 
environmental stimuli, medication and orthostatic position.  It is normally maintained in a 
relatively constricted state through inherent efferent nerve activity and external stimuli can 
also trigger sympathetic reflex responses to evoke changes in vessel resistance (Fullerton et 
al., 2002, Hagbarth et al., 1972).  Provocation tests can therefore be employed which permit 
quantification of a change from baseline resting flux level, as a result of the given stimulus.  
This allows evaluation of microcirculatory control mechanisms depending on the nature of the 
stimulus.  
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The most common tests used are: 
 
• Reactive hyperaemia – to test myogenic / metabolic mechanisms 
• Local heating or cooling – to test dilator / constrictor capacity  
• Maximal heating – to test axon reflex dilation and nitric oxide function 
• Iontophoresis – to test mainly endothelial reactivity 
• Postural vasoconstriction 
• FFT analysis of LDF signals during reactive hyperaemia, heating or 
iontophoresis 
 
Flowmotion!
 
Vasomotion or flowmotion is the rhythmical variation in blood flow within tissues and is 
distinct from flux.  It is composed of waves or ‘oscillations’ of different amplitudes and 
frequencies from vascular smooth muscle and reflects differing vascular regulatory processes 
(Cracowski et al., 2006, Tikhonova et al., 2010, Kvernmo et al., 2003).  Measurement of 
resting skin blood flow by LDF will continuously change with the microcirculatory milieu 
however; characteristic frequency bands have emerged over time originating from different 
mechanisms of vascular regulation. These waves were originally separated into ‘large’ and 
‘small’ reflecting a difference in amplitude and a concomitant variation in frequency. The 
former are more often seen in healthy individuals, with smaller waves of higher frequency 
seen in patients with increasing severity of vascular disease (Seifert et al., 1988).  Later, three 
bands emerged to include the addition of a ‘pulsatile frequency’, shown to be consistent with 
heart rate (Hoffmann et al., 1993).  Spectral analysis of LDF in the time and frequency 
domains has subsequently allowed discrimination between oscillations in skin perfusion.  
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Specific frequency ranges present in the signal can be sifted out and the total and individual 
power ascribed to them and their physiological origin can be identified. The five spectra and 
their associated frequency intervals are shown below: 
 
Interval Frequency (Hz) Physiological Origin 
I 
 
0.009-0.02 Endothelial/Metabolic  
II 0.02-0.06 Neurogenic 
III 0.06-0.15 Myogenic 
IV 0.15-0.6 Respiratory 
V 
 
0.6-2.0 Heart rate 
 
Table 5: Frequency bands of flow motion waves (Avery et al., 2009, Kvernmo et al., 1999, Stewart et al., 2004, Tikhonova et 
al., 2010). 
 
Minor variations exist in the exact intervals of frequency bands in the reported literature. 
Their origins are determined through systematic stimulation and blockade of substances 
known to have an effect on the specific pathways controlling vascular tone. The lowest 
frequency band reflects the intrinsic activity of the endothelium and contributes around 20% 
of blood perfusion in a healthy individual, despite oscillations only occurring at a frequency 
of approximately one minute (Kvernmo et al., 1999, Saumet et al., 1988, Kvernmo et al., 
2003).  Around 0.04Hz spontaneous fluctuations depend on axon reflex-mediated responses 
from autonomic sympathetic modulation. Administration of local anaesthetics or vagal 
stimulation can induce sympathetic denervation (Berardesca et al., 2002, Saumet et al., 1988).  
Myogenic vasomotion is due to inherent spontaneous variations in myogenic activity of the 
vascular smooth muscle cells of arteries and arterioles causing a change in microvascular 
calibre through contraction and dilatation.  The respiratory element corresponds to the 
changes in venous return, causing peripheral vasoconstriction and dilatation. The highest 
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frequency corresponds to the vascular wall transmission of the stroke volume. By assessing 
these parameters in normal and pathological conditions, the regulation of the microcirculation 
can be studied and deviation from the normal microvascular oscillations can be used as a 
marker of disease.  
 
Reactive!Hyperaemia!(RH)!
 
Post-occlusive reactive hyperaemia is a simple and non-invasive provocation test combined 
with LDF to measure skin perfusion.  It is defined as ‘the temporary increase in skin blood 
flow above baseline levels following the release of a brief arterial occlusion’ (Cracowski et 
al., 2006).  It is a quantitative global assessment of microvascular function, representing both 
the function of the cutaneous microvasculature and the haemodynamics of larger vessels, 
through its ability to compensate after a period of ischaemia (Arora et al., 1998, Wong et al., 
2003).  In a normal healthy individual with a functionally intact vascular bed, there would be 
a rapid yet ephemeral peak in flux within a few seconds of removal of the occlusion and then 
a sustained hyperaemia, before a return to baseline within minutes (Figure 9) (Van den 
Brande and Welch, 1988, Zhao et al., 2004).  The increase in blood flow allows repayment of 
the nutritional debt and clearance of metabolites, which accumulate during periods of 
circulatory compromise (Larkin and Williams, 1993, Wahlberg et al., 1995).  This is 
supported by the finding that the total hyperaemic response time and the peak flow values are 
increased with increasing arterial occlusion times in healthy individuals (Wong et al., 2003).  
It is suggested that the area under the curve is the equivalent of the debt accrued during the 
period of circulatory arrest, representing the excess blood flow ‘repayment’ during the 
hyperaemic period (Patterson and Whelan, 1955).  
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Figure 9: A PORH response in a control subject.  The black line is the signal averaged over one second.  The blood flux value 
drops almost immediately after cuff inflation, with a small residual output still present due to continuous red cell flux or 
vasomotion in the microcirculation. PU – perfusion units, tRF - time to resting flux, tMF – time to maximum flux, tHR – time to 
half recovery of PORH, MF- maximum flux, RF – resting flux (Morales et al., 2005). 
 
The exact mechanisms behind the response are complex and not fully defined.  Interactions 
and facilitation of other pathways and/or mediators, such as NO, are likely to be occurring 
simultaneously (Cracowski et al., 2006, Zhao et al., 2004).  Proposed mechanisms include: 
1. Vasodilator metabolite release from ischaemic tissues i.e. prostaglandins, 
adenosine, histamine which is released into circulation with removal of the 
cuff (Patterson and Whelan, 1955) 
2. Smooth muscle response to reduced oxygen tension 
3. Myogenic response to a reduction in the transmural pressure of a static 
circulation  
4. Stimulation of perivascular sensory nerve fibres causing release of potent 
vasodilators such as calcitonin gene related peptide (CGRP) and substance P 
neuropeptides (Larkin and Williams, 1993, Wong et al., 2003, Zhao et al., 
2004) 
5. Shear stress on the vessel wall following restoration of flow, acting as a 
stimulus for prostaglandin and nitric oxide production (Binggeli et al., 2003) 
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The complexity of the response is further highlighted by the inability to completely abolish 
the vasodilatory response when one or more of these mechanisms are blocked, either by 
inhibitors, antagonists or local anaesthetics (Larkin and Williams, 1993, Nowak and 
Wennmalm, 1979). 
 
Many parameters can be quantified from a single PORH response.  The commonest and most 
discriminative method is the time to peak (Tp).  This is defined as the time of the highest 
value after release of the pressure cuff and is determined by flow velocity (Wahlberg et al., 
1995).  Tp is affected by vessel compliance, capacitance of run-off vessels and blood 
viscosity.  Some descriptive measures have also been used to describe the shapes of the 
responses, such as whether it has a ‘single or double’ humped peak (Line et al., 1996).  
Additional quantitative parameters to Tp are used but many are exposed to more inter- and 
intra-subject variability than data expressed as maximum vasodilatation: 
 
 Raw value of the peak 
 Peak percentage from baseline value 
 Time to second peak 
 T/2 overshoot - time to reach 50% of the peak value on the down slope 
 T/2 recovery - time to reach 50% of basal blood flow 
 T recovery - time to reach basal blood flow value 
 Area under the curve (AUC) - total blood flow in excess of the resting level or 
total hyperaemic response (Wong et al., 2003) 
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Successive measures of reactive hyperaemia at the toe pulp and the ankle of the lower limb, in 
healthy subjects and/or PAOD subjects, have been shown to be highly reproducible using 
laser Doppler fluxmetry (Kvernebo et al., 1989, Van den Brande and Welch, 1988).  
Reproducibility has also been demonstrated between left and right upper limbs under the same 
conditions, suggesting that one limb can be used as a control for the other (Patterson and 
Whelan, 1955).  The average coefficient of variation for skin blood flow at the peak of the 
response was 8% in a group of 20 healthy volunteers, with 2 readings taken on the same day 1 
hour apart (Orlandi et al., 1988). 
 
Local!heating!or!cooling!
 
Temperature changes are provoked either directly from within the probe or by immersing the 
test area in cool water of around 15°c or water with a temperature of around 42°c to allow 
testing of dilator capacity of vessels.  This technique is not widely used in the context of 
PAOD as they already have maximally dilated vessels as a consequence of the disease 
process. 
 
Maximum!heating!
 
Local thermal hyperaemia causes a temperature-dependent sustained increase in cutaneous 
flow, with maximal dilatation between 42-44°c, corresponding to the maximum vasodilator 
capacity of the vessels.  This is mediated initially by a local axon reflex causing a rapid 
ephemeral rise in flow and subsequently by nitric oxide with a characteristic 20-30 minute 
plateau (Cracowski et al., 2006).  Whilst it provides some characteristic traces in certain 
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disease processes, it is difficult to extrapolate data due to differing responses to heating in 
different pathologies and not being able to distinguish between functional and structural 
deficiencies (Cracowski et al., 2006). 
 
Iontophoresis!
 
 
Whereas RH invokes a complex mechanism of vasodilation detectable by LDF, an alternative 
for assessment of specific vascular control mechanisms are the more invasive technique of 
iontophoresis. This utilises the principle that a charged vasoactive drug in solution will 
migrate across the skin under influence of a direct low-intensity electric current and 
chemically stimulate the endothelial release of nitric oxide, resulting in an effect on perfusion 
measured as a change in red cell flux (Cracowski et al., 2006).  The most commonly used test 
agent is acetylcholine (Ach), which stimulates nitric oxide production, hence mimicking NO-
dependent endothelial vasodilation and allowing assessment of endothelial vascular function.  
Other drugs are sodium nitroprusside, a NO donor used to test smooth muscle function, and 
the autonomic constrictors adrenaline and noradrenaline (Kvernmo et al., 1999). 
 
Postural!vasoconstriction!(PVC)!
 
 
PVC is a response of resistance vessels triggered by an increase in hydrostatic pressure in the 
microcirculation either on assuming the upright from the supine position (orthostasis), or on 
limb dependency. It is thought to be a protective mechanism that exists to minimise the 
effects of the increased pressure being transmitted to capillaries in order to prevent formation 
of oedema (Shepherd and O\berg, 1989, Wahlberg et al., 1990).  During orthostasis control of 
systemic arterial pressure is mediated by the central baroreflex as blood pools in the lower 
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body and central arterial and cardiopulmonary receptors are stimulated by the reduction in 
mean arterial pressure to generate sympathetic neural activation. In conjunction with this, 
there are two contributory local constrictor mechanisms, the myogenic response and the veno-
arteriolar response (VAR). The former occurs with the rise in arterial hydrostatic pressure, 
increasing pre-capillary arteriolar wall stretch and triggering intrinsic vascular smooth muscle 
contraction in the dependent limb /tissues.  The latter is evoked by hydrostatic elevation of 
venous transmural pressure above a threshold level of 25mmHg, which distends venous 
stretch receptors and induces pre-capillary vasoconstriction through a local sympathetic 
neural pathway (Okazaki et al., 2005).  The effect of both of these mechanisms can be 
eliminated with the use of local anaesthetic blockade or alpha antagonists to block adrenergic 
stimulation, suggesting the response is co-ordinated locally through nervous influence 
(Henriksen, 1976, Okazaki et al., 2005).  The VAR is independent of central control as it is 
observed during spinal block and is thought to be neural as it can be inhibited by local 
anaesthetic application, and to be an autonomic sympathetic neural mechanism as adrenergic 
antagonists attenuate it. The VAR can reduce skin flux by 50-70% in healthy individuals 
(Jelnes, 1986, Jepsen and Gaehtgens, 1995, Henriksen, 1976). 
 
Figure 10:  Schema of microcirculatory regulation mechanisms of skin perfusion with change to the sitting position.  Increase 
in orthostatic pressure with dependency activates two local vasoconstriction responses, the myogenic response and the 
venoarteriolar response  (de Graaff et al., 2003). 
 
 
 
41 
Height dependent vasoconstriction enables smaller central changes in resistance to maintain a 
constant mean arterial blood pressure (MAP), thereby limiting increasing afterload and 
redistributing flow to non-dependent tissues (Jepsen and Gaehtgens, 1995).  It is coupled to 
respiratory movement, with deep inspiration causing vasoconstriction even in the presence of 
dependency (Hagbarth et al., 1972, Jepsen and Gaehtgens, 1995).  The latter is likely to 
represent a more uniform response at rest and in orthostasis, to maintain steady flow despite 
alterations in systemic pressure.  Whereas the veno-arteriolar reflex (VAR), is generated when 
transmural pressures are increased locally (Jepsen and Gaehtgens, 1995, Rordam et al., 1988).  
The effect of the VAR is highlighted by the use of a foot pump.  In the dependent position, 
emptying the veins and reducing hydrostatic pressure attenuates the VAR.  This is due to the 
alteration in the AV pressure gradient, mediating a significant increase in flow, as detected on 
LDF.  This effect is not demonstrated in the supine position because hydrostatic pressures are 
not present in the lower limb (Abu-Own et al., 1993). 
 
The changes associated with an upright posture vary according to skin site along the axis of 
the body because of height-dependent hydrostatic loading.  From a series of LDF readings 
from the forehead to the lower limb, the postural vasoconstrictor response and associated 
reduction in flow become sequentially more pronounced with more distal readings; LDF 
decreased by 18.0 ± 7.1% above heart level, by 30.3 ± 9.1% at heart level and by 69.6 ± 9.6% 
at upper thigh level and in the more dependent skin regions, p<0.01 (Jepsen and Gaehtgens, 
1995). In the lower limb, constrictions were found to be comparable to one another, not 
demonstrating a height-dependent difference in response. Changes in LDF values on the 
plantar surface of the toe and palmar surface of the finger are related to the presence of 
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arteriovenous anastomoses and therefore a difference in flux would be expected between toe 
and shin locations but not between other skin regions of the lower limb such as shin and foot.   
 
 
Figure 11: Left: skin LD-flux in the standing subject.  Height dependent LD flux is only seen above heart level. Single stray 
points represent measurements at finger. Right: percent changes on standing up from recumbency of all measuring sites in 
relation to distance from heart level. Values are means ± SE of experiments in 6 subjects (Jepsen and Gaehtgens, 1995). 
 
When analysis was made between readings taken at the finger and toe in supine and standing 
positions, but with the finger or toe held at heart level, the relative reductions see in LDF were 
not significantly different (29.3 ± 13.0%) (Jepsen and Gaehtgens, 1995).  This technique 
eliminates the effect of hydrostatic pressure.  Similarly if only the position of the hand or foot 
relative to the heart level is altered without a change in body posture, alterations in LDF are 
also seen (Jepsen and Gaehtgens, 1995). 
 
Measuring PVC by LDF 
LDF is an ideal tool for directly measuring reflex cutaneous vascular responses to simulated 
orthostasis, which can be used in conjunction with sympathetic nerve blockade. Xenon 
washout techniques have also been used to measure blood flow in subcutaneous tissues in 
response to stimuli of vasoconstriction (Eickhoff and Henriksen, 1985, Henriksen, 1976, 
Rordam et al., 1988). 
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Independent assessment of the VAR has been measured using proximal cuff inflation at 
approximately 40-50mmHg, to induce venous congestion.  Whilst its advantage lies in not 
activating the myogenic arm of the response, it does however reduce the local perfusion 
pressure between arteries and veins and may subsequently overestimate the blood flow, 
independently to the VAR (Okazaki et al., 2005).  Assessing LDF in recumbence with only 
one limb in a dependent position without the use of proximal cuff inflation can alleviate this 
perfusion problem.  There will be no postural change and therefore no stimulation of the 
central baroreceptor reflex, so heart rate and MAP do not change.  It will however provoke 
the myogenic response due to the increase in arterial hydrostatic pressure gradient between 
the heart and limb (Okazaki et al., 2005). 
 
 
1.3!Control!Mechanisms!in!CLI!
Basal perfusion of skin in CLI 
 
In early studies the development of direct observational techniques enabled visualisation of 
skin perfusion in patients with peripheral arterial disease of varying degrees including CLI. 
Overall skin perfusion measured by LDF was reduced at rest in severe ischaemia in the 
plantar foot and heel (Saucy et al., 2006) and at the toes (Kvernebo, 1988), although there was 
some overlap in patients with less severe ischaemia.  Video microscopy established in healthy 
individuals that the capillary density in the toe was considerably greater than in the foot 
dorsum, the latter showing marked heterogeneity in distribution of capillary vessels (Lamah et 
al., 1996).  In patients with CLI and ulceration, capillary numbers in both regions were 2/3 but 
of these ‘anatomically present’ vessels in the dorsum, a much higher proportion (86%) were 
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perfused after Na fluorescein injection than in controls (55%) (Lamah et al., 1999).  Bongard 
and Fagrell found that total blood flow evaluated by LDF was significantly increased in the 
toes of PAOD patients, which may be explained by this phenomenon of proportional capillary 
perfusion (Bongard and Fagrell, 1990).  In addition, perfusion of foot capillaries was 
inhomogeneous and the vessels were dilated, displaying fluorescein leakage typical of 
ischaemic damage that promotes oedema formation (Junger et al., 1989).  This 
maldistribution of nutritive microcirculatory flow is typical when the supplying arterioles are 
maximally dilated in their state of vasomotor paralysis, as a mechanism for increasing oxygen 
and nutrient delivery to ischaemic skin. As a consequence of disrupted nutritive 
microcirculation, tissue oxygenation in the distal extremities is reduced in CLI. Scheffler & 
Rieger (1992) reviewed the utility of TcpO2 data in peripheral arterial disease, underlining 
that values in the symptomatic foot < 10mmHg when supine and 45mmHg when dependent 
were characteristic of chronic CLI and predictive of future amputation (Scheffler and Rieger, 
1992). 
 
Flowmotion in CLI  
 
Flowmotion is the rhythmical, cyclical variation of blood perfusion in a tissue due to changes 
in smooth muscle tone in the wall of small arteries and arterioles (Anvar et al., 2000b).  It is 
difficult to distinguish the corresponding origins of some of the early descriptions of ‘large’ 
and ‘small’ waves in reports of flowmotion in ischaemic patients, although a distinction based 
on different flowmotion patterns was certainly seen between healthy subjects and CLI 
patients.  ‘Large’ waves (0.051 ± 0.02Hz) were less evident with more severe ischaemia and 
‘small’ waves (0.362 ± 0.07Hz) were detected almost exclusively in patients with PAOD and 
were thought to be independent of respiratory frequency (Seifert et al., 1988).  Subsequently, 
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descriptive terminology was used to evaluate oscillation patterns such as ‘aperiodical’, 
‘sinoidal’, and ‘missing and small’ waves (Scheffler and Rieger, 1992).  Although many 
seemed to have overlapping frequency bands ascribed to them an attempt was made to 
associate each with a systolic or ankle pressure index range.   With worsening arterial disease 
a transition from aperiodical to sinusoidal occurred, with missing or small waves in CLI 
signifying a flatter trace, although this did not appear to be highly predictive (Scheffler and 
Rieger, 1992). 
 
In recent years, Rossi and colleagues looked at cutaneous flowmotion in 20 patients with 
intermittent claudication, both at baseline and during reactive hyperaemia using wavelet 
analysis and the 5 characteristic frequency bands. A severely blunted post-ischemic increase 
in skin endothelial, sympathetic and myogenic-dependent vasomotion was found in the 
diseased leg of stage II PAOD patients, when compared to the amplified response of these 
bands in healthy subjects. A preserved leg skin vasomotion was observed under basal 
conditions in the same PAOD patients, although amplification of endothelial, sympathetic and 
myogenic activity was observed and may represent compensatory change at rest (Rossi et al., 
2005, Rossi et al., 2008).  The reduction in frequency bands associated with heart rate at rest 
may simply reflect poor transmission of output along the length of disease vessels.  
Respiratory frequency band was found to be unchanged at baseline and during reactive 
hyperaemia.  Overall, in non-critical limbs flowmotion is not impaired during baseline but 
reacts with reduced vasomotion during periods of physiological demand (Rossi et al., 2005).  
In addition, Anvar and Khiabani observed a basally reduced skin endothelial, sympathetic and 
myogenic-dependent vasomotion power in the diseased leg of patients with CLI, suggesting 
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increasing degrees of impairment in vasomotion in more severe PAOD (Anvar et al., 2000b, 
Rossi et al., 2008). 
 
Reactive!Hyperaemia 
 
Reactive hyperaemia causes augmentation of blood flow through stenotic areas or high 
resistance collaterals.  Through provocating a hyperaemic response, the functional reserve of 
the limb is assessed and better differentiates PAOD patients from healthy subjects.  In PAOD 
the response is delayed, reduced, or even abolished, particularly in the most distal tissues, 
providing good discrimination and reproducibility of microvascular function (Figure 12) 
(Leonardo et al., 1987, Morales et al., 2005, Van den Brande and Welch, 1988).  Reactive 
hyperaemia has been shown to correlate with the severity of disease i.e. functional vs. critical 
ischaemia and also can identify the level in the arterial tree at which the occlusion or stenosis 
occurs (see page 49). Even distinction of sub-clinical disease in contralateral limbs can be 
made (Leonardo et al., 1987). 
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Figure 12: Typical reactive hyperaemia response curve in (a) totally healthy and arteriopathic limb, (b) arteriopathic limbs 
subdivided according to clinical picture, (c) limbs with more severe and less severe symptomatology of each patient.  The 
reaction is delayed and flatter, with a prolonged return to baseline (Leonardo et al., 1987). 
 
 
There have been a number of studies looking at reactive hyperaemia in healthy and diseased 
limbs in animals and humans.  They all use a similar technique but vary the location of the 
probe and the cuff.  Most studies use an occlusion time of 3 minutes and a static occlusion 
pressure of 250-350mmHg.  Alternatively the pressure used can vary in relation to the 
individual’s systolic pressure.  The table below summarises reactive hyperaemia studies in 
PAOD. 
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Author & 
Year 
Number Probe 
location 
Cuff location Occlusion 
time 
Pressure 
Del Guercio et 
al. 1987 
138 PAOD      
71 healthy limbs 
Pulp hallux Thigh 3 min 250 mmHg 
Van den 
Brande et al 
1988 
58 PAOD         
21 normal limbs 
Pulp hallux Upper calf 3 min 300mmHg 
Kvernebo et al 
1989 
85 healthy, 
elderly, IC, CLI 
Hallux pulp 
& leg 
Thigh 3 min 300 mmHg 
Kvernebo K et 
al 1992 
6 pigs with 
stenosis 
Hind limb ‘Proximal limb’ 3 min 350 mmHg 
Wahlberg E et 
al 1994 
40 pigs with 
stenosis 
Hind limb ‘Proximal limb’ 3 min 
 
350 mmHg 
Kvernebo et al 
1996 
9 pigs with 
varying stenoses 
Hind limb ‘Proximal limb’ 3 min 
 
350 mmHg 
Orlandi C et 
al. 1998 
20 HTN           
20 healthy 
Dorsum 
foot 
Ankle 3 min ‘Supra- systolic’ 
Ray S et al!
1999 
69 PAOD        
15 controls 
Dorsum 
foot 
Ankle 2 min 100mmHg above 
ankle pressure 
Morales F et al 
2005 
54 PAOD        
30 controls 
Dorsum 
foot 
Thigh 3 min 30mmHg above 
systolic arm 
pressure 
 
Table 6: Summary of studies recording reactive hyperaemia in animal and human subjects with and without stenoses, the 
location of the probe and the location of the cuff and its associated pressure and occlusion times. 
 
Many parameters can be quantified from a single PORH response and each has their own 
inherent advantages and disadvantages.  Prolongation of Tp is the one single outcome 
measure used consistently in studies, as it is a good discriminator of disease and it makes 
good sense to have a delay in response due to pressure losses across a stenosis (Wahlberg et 
al., 1994).  Interestingly, hypertensive patients have been observed to have a slower rise to 
peak flux when compared with normotensive patients, suggesting early impairment of 
endothelial cell function.  Neither the value at the peak of flux nor the recovery phase, 
assessed by t/2 recovery, have been shown to be consistently discriminative (Orlandi et al., 
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1988).  Table 7 below summarises some of the parameters used in the literature and whether 
they altered significantly with disease severity. 
 
Author & 
Year 
FRT/ fL t/2 recovery t recovery Tp/t max Peak flow t/2 
overshoot 
tT 
Del Guercio 
et al. 1987 
Higher Longer Longer * 
 
Longer Lower - Longer 
Van den 
Brande 1988 
Higher - - Longer Lower - Longer * 
Kvernebo et 
al 1989 
NS - - Longer Lower - - 
Kvernebo et 
al 1992 
NS - - Longer - - - 
Wahlberg E 
et al 1994 
- - 
 
- Longer - - - 
Kvernebo et 
al 1996 
NS - - Longer NS - - 
Orlandi C et 
al. 1998 
- Longer Longer Longer * 
 
NS NS - 
Ray S et al 
1999 
- - - Longer - - - 
Morales F et 
al 2005 
- Longer - Longer NS - Longer * 
Table 7: The parameters measured in analysis of the hyperaemic curve and how they changed with disease severity. FRT – 
flux reappearance time or fL – flux latency,  t/2 recovery – time to reach 50% of basal blood flow, t recovery – time lapse 
required to recover resting flux value, recorded prior to peak flux, Tp - time to peak or tmax – time to maximum peak,  t/2 
overshoot - time to reach 50% of the peak value on the down slope, tT – total hyperaemia time, *most discriminative measure 
in the study. NS not significant, - not tested. 
 
 
Severity!and!location!of!stenosis!
 
Wahlberg induced varying degrees of stenosis, from 5-100mmHg-pressure difference, in the 
peripheral vasculature of pigs (Wahlberg et al., 1994).  He showed a relationship between the 
severity of stenosis and the time to peak hyperaemic response with more severe occlusive 
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disease giving a greater the prolongation of Tp (r=0.86 p<0.0001) and clearly distinguishing 
occlusive disease from healthy controls.  This difference was most evident at larger pressures 
presumably because autoregulation is still present at lower pressure gradients (Wahlberg et 
al., 1994). 
 
Similarly in humans, Kvernebo found that time to peak flux was intimately related to 
increasing disease burden and Tp was the parameter which most clearly separated the groups 
(Kvernebo et al., 1989).  Others have also supported this quantitative finding (Larkin and 
Williams, 1993, Line et al., 1992, Line et al., 1996, Wahlberg et al., 1995).  Tp was shorter in 
healthy volunteers of all ages compared to claudicants (p<0.01) and claudicants compared to 
CLI (p<0.01). Indeed many of the patients with critical ischaemia did not even have sufficient 
systolic pressure or remaining vasomotor function to the foot to show a pulp reactive 
hyperaemia response at all (Kvernebo et al., 1989).  Diabetics were excluded.  In contrast to 
Wahlberg, Kvernebo found that peak hyperaemic flux values also displayed a significant 
difference between patients and controls (Kvernebo et al., 1989, Wahlberg et al., 1994).  
 
It has been suggested that the shape and pattern of the curve/s detected following release of 
the cuff, may provide insight into the anatomical distribution and physiological importance of 
arterial pathology. When Kvernebo experimented on 9 pigs with stenoses at different levels 
from aorta to superficial femoral artery, the time to peak was not significantly different 
between sites (Line et al., 1996).  It is therefore likely that Tp reflects the vascular resistance 
of the limb as a whole. 
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Shape!of!the!curve!
 
Kvernebo also investigated whether the shape of the curve reflected peripheral vascular 
resistance, from lesions proximal to the tourniquet.  He found that pig subjects without 
significant stenosis had an immediate single peak response following cuff release (Line et al., 
1992, Line et al., 1996).  ‘Double-humped’ curves where two or more peaks of hyperaemia 
were shown in quick succession were present when a significant arterial pressure gradient was 
present, irrespective of the site of stenosis (p<0.0001)  (Line et al., 1992, Line et al., 1996).  
The greater the pressure gradient, the more pronounced the double humped appearance 
became, as measured by fdiff (the difference between the flux value of the first peak and the 
minimum flux value between the two curves).   The critical stenosis required to produce a 
difference had to exceed 70mmHg more proximally in the aorta but was less as the stenosis 
moved more distally to the CFA (40mmHg, p<0.05) (Line et al., 1996).  It seems likely that 
this initial first peak, of a ‘double-humped’ response is unrelated to flow, rather the 
transmission of pressure from the arterial wall and surrounding tissues detected by the 
sensitivity of the laser Doppler at the time of cuff insufflation.  The finding that the onset of 
the first hump was timed as central blood pressure exceeds distal tourniquet pressure 
reinforces this (Line et al., 1992).  The distal vasculature is subsequently in a vasodilated 
state, whilst transiently without volume flow. The delayed flow from the hyperaemic 
reperfusion is then seen as the second hump in diseased vessels (Line et al., 1996).  These two 
phases are indistinguishable in subjects with healthy vessels.  The number and size of the 
collateral circulation filling the microvasculature may explain why more proximal disease has 
a less pronounced first peak, until the severity of the stenosis reaches a critical point. The 
minimum flux between the two humps is thought to reflect the lowest distal pressure at the 
same time as the maximal arterial flow, as a consequence of pressure drop across the stenosis 
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from turbulent flow.  Despite this initial shape change of the curve, the site of the lesion did 
not affect the overall time to peak significantly; only the increasing severity of stenosis would 
alter this. This is in favour of time to peak hyperaemia reflecting total vascular resistance of 
the limb (Line et al., 1996).  This study however does not give insight into how more complex 
multi-level disease and influences the shape of the curve, or the effect that collateral 
circulation may have in lowering sensitivity to proximal disease. 
 
Similarly Ray et al looked at the shapes of the hyperaemic curves in 69 PAOD patients and 15 
controls and compared them to the anatomical distribution of disease and the ABPI of the 
subjects.  They described the output as type I, II and III, rather than single or double humped 
curves.  In this population they found type I curves with an immediate large amplitude peak 
was related to either normal vessels or proximal arteries (supra-geniculate vessels) with a 
single lesion (PPV 77%), consistent with low resistance transmission of the pressure/flow.  
Furthermore, the Tp in type I curves was always less than 10secs (Ray et al., 1999).  Type II 
curves had multiple large amplitude peaks with delay in the highest peak and were associated 
with multiple proximal lesions (PPV 61%).  It appeared that the stenoses and/or the presence 
of collaterals gave a disparate transmission of pressure and volume, represented by the 
numerous peaks.  Finally, type III curves where there was a gradual increase in LDF over 1 
minute or more towards pre-occlusion levels but did not show any large peaks.  This pattern 
correlated with discontinuous run-off below the knee suggested that a patent tibial vessel is 
necessary to produce an LDF peak. (PPV 86%) Types I and II were strongly associated with 
one or more patent vessels from knee to ankle.  Of note, the mean ABPI did not change 
significantly across the three groups, but there was a tendency for it to be lower with 
progression from type I to type III (Ray et al., 1999). 
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Figure 13: The three graph types I, II, III laser Doppler curve following 2 min arterial ischemia (Ray et al., 1999). 
 
Van De Brande and Welch however, suggested that the time that the hyperaemic response 
starts after release of occlusion (T0, or FRT) is the most discriminating parameter between 
PAOD and normal subjects (Van den Brande and Welch, 1988).  In a small subset of PAOD 
patients however, they described a T0 of zero and an ‘s-shape’ response which infers 
analogous findings to the ‘double-humped’ response described above. 
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Location!of!cuff!and!probe%
 
If Tp is a reflection of total limb resistance rather than outflow peripheral resistance, the 
position of cuff should not affect the time. Wahlberg et al showed that the Tp unaffected by 
location of tourniquet above or below the stenosis (Wahlberg et al., 1994).  Probe placement 
and distance from the tourniquet should be standardised in any hyperaemia study as this has 
been shown to affect the time to peak (Line et al., 1996).  Kvernebo found that whilst the Tp 
was not significantly prolonged by the location of the stenosis per se, it was prolonged by the 
location of the probe in relation to cuff.  The further away the probe was sited from the 
tourniquet, the longer the time to peak in femoral artery stenosis, with a median difference of 
15.6secs 22cm vs. 15cm (p<0.05). There was an insignificant trend towards a longer peak 
time was identified in more proximal iliac disease (Line et al., 1996). 
 
The curve pattern was also different with a lower first-peak flux value with a longer distance 
from the tourniquet in the femoral stenoses. This may simply represent swifter detection of a 
change in pressure and flow in the arterial wall over a shorter distance, which is amplified 
when in a more distal stenosis, as the relative increase from the cuff is greater than a more 
proximal stenosis. This would explain the trend found in iliac disease rather than a significant 
difference.   
 
Kvernebo also looked at RH at sites with and without AV anastomosis (hallux pulp vs. ankle) 
in 85 patients, at different stages of PAOD.  Subjects were divided into four groups; young 
healthy, elderly healthy, claudicants and CLI.  Resting flux and peak flux values were 
consistently higher in the toe pulp (3-6 times) compared to values from the leg (p<0.01) 
consistent with greater AV anastomoses.  The time to peak had a tendency to be longer at the 
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toe pulp across all the groups, although this was not statistically significant (Kvernebo et al., 
1989).   
 
 
 
 
 
 
 
 
Postural Vasoconstriction in CLI  
 
Perhaps rather counter intuitively after the PVC mechanisms described above, patients with 
critical limb ischaemia hang their leg in a dependent position to get relief from their 
symptoms, suggesting this provides an increase in peripheral flow and a reduction in local 
ischaemia.  In CLI, the reduction in blood pressure at the ankle is compensated with regional 
passive dilatation and lowered peripheral resistance, thus increased capillary flow from raised 
hydrostatic pressure.  Furthermore, increased venous transmural pressure and venous 
distension does not evoke the VAR in individuals with CLI and consequently there is a rise in 
capillary pressure.  Therefore, patients with severe disease react with an increase in flow in 
dependency. Subsequently, the foot is suffused with blood and becomes hyperaemic in 
dependency.  Equally elevation causes pallor, as a result of microcirculatory dysfunction.  
 
Those with non-critical or functional ischaemia do not present this finding, although they do 
display a comparative reduction in peripheral vascular resistance compared to healthy 
Reactive Hyperaemia: 
o Severity of stenosis 
o Magnitude of collaterals 
o Distal disease 
o Distance between tourniquet & probe 
o Time to peak most consistent variable related to severity of disease 
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individuals. This is reflected by a similar horizontal resting flux on LDF, but a significantly 
higher flux on sitting, compared to healthy individuals, see figure 14 below  (Abu-Own et al., 
1993, Delis et al., 2001, Otah et al., 2005). This has also been demonstrated using Xenon 
washout techniques, with claudicants having a significantly higher local blood flow during 
dependency than normal subjects (p=0.01), suggesting a reduction in local peripheral 
resistance (Eickhoff, 1980). 
 
 
 
Figure 14: Median skin blood flux in horizontal and sitting positions in normal subjects and patients with stable intermittent 
claudication.  There was no significant difference in flux in the horizontal position between the groups. In the sitting position, 
skin flux in claudicants was higher than in the normal subjects (p<0.001) (Delis et al., 2001). 
 
Eickhoff and Henriksen also demonstrated that during lowering, blood flow in the limbs with 
intermittent claudication decreased less than in the normal limbs (p=0.04), however the 
calculated local vascular resistance was not found to be significantly different to that of 
normal individuals suggesting that autoregulation is preserved in non-critical limbs (Eickhoff 
and Henriksen, 1985).  That said claudicants do exhibit more of a decrease in blood flow on 
elevation than normal subjects, indicating some impairment early in the disease process.  
Nevertheless, despite attenuation at this stage they are able to adapt and compensate through 
an intact reflex mechanism and increase their local vascular resistance. 
Horizontal 
Sitting 
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In limbs experiencing rest pain, blood flow increased by 28% during lowering from the 
supine position (Eickhoff and Henriksen, 1985).  It was however suggested that this was not 
due to passive dilatation of resistance vessels, but a consequence of an associated additional 
increase in arterial pressure on lowering of the limb, as there had still been a calculated 
increase in local vascular resistance of 21% suggesting that some vasoconstriction was still 
occurring (Eickhoff and Henriksen, 1985).  A greater orthostatic response was also seen in a 
group of critically ischaemic patients compared to normal subjects across three different 
anatomical areas as a result of increased flow in dependency on LDF; pulp of the great toe, 
level of the second metatarsal body and anterolateral part of the ankle (p<0.001, p<0.008 and 
p<0.001 respectively). This response was twice as great at the toe compared to the foot and 
ankle locations, predominantly because the perfusion during dependency was much greater 
than in the horizontal position at the toe (p<0.008), with no significant differences at the foot 
and ankle positions between supine and dependency.  It may be that the presence of AV 
shunts in the toe gives the greatest potential for skin perfusion to increase (Khiabani et al., 
2000a).  In addition transmural pressure will be greater at the toe because its location is more 
distal.  It is not clear whether this is primarily due to a deranged nervous reflex mechanism or 
diminished contraction of smooth muscle due to structural or functional adaptation.   In 
healthy individuals postural change in flow is not affected by location (Khiabani et al., 
2000a). 
 
In a small cohort of normal subjects (n=12), claudicants (n=8) and critically ischaemic 
patients (n=7), ankle and toe pressures were found to increase significantly from supine to 
sitting in all groups, as expected (de Graaff et al., 2003).  There was however a significant 
increase in capillary pressure on sitting in all three groups, which was related to orthostatic 
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blood pressure increase i.e. the postural increase in toe pressure in all groups was not 
significantly different from the postural increase in capillary pressure (p=0.88, p=0.26, p=0.46 
respectively), suggesting that capillary pressure is maintained at the expense of capillary 
perfusion in response to lower arterial pressure (de Graaff et al., 2003). 
 
Oedema 
 
The postural vasoconstriction mechanism is thought of by some as the “oedema protection 
reflex”, (Abu-Own et al., 1993) as persistent vasomotor dilatation/paralysis is suggested to 
favour oedema, secondary to increases in arterial hydrostatic pressure.  More than 50% of CLI 
patients have oedema at presentation and there can be as much as 13 ±9% mean volume 
difference between contralateral limbs without CLI (Anvar et al., 2000a, Anvar et al., 2001, 
Khiabani et al., 1999b).  In addition to the reduction in peripheral vascular resistance in this 
cohort there is a relative increase in the time spent in the dependent position due to second or 
third degree rest pain, which necessitates limb dependency or even a constant seated position 
to relieve the pain.  The associated increase in tissue pressure exceeds capillary pressure 
favouring transudation of fluid into the interstitial space.  The oedema tends to be localised to 
the distal leg and foot and is pitting in nature and hence represents extracellular interstitial 
fluid (Khiabani et al., 1999a).  As a consequence the tissues are saturated, nutritive capillaries 
may be compressed and the diffusion distance for nutrient exchange is greater and may in 
itself lead to further deterioration in tissue oxygenation. (Coats, 2003, Falluji and Mukherjee, 
2012, Khiabani et al., 1999b).  The normal integrity of tissue cannot be maintained and 
certainly once a wound or an ulcer has been formed, nutritional blood flow and extraction of 
oxygen cannot be increased by normal means through increasing total blood flow or by 
redistributing flow from non-nutritional to nutritional circulation via AV shunts.  Infection 
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also raises the metabolic demands of the tissues and must be treated immediately (Khiabani et 
al., 1999a, Gresele et al., 2011).  Presumably, persistently low distal pressures explain the 
absence of oedema observed in some patients suffering CLI. 
 
Starling forces regulate fluid homeostasis, which represents the balance between hydrostatic 
and colloid oncotic pressures intra-luminally and in the interstitium (Anvar et al., 2001, 
Khiabani et al., 2000b, Khiabani et al., 1999b).  A disparity in this balance is evident in CLI 
patients such that hydrostatic pressure in the capillaries is increased due to a reduction in pre-
capillary resistance.  Techniques to collect interstitial fluid have shown the colloid osmotic 
pressure in limbs with CLI to be significantly lower than in the limbs without CLI (2.3 SD 
0.5mmHg vs. 3.1 SD 0.7mmHg, p<0.0001), indicating a reduction in proteins in this fluid. 
(Khiabani et al., 2000b) In the plasma, osmotic pressure is reduced predominantly due to a 
reduction in albumin with total protein levels being within normal range (Khiabani et al., 
2000b, Khiabani et al., 1999b).  In fifteen CLI patients Khiabani and colleagues found the 
mean plasma albumin concentration, which usually accounts for more than two-thirds of 
plasma oncotic pressure, to be 28.5±6.6g/l, significantly lower than reference intervals 
(Khiabani et al., 2000b, Khiabani et al., 1999b).  The net result is an increase in interstitial 
fluid formation, which accumulates in the compliant subcutaneous tissue. Whilst the 
reduction in albumin would account for bilateral oedema, it does not explain unilateral 
swelling and hence it is not felt to be the only source of oedema formation.  
 
Furthermore, the capillary filtration coefficient (CFC), which is a functionality of the 
‘leakiness’ of the capillaries combined with their available surface area, has been shown to be 
twice as great in patients with oedema (p<0.01), compared to either the contralateral limb or 
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control subjects (Anvar et al., 2000a).  This increase in ‘hydrodynamic conductivity’ may be 
as a direct result of the disruption to the endothelium.  One of the functions of the vascular 
endothelium is to regulate permeability, which may be damaged as consequence of 
metabolites produced by ischaemia (Khiabani et al., 2000b). Studies utilising transmission 
electron microscopy in CLI reveal swollen and deranged endothelial cells with large 
intercellular gap junctions, which are predominantly manifested at more distal locations 
(Anvar et al., 2000a, Anvar et al., 2000c).  There was, however, no significant correlation 
found between total leg-foot volume and CFC (p>0.05) (Anvar et al., 2000a).  Of note, there 
were no significant differences found in CLI patients with and without limb oedema, on 
analysis of flowmotion FFT in horizontal and dependent positions.  Both low (endothelial, 
myogenic and neurogenic) and high frequency (respiratory) oscillations did not differ between 
these two groups (Anvar et al., 2000b). 
 
The impairment of VAR is likely to play a contributing role with elevated venous pressure 
transmitting to the capillaries. Khiabani and colleagues however have demonstrated that 
whilst there is an impaired orthostatic response in the toe pulp of patients with CLI, this does 
not differ significantly between those with and without oedema pre-operatively, nor were they 
able to demonstrate a correlation between the degree of oedema and the orthostatic response 
(Khiabani et al., 2000a).  Functionally significant DVT as a cause of limb swelling due to 
relative stasis has been excluded using plethysmography and colour flow duplex techniques 
(Khiabani et al., 2000a, Khiabani et al., 1999b).  All of these potential contributory factors 
suggest that the development of oedema is a multifactorial process, not solely as a result of 
attrition of the VAR, CFC or a change in haemodynamics, particularly as there does not 
 
 
61 
appear to be a linear relationship between attenuation of these individual factors and limb 
volume.  
 
Measurement of oedema through measuring limb volume can be achieved with a number of 
different methods including water displacement volumetry (WDV), which assumes that 
displacement of 1ml if water is equivalent to 1g volumes (Khiabani et al., 1999b).  Alternative 
methods include infrared optoelectronic volumetry, which is expensive, and the disc model 
methods that assume a truncated cone for shape of lower limb for estimation. This is easier 
and cheaper to perform although may be less reliable if the oedema is localised to foot and 
ankle.  In our experience the oedema is often involving the calf in addition to the ankle. 
!
1.4!Diabetes!!
Diabetes adds extra complexities to the recognition, diagnosis and management of CLI.  
Approximately 2million people in the UK are affected by diabetes and its prevalence is 
expected to double in the next two decades (Price et al., 2008).  Not only is diabetes a risk 
factor for the development of ischaemic foot ulceration, it also has its own inherent 
complexities as a consequence of the pathophysiological changes that occur in the foot.  
These are not exclusively related to ischaemia, but also the associated sensory motor 
impairment and autonomic dysfunction (Schramm et al., 2006).  They also have a 
significantly reduced resistance to infection, helping to account for the 12-15x higher 
amputation rates in this group (Abbott et al., 1998, Fosse et al., 2009).  Furthermore, the 
typical symptoms of CLI are not always present in this population. 
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The skin circulation in diabetes  
 
Atherosclerotic disease tends to be more severe compared to non-diabetics, with early large 
vessel involvement and poor collateralisation.  This is accelerated by poor glucose control, 
with every 1% increase in HbA1c giving rise to a 25-28% relative risk of peripheral arterial 
disease (Jorneskog, 2012, Lepantalo et al., 2011).  In contrast to non-diabetics, men and 
women affected equally (Jorneskog, 2012).  Fosse et al found that 95% of lower limb 
amputations in diabetics were associated with PAD (Fosse et al., 2009). 
 
Poor glycaemic control also contributes to metabolic dysfunction and an impoverished 
microvasculature, with increased vascular permeability and impaired autoregulation of blood 
flow and tone (Schramm et al., 2006).  Subsequently, wounds fail to heal from relatively 
minor trauma.  Peripheral neuropathy synergistically acts to reduce capillary blood flow in the 
foot and it has been suggested that this is the main cause for reduced microvascular reactivity 
(Brooks et al., 2008, Schramm et al., 2006) (See below).  Equally, microvascular 
abnormalities may contribute to endoneural perfusion and hypoxia, exacerbating peripheral 
neuropathy (Brooks et al., 2008). 
 
As previously mentioned, ABPI measurements are inherently unreliable in the diabetic 
population and toe pressures can be difficult to measure in the presence of digital amputations 
or gangrene.  Even when these measures are feasible, the value and accuracy at which limbs 
are considered ‘critical’ is at a different threshold to non-diabetics, particularly in view of the 
effects of neuropathy. 
 
 
 
63 
Neuropathy 
 
Diabetic peripheral neuropathy (DPN), most commonly a distal symmetrical sensory 
polyneuropathy, is a feature of diabetic disease in 28% of type one diabetics and up to 50% of 
patients with type two diabetes and its development and progression is related to defective 
glycaemic control (Apelqvist et al., 2008, Aring et al., 2005, Boulton et al., 2006, Parry, 
1999).  It is therefore, the commonest complication of diabetes and can present clinically or 
be in apparent and often symptoms do not correspond with nerve function (Arezzo, 1999, 
Garrow and Boulton, 2006).  It has been estimated that 15% of all diabetics will develop a 
foot ulcer in their lifetime (Miranda-Palma et al., 2005) and DPN is the causal factor in most 
foot ulcerations, (Garrow and Boulton, 2006) although the pathway to ulceration often 
requires two or more of the following risk factors to be present: 
 
1. Metabolic and microcirculatory compromise 
2. Atherosclerosis 
3. Neuropathy 
4. Mechanical deformity 
5. Infection (Boulton et al., 2006) 
 
Neuropathy in combination with one of these risk factors raises the incidence of ulceration to 
25-30%, a twelve-fold higher risk (Frykberg et al., 1998, Lepantalo et al., 2011).  The 
EURODIAB prospective study showed that this risk factor profile for the development of 
DPN is similar for the development of PAD including age, duration of diabetes, hypertension, 
smoking, hyperlipidaemia in addition to poor glycaemic control (Tesfaye et al., 2005).  
Consequently, a relatively lesser degree of macrovascular compromise may exist in the 
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diabetic patients, to give rise to comparatively more extensive tissue loss than in a non-
diabetic patient. Of course, once ulceration ensues healing is far more difficult to achieve as a 
consequence of the ischaemia and microvascular compromise that already exists. 
 
Concurrent autonomic neuropathy causes similar disturbances in microcirculatory flow by 
causing AV shunts to open, diverting blood away from nutritive beds into sub-papillary 
vessels and depriving capillaries of blood flow, hence reducing skin perfusion.  Overall there 
is a normal or increased total skin microcirculation but a reduction in capillary circulation.  
This shunting occurs because autonomic neuropathy effectively ‘denervates’ the A-V shunts 
and loss of sympathetic vasoconstrictor tone allows these vessels to stay open with blood flow 
by-passing the capillaries. Paradoxically patients are seen to have a warm, pink and dry foot, 
as total skin circulation may be normal or over perfused (Schramm et al., 2006).  This 
accounts for similar TcpO2 values recorded in diabetics as non-diabetics with PAOD (Junger 
et al. 1989; Creuzig et al. 1991) while capillary circulation is markedly reduced. Jorneskog et 
al named this ‘chronic capillary ischaemia’, (Figure 15) (Jorneskog, 2012).  These 
neuroischaemic features of the diabetic foot make typical symptoms such as rest pain and 
pallor less common. Certainly the diabetic circulation cannot initiate a hyperaemic response to 
further increase flow during periods of increased requirements such as ulceration or tissue 
necrosis.  Patients should be screened regularly to identify insidious loss of this sensation and 
is crucial for preventing further deterioration in high-risk feet.  
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Figure 15: Chronic capillary ischaemia in the diabetic foot.  1) Thermoregulating arteriovenous (AV) shunts are innervated 
by the sympathetic nerve system.  In diabetes, autonomic neuropathy may lead to denervation of the AV shunts, which loose 
their normal contraction leading to blood passing through these shunts instead of the capillaries. 2) Endothelial dysfunction 
with a disturbed balance between endogenous vasodilators and vasoconstrictors leading to precapillary vasoconstriction 3) 
Hemorheological alterations such as elevated levels of plasma fibrinogen (Jorneskog, 2012). 
 
Furthermore, injury and damage to the foot is much more likely as sensation is deficient in 
peripheral neuropathy and anatomy and weight bearing dynamics of the foot are altered, 
further increasing the risk of ulceration (Lepantalo et al., 2011).  Structural diabetic 
microangiopathy also serves to increase capillary leakage and venous pooling, thereby further 
impairing oxygen delivery to the tissues.  Reduced inflammatory response to tissue injury and 
decreased resistance to infection increases the risk of foot ulcer and infections for diabetic 
CLI patients. Impaired sensory feedback means that the ischaemic process progresses silently 
(Lumsden et al., 2009).  These complex processes and haemodynamic changes are difficult to 
detect with conventional assessment alone, such as ankle and toe pressures (Jorneskog, 2012). 
%
Methods of assessing DPN  
 
There are several well-defined screening methods to assess the functional integrity of sensory 
fibres through light touch, pressure or vibration sense (Goldberg and Lindblom, 1979).  
Assessment of the presence or absence of neuropathy and/or the degree of neuropathy present 
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can be used reliably to predict the likelihood of foot ulceration (Young et al., 1994).  Clinical 
examination is supplemented with non-invasive screening tests such as the10g Semmes-
Weinstein Monofilament (SWM) to assess touch/pressure sensation, the Rydel-Seiffer tuning 
fork for vibration sense and a Neurothesiometer to quantitatively assess vibration perception 
threshold.  In addition, electrophysiological studies of peripheral nerve function can be 
employed to look for attenuation of evoked nerve action potentials.  
 
Neurothesiometer 
 
The Neurothesiometer is an electromechanical instrument used to objectively evaluate 
sensory function in large and myelinated nerve fibres, by delivering vibrations of increasing 
strength (Krishnan et al., 2004, O'Neill et al., 2006).  An increased VPT value (the lowest 
voltage at which vibration can be detected at least 50% of the time) (Garrow and Boulton, 
2006) is one of the first clinical signs of peripheral neuropathy (van Deursen et al., 2001).  It 
is quick, portable and relatively inexpensive (Thomson et al., 1992).  Quantitative sensory 
testing has been shown to have a higher positive predictive value in detecting abnormalities 
than by clinical examination alone, thus it can be used to detect and monitor neuropathic 
progression (Abbott et al., 1998, Miranda-Palma et al., 2005).  However, patients do need to 
be motivated and focused to comply with the testing, in order to achieve accuracy.   
 
It is thought to relate better to clinical function than the non-parametric tests such as the 
standard non-graduated 128Hz tuning fork, which is only able to grossly identify the presence 
or absence of vibration perception, rather than the amplitude at which vibration is perceived 
(Garrow and Boulton, 2006).  Kastenbauer et al and O’Neil et al showed that there was high 
agreement in vibration perception threshold (VPT) on the great toe pulp of diabetics between 
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these two devices, but there was greater inter-investigator agreement for the neurothesiometer 
than for the graduated tuning fork (O'Neill et al., 2006, Kastenbauer et al., 2004).  
Furthermore, VPTs procure a higher positive predictive value for ulceration than SWM. 
(Garrow and Boulton, 2006) Incidentally, VPTs were also higher in patients with higher 
HbA1c’s and a longer duration of diabetes (Kastenbauer et al., 2004).  This correlation was 
also found by Bril and Perkins in a larger cohort n=478 (Bril and Perkins, 2002). 
 
Young et al conducted a prospective study and illustrated that a VPT value of >25V in at least 
one foot was associated with a high cumulative incidence of neuropathic ulceration compared 
to patients with a VPT of <15V (19.8% vs. 2.9%, p<0.01) (Young et al., 1994).  This was 
further substantiated by a large prospective multi-centre trial (n=1035), confirming that VPT 
was an independent prognostic factor for foot ulceration in patients with established DPN, 
with a seven-fold risk for foot ulceration >25V and a 5.6% increase in the hazard of a first 
foot ulcer for every 1V increase thereafter (Abbott et al., 1998, Frykberg et al., 1998).  The 
monofilament was not found to have the same predictive properties.  High sensitivity is 
reported for VPTs at 92%, while the specificity appears much lower at around 39%, although 
appreciably over caution with good foot care and education as a result is not harmful 
(Miranda-Palma et al., 2005).  Accordingly, Rayman et al found significant differences in 
VPT (12.0, IQR7.9-18.6V vs. 51.0, IQR40.0-51.0V) and VDT (21.0, IQR19.3- 22.3 vs. 26.0, 
IQR 22.6-26.0) p<0.0001, in diabetic patients with and without existing ulceration using the 
neurothesiometer (Krishnan et al., 2004). 
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Bril and Perkins also found that VPT values correlated strongly with the electrophysiological 
parameters, specifically sural nerve action potentials, which in turn corresponds with 
structural nerve abnormalities observed in diabetics (Bril and Perkins, 2002). 
 
The VPT increases with age, implying an additional age-related neuropathy (Frykberg et al., 
1998, Goldberg and Lindblom, 1979, Williams et al., 1988, Bergin et al., 1995, van Deursen 
et al., 2001, Kastenbauer et al., 2004).  Bloom calculated estimates of centiles in relation to 
age in 519 non-diabetic subjects (see Figure 16 below).  The data was arranged as centiles 
according to age.  There was a linear relationship between the log transformation of the 
threshold readings and age. Interpretation of VPT in the elderly is much more difficult due to 
the broader ‘normal range’ of VPT in this group.   
 
 
Figure 16: Mean and range of vibration threshold with age (2.5 and 97.5 
centiles enclose 95% range) (Bloom et al., 1984). 
 
It is important to recognise that vibration sensitivity is age dependent so that normal and 
pathological thresholds can be distinguished. Interestingly, Karvestedt et al conducted a 
population-based study on type two diabetics and as well as substantiating the link between 
DPN and age, they also found that it was independently associated with retinopathy.  Patients 
with retinopathy have a longer disease history and also poor glucose control, which may 
explain the preponderance for more associated complications.  Furthermore, the alliance 
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between evidence of DPN and peripheral vascular disease +/- ulceration was particularly 
prominent in patients who did not have associated retinopathy.  This suggests a causal link 
with macrovascular, as well as microvascular disease in the pathophysiology of DPN. 
(Frykberg et al., 1998) Equally, the presence of peripheral pulses in diabetics has been shown 
to be protective for ulceration (p=0.000) (Frykberg et al., 1998). 
 
Using the biothesiometer, an earlier device, Williams et al demonstrated wide variation of 
VPTs between different sites in the same subject, both ipsilateral and contralateral.  They used 
a comparatively younger, but wider age range of 15-65years than Bloom. The variability was 
however less among non-diabetics, as expected if there is an element of neuropathy present 
(Williams et al., 1988).  Although there was variation between the same sites on different 
sides of the body in all individuals (-30%), there was still a highly significant positive 
correlation between the two sites overall (r=0.85).  Other investigators have also found 
correlation between different limbs, at the same site (Cassella et al., 2000, (Bloom et al., 
1984, Thomson et al., 1992).  Williams does not specifically make reference to consecutive 
readings at each site, although the methodology of the two studies differs, with the Williams 
disregarding the first set of readings, which may potentially alter overall accuracy.  In 
contrast, Bril et al only found the variability to be between 6-8% using the neurothesiometer 
on the toes, concluding that it was in fact reflective of peripheral nerve function (Bril et al., 
1997).  It should be noted that much of the data using a biothesiometer, not a 
neurothesiometer, was attained greater than twenty years ago and this had inherent 
discrepancies in calibration, electrical safety and sensitivity at both higher and lower voltages.  
The more recent neurothesiometer should have alleviated many of these concerns (Thomson 
et al., 1992, Williams et al., 1988, van Deursen et al., 2001).      
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As far as different anatomical locations are concerned, the evidence is quite unanimous that 
distinct sites such as finger, ankle, toe, will provide different readings (Armstrong et al., 1998, 
Bloom et al., 1984, Dimitrakoudis and Bril, 2002, Goldberg and Lindblom, 1979, Thomson et 
al., 1992, Williams et al., 1988).  Variation in stiffness of different tissues will affect the 
mechanical impedance from the neurothesiometer and is therefore likely to affect the 
vibration experienced, potentially explaining some of the variability.  Testing should therefore 
take place in identical locations for comparison and multi-site testing is unlikely to yield a 
large benefit. 
 
Comparison of VPT at least 6 weeks following revascularisation, in 56 patients with insulin 
dependent diabetes, did not show any improvement from pre- to post-intervention, despite a 
significant increase in transcutaneous oxygen tension (Veves et al., 1996). 
 
Which control mechanisms are affected? 
 
Basal flow and frequency analysis 
 
Commonly, resting basal flow has not been shown to be different between diabetics and 
controls using LDF, nor in patients with diabetes and PVD (Forst et al., 1998, Rayman et al., 
1986, Jorneskog et al., 1995, Parkhouse and Le Quesne, 1988).  
 
Analysis of basal flow for its oscillatory components using wavelet analysis has not shown 
any significant differences between diabetic patients and controls, with or without PAD 
(Urbancic-Rovan et al., 2006).  In general lower values were observed in diabetics compared 
with controls, which may be due to the large compensatory reserve of the skin in its basal 
state. However, a positive correlation was identified between ankle and brachial systolic 
 
 
71 
pressure and endothelial activity in the diabetic group.  This was not identified in the control 
group suggesting that systemic pressure may have a greater influence on endothelial activity 
in diabetic disease (Urbancic-Rovan et al., 2006).  In contrast, Jaffer et al used fast Fourier 
transformation in spectral analysis of resting vasomotion and found that the frequency was 
significantly raised in diabetes compared to controls (Jaffer et al., 2008). 
 
Veno-arteriolar Reflex 
 
Peripheral neuropathy affects both the somatic and autonomic nerves.  Consequently, the 
sympathetically mediated VAR is attenuated in diabetics, approximately one third of the 
response expected in healthy individuals (Abularrage et al., 2005, Wahlberg et al., 1990).  The 
subsequent increase in transmural pressure causes an increase in arteriovenous shunting with 
increased capillary pressure and long-term effects such as thickening of the basement 
membrane and dysregulation of microvascular function prevails (Cacciatori et al., 1997). 
 
In a cohort of 47 insulin diabetics without PAD, significant correlation was found between 
vibration perception thresholds suggesting impairment of large somatic fibres, and VAR, 
impairment of peripheral sympathetic fibres (Cacciatori et al., 1997).  This was progressive 
through from controls, to patients with out clinical signs of neuropathy to those with overt 
foot ulceration (p<0.001).  Even those patients with diabetes but without clinical evidence of 
neuropathy demonstrated an impaired VAR, despite similar resting values (Cacciatori et al., 
1997).  The investigators were careful to measure VAR with the patient in the supine position 
and the leg lowered below the level of the heart to ensure central mechanisms were not taken 
into account.  Evidence of this impaired mechanism is also apparent in post-pubertal children 
with diabetes compared to their healthy peers (Shore et al., 1994).  In this instance no 
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association was found with diabetic control or duration of diabetes and it had manifested 
before any clinically detectable microvascular complications. 
 
Belcaro et al studied 300 subjects, equally divided between control and diabetic with/out 
neuropathy.  They found the VAR to be 13% in diabetics with neuropathy, 28% in those 
without neuropathy and 46% in control subjects (p<0.02) (Belcaro et al., 1992).  On review of 
these patients 3 years later, the VAR was further attenuated, with an associated increase in 
capillary filtration in both groups of diabetics.  They did not assess peripheral oedema in this 
group to see if this was allied to greater capillary filtration. 
 
Most papers have excluded PAD as a potentially conflicting variable in assessing the 
microcirculation in diabetes. Wahlberg et al specifically looked at VAR in PAD (claudicants 
and CLI) patients with and without diabetes. On dependency, the reduction in flow of the 
diabetic group was one third of the reduction seen in the controls and in the PAOD group the 
average flux actually increased by a small amount (Wahlberg et al., 1990).  This may be 
explained by the higher resting flux that was initially observed in the diabetic group when 
supine, thereby being unable to further increase flow on dependency.   
 
Microcirculatory Control Mechanisms 
 
Functional changes in the endothelium occur early in the pathogenesis of diabetes and even 
those with a family history and at increased risk of developing diabetes show reduction in 
vessel reactivity compared to controls, at the foot and the forearm, using iontophoretic 
techniques and heating of the skin (Arora et al., 1998, Caballero et al., 1999, Hamdy et al., 
2001, Tooke et al., 1983).  Impairment in vasodilatory responses including post-occlusive 
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reactive hyperaemia is representative of the normal response to injury and is therefore 
important when considering wound healing even in the absence of large vessel disease.   
Neuropathy renders the foot functionally ischaemic as blood flow fails to increase during 
periods of stress (Schramm et al., 2006). 
 
Nerve-Axon Reflex 
In addition to the endothelium-dependent pathways, impairment of the nerve-axon reflex 
mechanism contributes significantly to impaired vasodilatation in this population (Arora et 
al., 1998, Schramm et al., 2006, Veves et al., 1996).  By monitoring capillary blood flow 
following neurovascular stimulation with acetylcholine, Forst and colleagues found that flow 
increased significantly in the control group and in diabetics without clinical neuropathy and 
did not increase significantly in those with neuropathy.  These findings were attributed to loss 
of nociceptive C fibre function in the neuropathic group (Forst et al., 1998).  Disturbances in 
capillary flow in the foot using video capillaroscopy were evident in diabetic patients 
following arterial occlusion (Jorneskog et al., 1995).  However, the total skin blood flow 
assessed by LDF was normal, suggesting redistribution via the AV anastomotic network in 
these patients due to impaired nerve-axon pathway.  Stansberry et al likened this 
neurovascular deterioration in diabetics to advancing age in non-diabetics, when they tested 
vasoconstriction and dilatation at the finger with LDF and found that blood flow in younger 
diabetics was similar to that of older controls (Stansberry et al., 1997).  Rayman and 
colleagues found that an impaired hyperaemic response to minor thermal and needle trauma 
was related to duration of type I diabetes (Rayman et al., 1986).  This occurred at sites on the 
feet and on the abdominal wall, suggesting a global impairment of the microcirculation.  It is 
unclear whether the severity of impairment is a result of a reduction on vasoactive mediators, 
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structural microvascular abnormality limiting vasodilatory capacity or indeed a combination 
of these.  
 
Local Heating  
Analysing hyperaemia in diabetic patients with and without foot ulceration by their response 
to heating, did not declare a difference between the two groups.  There was only a notable and 
statistical difference between control and diabetics overall, rather than the subgroups.  The 
neurological parameters however did discriminate between patients with and without 
ulceration (Krishnan et al., 2004). 
 
Reactive Hyperaemia 
The hyperaemic response of the microcirculation to stimuli is attenuated in the diabetic 
population compared to healthy controls. Jaffer et al used a three-minute cuff occlusion time 
in a prospective case controlled study and found that both the percentage increase in flux from 
baseline (234±62 vs. 453±155%, p<0.001) and the time to peak (21.4±0.4 vs. 12.8±5.4sec. 
p<0.05) using LDF, were significantly different compared to controls (Jaffer et al., 2008).  
However, the coexistence of peripheral neuropathy and peripheral vascular disease has not 
been shown to further reduce endothelium-dependent vasodilatation any further than 
neuropathy alone (Schramm et al., 2006).  In a single study specifically looking at the 
interaction between PAOD patients with and without diabetes, it was found that patients with 
diabetes had a shorter time to peak when compared to patients without diabetes (Wahlberg et 
al., 1990).  This may be explained by the rigid nature of the diabetic vessels and the 
propensity of the pressure wave down it giving rise to a primary peak prior to the onset of the 
formal red cell flux.  When the hyperaemia was repeated in the sitting position both PAOD 
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groups with and without diabetes had a significant increase in flux, in contrast to the reduction 
seen in the controls indicating the passive nature of filling in the vascular bed in patients who 
do not exhibit pre-capillary constriction (Wahlberg et al., 1990). 
 
It is the case with all of these studies that many patients are excluded due to coexisting 
morbidities such as peripheral vascular disease and hypertension and the use of vasoactive 
medications.   Many reactive hyperaemia papers exclude diabetics due to their stiffer arterial 
walls exhibiting a shorter Tp (Wahlberg et al., 1994). 
 
DIABETES: 
o Neuropathy is the result of a functional disturbance or pathological change, 
due to impaired endothelial function and impaired C-fibre axon reflex dilation. 
o Impaired sympathetic vasoconstrictive responses to a variety of stimuli 
including postural change 
o Impairment in vasodilatory responses including post-occlusive reactive 
hyperaemia 
 
 
The microcirculation is a complex and dynamic environment, intimately associated with the 
macrocirculation.  Normal homeostatic mechanisms to maintain local pressure and perfusion 
are affected early by ischaemia and are initiated before the onset of clinical signs and 
symptoms and are not amenable to detection through routine pressure measurements.  
Parameters of microvascular dysfunction are numerous and will often correlate with severity 
of disease, such as reactive hyperaemia and time to peak.  Attenuation of mechanisms such as 
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PVC can potentially result in significant limb oedema and exacerbate nutrient exchange and 
integrity of the tissues. Diabetic patients represent an increasingly challenging cohort as 
neuropathy renders the foot functionally ischaemic and can complicate interpretation of 
microcirculatory investigations.  Specialist attention is required in disease detection and 
instigating the appropriate treatment pathway if prognosis is to be improved. 
 %%Summary%
 
The table below broadly summarises the changes observed in the microcirculation in patients 
with CLI, with diabetes and those who have both CLI and diabetes.  Of note, lower limb 
oedema in the diabetic population is not differentiated from patients with or without CLI in 
the literature. 
 
Variable CLI Diabetes CLI & Diabetes 
Basal Flux ↓ → → 
Reactive Hyperaemia ↓ ↓ Shorter Tp 
VAR ↓ ↓ → 
Oedema >50% NC NC 
 
Table 8: Summary of changes in microcirculatory control mechanisms in CLI and in diabetes compared to controls and in 
patients with CLI AND diabetes compared to CLI alone. ↓attenuated, → the same response as comparative group. NC, not 
specifically commented on in literature. 
 
 !
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1.5!Treatment 
Recommendations 
 
CLI is treated with revascularisation of the limb, either with endovascular or open surgical 
techniques.  Appropriate treatment is dependent upon the outcomes of the haemodynamic, 
physiological and anatomical assessments and the availability of autogenous conduits.
 
The TASC II classification categorises patients based on: 
 Anatomical distribution of disease 
 Extent of disease - multiple vs. single level 
 Degree of stenosis/occlusion (Table 9) 
 
The recommendation for treatment of choice is endovascular with TASC A classification and 
the preference progresses to surgery as the level and severity of disease progresses.  The long-
term prognosis and patient survival are directly related to the extent of the disease (Conte, 
2010a). 
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Classification Femoro-popliteal lesions Aorto-Iliac lesions 
TASC A 
 
-Single stenosis <10cm in length 
-Single occlusion <5cm in length 
-Unilateral or bilateral stenoses of CIA 
Unilateral or bilateral single short stenosis ≤3cm 
of EIA 
TASC B 
 
-Multiple lesions (S or O) ≤5cm in 
length 
-Single S or O ≤15cm not involving 
infragenicular PA 
-Single or multiple lesions in the 
absence of continuous tibial vessels to 
improve flow for a distal bypass 
-Heavily calcified occlusion ≤5cm 
- Single popliteal stenosis 
Short ≤3cm stenosis of infrarenal aorta 
-Unilateral CIA occlusion 
-Single or multiple stenosis totalling 3-10cm 
involving EIA & not extending into CFA 
-Unilateral EIA occlusion not involving the 
origins of IIA or CFA 
TASC C 
 
-Multiple S or O totalling >15cm 
with/out heavy calcification 
-Recurrent stenoses or occlusions that 
need treatment after 2 endovascular 
interventions 
 
-Bilateral CIA occlusions 
-Bilateral EIA stenoses 3-10cm long not 
extending into CFA 
-Unilateral EIA stenosis extending into CFA 
-Unilateral EIA occlusion that involves the origins 
of IIA and/or CFA 
-Heavy calcified unilateral EIA occlusion with/out 
involvement of origins of IIA and/or CFA 
TASC D -Chronic total occlusions of the CFA or 
SFA (≥20cm involving PA) 
-Chronic total occlusions of PA and 
proximal trifurcation vessels 
 
-Infrarenal aortic occlusion 
-Diffuse disease involving aorta & both iliac 
arteries requiring treatment 
-Diffuse multiple stenoses involving the unilateral 
CIA, EIA, CFA 
-Unilateral occlusions of both CIA & EIA 
-Bilateral occlusions of EIA 
-Iliac stenoses in patients with AAA requiring 
treatment & not amenable to endograft placement 
or other lesions requiring aortic or iliac surgery 
 
Table 9: TASC II classification of iliac and femoro-popliteal arterial lesions. S – stenosis, O – occlusion, AAA – abdominal 
aortic aneurysm, CIA – common iliac artery, EIA – external iliac artery, IIA – internal iliac artery, CFA – common femoral 
artery, SFA – superficial femoral artery, PA – popliteal artery (Norgren et al., 2007). 
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In addition, the co-morbid status of the patient is of crucial importance.  They are a high-risk 
group of patients that often have significant disease in other vascular beds, limiting their 
lifespan and their ability to withstand high-risk procedures.  There should be a clear aim to the 
treatment, which may include wound healing, limb salvage, ambulation, and/or long-term 
patency.  The aim should be consistent with the expected longevity of the patient (Bradbury et 
al., 2010).  Primary amputation should be reserved for cases that are non-salvageable due to 
extensive tissue loss or those with limited functional capacity. Timely decisions regarding 
primary amputation however, can reduce associated morbidity and mortality if appropriate 
rehabilitation is put in place (Dawson and Mills, 2007). 
 
Treatment Comparison and Outcome Measures 
 
The goals of treatment for CLI include the restoration of pulsatile, inline flow to the foot to 
assist wound healing, the relief of rest pain, the avoidance of major amputation, preservation 
of mobility and improvement of patient function and quality of life (Lumsden et al., 2009, 
Subherwal et al., 2012).  The composite outcome of limb salvage and survival (amputation 
free survival AFS) is a commonly used outcome measure (Conte, 2010a).  These goals are 
predominantly achieved with endovascular or open surgical techniques; although attempts at 
medical therapies have been tried and biological treatments are under investigation.  Bypass 
with autogenous vein is still considered to be the gold standard (Conte et al., 2009, Conte et 
al., 2006).  The morphology of the arterial lesion (e.g. site, length, type) and the patient 
characteristics influence the treatment and prognosis (Muradin et al., 2001). 
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Outcomes of recanalisation procedures can be measured using clinical endpoints or quantified 
from a haemodynamic standpoint. The table below summarises commonly used outcome 
measures: 
 
 
 
 
 
 
Table 10: Outcome measures following revascularisation 
 
Clearly, clinical outcome measures are easily accessible to record and are of paramount 
importance to the patient.  Haemodynamic markers assess the magnitude and durability of any 
improved perfusion to correlate with treatment efficacy (Conte, 2010a).  What is sometimes 
difficult to address is whether there is a direct relationship between outcomes and treatment 
failure, particularly with respect to limb salvage & mortality. 
 
Clinical 
 
Limb Salvage  
 
Limb salvage or amputation free survival has traditionally been the benchmark of successful 
revascularisation in CLI. Whilst they are crude markers of success they are easy to measure 
and encompass the primary aim of treatment of CLI; limb salvage.  It assumes that 
amputation rates will reduce as successful revascularisation procedures increase.   
 
 
Outcome Endpoint Measure 
CLINICAL Limb salvage Amputation 
Amputation-free survival 
 Anatomical 
 
Patency rates 
 
 Reintervention Reintervention rates 
 
 Patient perspective 
 
Symptom relief 
Quality of life 
HAEMODYNAMIC Haemodynamics 
 
Pressures 
 
 Physiology 
 
Tissue perfusion 
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Patency Rates  
 
Patency rates measure the success of the intervention itself and can be considered as primary 
or secondary patency depending on the requirement for reintervention.  A radiological 
residual stenosis of <30% would be considered ‘patent’.  However, closure of surgical grafts 
or restenosis of an angioplastied vessel does not always represent failure if wounds have 
healed or rest pain has been resolved.  Limb salvage rates have been shown to exceed graft 
patency rates and not all limbs become re-threatened (Dawson and Mills, 2007, Dorros et al., 
2001).  Patency rates vary depending on the anatomical site and severity of disease, and the 
type of graft material used (Conte, 2010a).  Reintervention free survival takes into account the 
need for secondary procedures and is an important outcome which few studies make reference 
to.   
 
Patient Perspective  
 
Symptom relief is an important outcome measure.  Amelioration of pain and wound healing 
are key and are not always synonymous with patency rates.  Quality of life outcomes show a 
marked improvement in those patients who undergo successful revascularisation and 
consequently require less hospital care (Adam et al., 2005).  Increases in walking distance or 
improvements in mobility are seldom recorded. 
 
 
Haemodynamics 
 
Pressures 
 
Following a successful intervention, it seems intuitive that a post-intervention increase in 
ABPI’s of at least 0.1 would signify an increased perfusion pressure and therefore an 
efficacious outcome.  The increase often occurs in the first 24 hours but maximal 
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improvement can take up to one month.  Jelnes and Wagner both showed a clear improvement 
from baseline ABPI following open (p<0.001) and endovascular (p<0.05) treatment 
respectively, in a mixed cohort of claudicants and CLI patients (Jelnes, 1986, Wagner et al., 
2003).  Saucy et al demonstrated a mean ABPI rise of 0.4 to 0.8, p0.002 following successful 
surgical revascularisation in CLI and an associated rise in toe pressures from 21 to 40mmHg, 
p0.001, in the immediate post-operative phase (Saucy et al., 2006).  In a cohort of claudicants 
undergoing PTA, Husmann and colleagues however found that ABI was not significantly 
different up to six months post-intervention compared to pre-intervention (0.89, r0.72-1.10 vs. 
0.71, r0.52-0.85 respectively) (Husmann et al., 2006).  
 
ABPI is, of course, still subject to the same problems that it suffers when diagnosing CLI, 
particularly in regard to mediocalcinosis and its inability to identify disease distal to the cuff 
and the overall circulation of the foot. It may therefore, not be a sensitive indicator of 
predicting success and patency in the longer term.  In a study by Ray et al looking at 
outcomes of 41 patients with CLI (Fontaine stage III and IV), toe pressure measurements 
before the intervention were similar in patients who showed a clinical response to treatment 
and those that did not benefit at six months (19.4±20.4 vs. 20.0±20.8, NS). The positive 
predictive value of a toe systolic pressure <30mmHg was 21% (Ray et al., 1997a).  Equally, 
pre-intervention ABPI’s did not correlate with clinical outcome at six months either 
(0.35±0.24 vs. 0.27±0.27) (Ray et al., 1997a). 
 
ABPIs have been adopted by some as a clinical screening tool for surveillance of grafts or 
angioplastied vessels.  The intention is to increase detection of disease progression and those 
requiring further screening or observation. However, they are not very specific in detecting 
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those grafts, which may be at risk of failure (Wyatt et al., 1990).  A large retrospective study 
of 270 infrainguinal bypasses, demonstrated a poor predictive value for ABPI <0.2 and ankle 
pulse volume recording (APVR) <5mm on detecting either early or late graft closures 
(Samson et al., 1985).  Furthermore, it is not sensitive in predicting wound healing as there 
was shown to be no significant difference in the ABPI between those whose ulcer did and did 
not heal (Castronuovo et al., 1997). 
 
Normalising perfusion of the large vessels may only be one part of a multifaceted process and 
may not reflect transformations that occur in the microcirculation in CLI.   
 
Improvements%in%Outcome%Measures!
 
Conventional treatment outcome measures have focused on clinical and haemodynamic 
markers of success, which have not shown a longer-term predictive value or correlation with 
patency or symptom relief.  The adaptive microvascular changes and endothelial dysfunction 
that occur in critical ischaemia are well documented and contribute significantly to the clinical 
picture, but are not delineated by these methods. Whether these microcirculatory changes are 
reversible or permanent affects the clinical outcome and directly measuring them is a useful 
complement to the established techniques to detect success of treatments in terms of skin 
perfusion (Norgren et al., 2007). 
 
 
Physiology: skin perfusion pressure 
 
Restoration of microcirculatory flow after a period of occlusion is measured using a laser 
Doppler to detect the blood pressure at which this occurs.  CLI is distinguished by a SPP of 
<30mmHg.  Whilst it has been shown to be a reliable, non-invasive method of detecting 
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severity of disease and predicting ulcer healing, its continued monitoring following 
intervention is under utilised.   
 
A novel angiographic technique suggested as an early surrogate marker of limb salvage is 
‘wound blush’, comprising contrast opacification of the vessels around the wound 
immediately after endovascular treatment (Utsunomiya et al., 2012).  In 93 limbs with 
Rutherford 5 or 6 disease, this correlated with limb salvage at one year and also with a higher 
pre-intervention SPP 26.1±12.4mmHg vs. 20.9±8.5mmHg, p0.027. This phenomenon may 
characterise patients with preservation of their microcirculatory function (Utsunomiya et al., 
2012). 
 
Surgery 
 
Patients requiring surgical management are a particularly challenging group, as peri-operative 
morbidity and mortality is high and long-term patency rates can be poor.  Whilst procedures 
can be performed under local anaesthesia, regional or general anaesthetics are commonplace. 
A period of stay in hospital is required, in the region of five to ten days, and may be longer in 
patients who need more extensive rehabilitation or suffer complications.  In the BASIL trial 
the 30-day mortality rates were equal between the two arms but the surgical group suffered 
higher morbidity with longer hospital stay, a two-fold increase in myocardial infarctions and a 
three-fold increase in the risk of stroke (Falluji and Mukherjee, 2012). 
 
Whilst there is no uniform or successful way to predict whether grafts will remain patent, 
good general principles can be applied to increase the chances of success. If the graft fails in 
the short term it is usually due to a technical failure.  Embolectomy or graft revision can be 
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performed but subsequent risk of failure remains high.  In the longer term 30-50% of lower 
extremity bypasses are reported to stenose or occlude within three to five years (Rutherford, 
2000).  Inflammatory, haemodynamic and humoral injury have been cited as causes (Conte et 
al., 2006). 
 
Grafts should preferentially be performed using an autologous venous conduit such as the 
long saphenous vein, which has superior patency to cephalic or short saphenous vein at one 
year (64.4% vs. 51.5% respectively) (Conte et al., 2006).  Thromboembolic complications 
occur more frequently with prosthetic grafts, especially when they are used more distally and 
are significantly inferior to vein grafts at any level (66% vein vs. 33-47% below and above 
knee PTFE respectively at 5 years) (Beard, 2008).  Furthermore, they should not be used in 
the presence of active infection in the bone or soft tissue.  The length and diameter of the graft 
also have an effect on long-term patency; with smaller (<3mm) and shorter (<40cm) vein 
grafts achieving lower patency rates at one year (diameter <3mm 42.4% and >3mm 68.4%, 
length <40cm 69.0% and >60cm 53.7%) (Conte et al., 2006). 
 
The inflow and outflow should ideally be continuous with the pedal circulation to further 
augment success rates (Dawson and Mills, 2007).  High vascular outflow resistance makes it 
more likely that the graft will fail.  Inflow procedures can be performed in conjunction with 
bypass grafts, as can vessel endarterectomy.  Complex, multi-level disease may necessitate 
sequential ± composite grafts to more than one outflow vessel. 
 
Complications of surgery are early and late and include wound or chest infection, bleeding, 
myocardial infarction, stroke, graft failure and limb loss. 
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Endovascular 
 
Until the latter two decades of the twentieth century it was conventional for all patients with 
CLI to be offered treatment with open arterial bypass surgery, which had been an established 
and effective technique since the 1950’s, by surgeons including Kunlin and Hall (Goodney et 
al., 2011, Friedman, 2005).  This policy reflected the absence of any alternative therapeutic 
options but it has been increasingly challenged over 20-30 years by the development of 
endovascular-based approaches.  As a consequence, the number of infrainguinal bypass graft 
performed over the last decade has reduced significantly and the versatility of endovascular 
devices has developed (Beard, 2008).  Advances in endovascular approaches in terms of 
imaging, equipment and technical ability have allowed greater numbers of patients to be 
deemed ‘suitable’ for this treatment and for more complex disease to be treated by minimally 
invasive methods. The term ‘endovascular’ encompasses percutaneous balloon angioplasty 
and more complex techniques, including an armamentarium of stents (un/covered, medicated) 
or atherectomy devices to improve success rates.  The superiority of covered vs. uncovered 
stents has not been demonstrated nor a consistent and proven benefit of other accessory 
devices such as atherectomy balloons and laser (Beard, 2008, Lumsden et al., 2009).  
Angioplasty can be performed using conventional anatomic luminal techniques or newer sub-
intimal techniques to treat long segment lower extremity disease, involving femoro-popliteal, 
crural or pedal levels. By directing a more flexible wire intentionally out of the lumen in a 
subluminal passage, very diffuse and/or calcified disease can be crossed before directing the 
wire back into the true lumen.  The changes in clinical practice and new data available have 
rendered some of the TASC criteria out of date (Adam and Bradbury, 2007).  That said, 
approximately one quarter of CLI patients may not be amenable to endovascular 
revascularisation because of unsuitable anatomy (Lumsden et al., 2009). 
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The advantages of angioplasty may be substantial in cohorts of patients with considerable co-
morbidities.  Firstly, the procedure is performed under local anaesthetic and therefore does not 
necessitate a general or regional anaesthesia or impose the stresses of surgery.  Most cases can 
be performed as a day case.  It can treat both inflow and outflow disease.  The technical 
success rates for endovascular procedures are high; however, longer-term success is more 
intangible, particularly in the CLI population. Certainly the techniques do not tend to be as 
durable as bypass surgery if the disease is very distal, involves a long segment, or is very 
extensive (Dawson and Mills, 2007).  As one might expect stenotic compared to occlusive 
disease is more amenable to successful intervention, which often delineates claudicants from 
critical limb ischaemia.  
 
Kandarpa et al reported a technical success rate of 90% and 75% in CLI patients with 
occlusions and stenoses respectively.  However at one-year patency rates were 62% at one 
year and 54% at 3yrs in those treated for stenotic disease and 26% and 18% at 1 and 3 years 
in those treated with occlusion (Kandarpa et al., 2001).  Focal disease, in non-calcified 
vessels, with restorable run-off vessels is preferable for this treatment option, rather than 
diffuse disease with compromised distal vessels (Dawson and Mills, 2007).  That said, 
interventions in below knee vessels area being increasingly used for treatment of CLI (see 
infrapopliteal section) (Clair et al., 2012). 
 
Most reports of ‘success’ following angioplasty are made on clinical grounds from resolution 
of clinical symptoms or limb salvage, and morphologically from immediate technical success 
and long-term patency with serial ultrasound scans. A residual stenosis <30% is generally the 
accepted level of success.  If the procedure is deemed to have ‘failed’ in the longer term it 
 
 
88 
may still provide enough distal perfusion to aid healing or resolve rest pain, particularly if it is 
single-level disease and has been described as a ‘temporary bypass’ to provide wound healing 
and limb salvage by Met et al (Met et al., 2008).  This phenomenon is brought about by the 
discrepancy between vessel patency and limb salvage rates in the endovascular cohort. In a 
systematic review of subintimal angioplasty Met et al found a technical success rate of 80-
90% in infrainguinal vessels, with primary patency rates of 50% at one year and clinical 
success varied from 50-70%.  Limb salvage rates however, were substantially higher than this 
at one year (80-90%) (Met et al., 2008).  Of note, this review included a mixture of patients 
with claudication and CLI and the associated technical success was lower in the CLI group 
compared to the claudicants.  Failure is more likely if there is extensive disease or there are 
infected tissues (Dawson and Mills, 2007).  Furthermore, all the articles Met reviewed were 
observational studies and the materials and experience with sub-intimal angioplasty were only 
just evolving in some of the earlier papers reviewed from the 1990s. 
 
Whilst there is a significant restenosis rate in the longer term, this treatment is thought to 
preserve surgical options, if required at a later date or for additional endovascular procedures. 
However, on later analysis the BASIL trial found that a failed angioplasty and subsequent 
bypass surgery resulted in poorer outcomes than those who went straight to surgery and as 
such, should not be regarded as a risk-free procedure (Figure 17) (Conte, 2010a, Bradbury et 
al., 2010).   
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Figure 17: A) Amputation free survival and B) overall survival in patients randomised to and undergoing bypass surgery and 
in patients undergoing bypass surgery after failed balloon angioplasty (Bradbury et al., 2010). 
 
CLI multi-level disease does often necessitate multiple-site angioplasty to achieve cure 
(Lumsden et al., 2009).  Ryer et al found that 18% of patients with chronic limb ischaemia 
had recurrent stenoses (82% within 18 months) following PTA with or without stenting and of 
those 82% underwent repeat endovascular procedures, 11% had surgical revascularisation and 
4% went straight to amputation. The limb salvage rate at 12months was 86% in a mixed 
cohort (Ryer et al., 2006). 
 
Complications of endovascular management range from 8-17% and include bleeding, 
haematoma, vessels perforation, contrast-induced renal failure and emergency surgery from a 
dissection or embolus.  On a microvascular level, trauma to the arterial wall causing distal 
emboli can cause microvascular impairment (Bongard et al., 1994, Met et al., 2008). 
!
Femoropopliteal!Disease!
 
A number of adjuncts, predominantly stents, which provide a constant radial force on the 
arterial wall, are available to assist in primary patency of PTA (Lumsden et al., 2009).  A 
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meta-analysis of stent implantation and balloon angioplasty of the femoro-popliteal segment 
in PAOD, found that stents might give a more favourable outcome than balloon angioplasty in 
more severe cases of CLI (3yr patency 63-66% vs. 30-43% respectively).  The numbers of 
studies using stents in the analysis however were low as most of the stent data relates to 
claudicants (Muradin et al., 2001).  Clearly stents carry their own risk particularly in reference 
to thromboembolism and there is usually a requirement for subsequent antiplatelet agents.  In 
addition, most stents are used based on the anatomy of the lesion rather than the patient 
characteristics and symptomatology, making comparison of outcomes difficult.   
%
Infrapopliteal!Disease%
 
Angioplasty below the knee was traditionally reserved for life and limb-threatening disease 
due to the likelihood of occluding the tibial vessels and rendering the limb non-viable.  Whilst 
this still remains a significant risk, the procedure has been shown to be effective with 
technical success rates approaching 100% in some studies (Lumsden et al., 2009).  Primary 
patency rates however, vary greatly with reports from 13%-81% at one year and stenoses tend 
to do better then occlusive lesions, as one may expect (Lumsden et al., 2009).  As with 
femoropopliteal disease, longer lesions are most often approached with sub intimal 
recanalization whereas stenoses and short occlusions are generally managed with intraluminal 
angioplasty.  
 
Primary stent treatment of infrapopliteal lesions has been used with array of success with the 
aim of securing inline flow to the foot. Proximal crural lesions have better one-year patency 
and limb salvage rates than more distal lesions (85.1% and 48.5% patency and 100% vs. 
81.8% limb salvage respectively) usually as vessels tend to be more tortuous and calcified 
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more distally (Lumsden et al., 2009).  Accordingly, technical success is usually lower in 
crural interventions compared with femoral procedures (Met et al., 2008).  There are no trials 
of stent vs. surgical bypass grafts to the infrapopliteal region, which is most often required in 
critically ischaemic patients (Beard, 2008). 
 
In a series of 284 limbs that underwent tibio-peroneal angioplasty 168 (59%) of ischaemic 
limbs also required inflow angioplasty (Dorros et al., 2001).  Patients with class III disease 
were more likely to have a successful outcome than those with class IV disease (99% vs. 
90%), reflected by fewer bypasses required as secondary treatment for class III disease (3% 
vs. 16%) and a greater number of subsequent amputations in class IV patients at 5 years 
(Dorros et al., 2001).  
 
Iliac,!Femoral!and!Infrapopliteal!Disease!
 
In a retrospective cohort study by Kudo et al of exclusively 138 CLI limbs undergoing PTA, 
the 5-year primary patency was 31.4%, with assisted primary and secondary patency rates of 
75.5% and 79.6% respectively, with a limb salvage rate of 89.1%.  The low primary patency 
rate is consistent with severe occlusive disease (Kudo et al., 2005).  Nine limbs required 
major limb amputation; five (3.6%) were within 30 days and 2/3 were diabetic with 
unreconstructable distal vessels and/or advanced gangrene in all but one. Twenty-four percent 
of patients were over the age of 80years.  Average ABI was 0.4 with a range of 0.19-0.89, 
excluding 10% who had significant medial calcinosis.  Primary patency rates reduced with 
more distal disease (iliac 51.6±11.0%, fem-pop 49.4%±11.9%, below-knee 23.5%±10.7% at 
36 months).  Patients whose main lesions were distal however, were not always treated with 
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concomitant proximal angioplasty and they carried more risk factors (60% diabetic, 1/3 CRF, 
1/3 >80yrs) (Kudo et al., 2005). 
 
Most patients were TASC C (54%), 37% were TASC D and 9% were TASC B.  However, 
this study encompassed selected CLI patients who had not fulfilled the criteria for open 
surgery (1, bilateral common iliac disease 2, unilateral external iliac occlusion 3, long >10cm 
infrainguinal occlusion starting from the orifice of the SFA). In one third of cases iliac 
angioplasty was the most distal artery treated and 55% of patients only had one segment 
treated.  On univariate analysis, TASC classification was the most striking independent 
variable which significantly reduced primary± assisted patency (p0.02 & 0.0015), secondary 
patency (p0.098), clinical improvement (p0.053) and ultimately limb salvage (p0.0034).  The 
number of segments treated and the most distal vessel treated significantly affected primary 
and secondary patency but not clinical improvement or limb salvage. Of note, 9.4% 
underwent subsequent surgical revascularisation within 30days following PTA, although the 
individual details of these patients are not mentioned (Kudo et al., 2005). 
 
Certainly the long-term limb salvage rates are high in this study and PTA may simply be 
increasing the perfusion required to heal the wounds and allow collateral channels to form.  
This would be consistent with the almost 60% difference in primary patency rates and limb 
salvage at 5 years. It is however, difficult to gauge the severity of disease in this population 
given the numbers of patients who had ABI >0.4 and those who only required single segment 
revascularisation and hence whether they strictly fall into the classification of CLI.  
Consistent with mortality reports in CLI populations, only 44% of patients were alive at 5 
years and those with the most severe TASC D disease did the least well (Kudo et al., 2005). 
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Surgery and Endovascular  
 
Al-Omran et al retrospectively analysed over 27,000 endovascular and open procedures over a 
seven year period and showed that overall the 5-year survival rate for patients undergoing 
open surgery was 61.5%±0.38% compared with 69%±0.6% for those who underwent 
endovascular treatment. Furthermore, amputation free-survival at 5-year was also better in the 
endovascular group than the surgical group (92.2%±0.34% vs. 83.4%±0.37% respectively) 
(Al-Omran et al., 2003).  However, patients were not stratified according to their disease 
classification or whether they were non/critical or acute/chronic ischaemia and these two 
intervention groups have very different characteristics and anatomy of disease.  The pattern of 
disease plays a huge role in the outcome of the procedure, as demonstrated by the vast 
difference in death rates between supra-inguinal and infra-inguinal procedure survival 
outcomes of 74.7% and 56.8% respectively. They did comment that the endovascular group 
was significantly younger than the open group.  Male sex and increasing age was a common 
risk factor for risk of death to both groups and coronary artery disease and diabetes were 
significant risk factors in the surgical group.  As such, the two groups are likely to represent 
very different patient populations with different disease profiles. 
 
The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial is the only 
randomised trial to date comparing open and endovascular interventions for severe and CLI.  
It ran over a 5-year period with 27 centres, randomising 452 patients (Adam et al., 2005).  
Patients were considered eligible if they met Rutherford classification 4-6, with no strict 
haemodynamic cut-off per se, hence encompassing patients considered as severe limb 
ischaemia (SLI) as well as critical limb ischaemia (Conte, 2010a).  Of all patients presenting 
with severe/CLI, 10% considered to be in clinical equipoise with regards to the optimum 
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treatment were enrolled in the trial.  There were however, no anatomic or clinical guidelines 
considered as ‘equipoise’, and therefore the individual centres dictated this (Conte, 2010a).  
The outcomes after 2-year follow up showed that overall survival and amputation free 
survival were not statistically different between the two groups, with an increased cost 
associated with surgery.  In keeping with previous trial results on conduit material, BASIL 
found that prosthetic material was associated with significantly worse outcomes compared to 
autologous vein.  Prosthetic graft constituted 25% of the surgical group.  Post hoc analysis ten 
years on has demonstrated notably enhanced clinical outcomes in the group randomised to 
surgery.  Seventy percent of patients survived beyond 2 years and in this group overall 
survival and amputation free survival increased. (Bradbury et al., 2010) 
 
Skin%Control%Mechanisms%after%Treatment%
 
The assessment of skin microcirculation has a predictive capability in patients with non-
reconstructable disease and whether or not they will require a limb amputation over the next 
18 months (Ubbink et al., 1999).  Macrocirculatory measures such as ABPI does not offer any 
predictive capacity as all subjects share a similar reading in CLI. Combined assessment with 
capillary microscopy, transcutaneous oximetry and laser Doppler perfusion has shown 
additional capacity to distinguish those with particularly poor circulation.  With cut off values 
of capillary density <20mm2, TcpO2 <30mmHg and absent reactive hyperaemia there is a 
specificity of 87% and predictive value of 73% for amputation (Ubbink et al., 1999). 
 
The success of revascularisation in CLI is dependent on reconstituting a normal and effective 
skin microcirculation. To this end, measures of skin haemodynamics should be a useful 
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adjunct in predicting outcomes and establishing what happens to control mechanisms in the 
skin after treatment. 
 
Surgical Revascularisation 
 
Laser Doppler Fluxmetry (LDF) and Laser Doppler Imaging (LDI) 
 
In a small prospective study of ten patients undergoing infrainguinal reconstruction, with a 
pre-operative mean toe pressure of 21mmHg, a global increase was found in foot perfusion 
ten days following surgery using laser Doppler imaging (LDI) (Saucy et al., 2006).  This was 
irrespective of which crural and foot vessels were patent pre-operatively and included three 
diabetic patients.  In addition, it was associated with significant rises in ankle and toe 
pressures (p0.002 and p0.001) and subsequent ulcer healing in the affected limb.  
Interestingly, they found that skin blood flow reduced after surgery on the untreated side.  
Perhaps this was a consequence of neural stimulation from a relative increase in flow and 
pressure (see ‘VAR’ below).  This study demonstrates the importance of skin microcirculation 
as a marker of successful revascularisation, however there are no inclusion or exclusion 
criteria mentioned, nor is there a control group or comparison with limbs that have failed to 
improve and what changes occur in their microcirculation and associated haemodynamic 
measures.   Two studies used LDF fluxmetry for treatment evaluation after surgery.  One 
found that resting flux values were enhanced following surgery, but this was subject to large 
overlap between pre and post-operative values and no correlation was found with these 
measures and ABPI (Wahlberg et al., 1995).  The other found that there were no significant 
differences seen in basal flow, suggesting that this is not a discriminatory test (Delis et al., 
2001).  Using Xenon washout techniques, Eickhoff demonstrated that post-reconstructive 
hyperaemia or increased flow at rest manifested only in the presence of an attenuated VAR 
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pre-operatively (Eickhoff and Engell, 1982b).  This represents the most severely ischaemia 
group and perhaps more passive perfusion until autoregulation is resumed. 
 
 
Reactive Hyperaemia 
 
Given that reactive hyperaemia can distinguish between healthy individuals and those with 
PAOD, it seems rational that the same measure could be used to determine successful 
outcomes following revascularisation. Wahlberg et al carried out a prospective study of 60 
consecutive patients undergoing open surgical infrainguinal revascularisation for claudication, 
rest pain or gangrene (Wahlberg et al., 1995).  The reactive hyperaemia (RH) was conducted 
with the probe on the base of the first toe, with a cuff at the ankle inflated to 250mmHg for a 
3 minute occlusion time, the day before surgery and on the first or second post-operative day 
± at day 5 if post-operative values were within 5% of pre-operative measurements.  Eight 
patients who did not have a detectable RH response were excluded. All of these patients had 
ankle pressures less than 25mmHg and 4 had multi-segment disease. 
 
Figure 18: Reactive Hyperaemia curves from a patient with a preoperative ABI of 0.15 before (A) and after (B) infrainguinal 
reconstruction (Wahlberg et al., 1995). 
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Following surgery, a significant decrease in time to peak was found (p<0.001) and this 
correlated with an improvement in ABPI of more than 0.15 (r= - 0.51). In patients whose 
ABPI did not increase by more than 0.15, none of the microcirculatory parameters improved, 
despite some clinical improvement in over 50% of patients in this group.  However, on 
subgroup analysis time to peak was able to distinguish a difference between those who gained 
clinical improvement, regardless of ABPI (p<0.001).  The discrepancy suggests that 
microcirculatory impairment affects clinical outcome and is a more sensitive indicator than 
ABPI (Wahlberg et al., 1995). 
 
The cohort itself contained a mixture of PAOD patients and does not relate strictly to CLI, 
with one third being claudicants.  Furthermore the exclusion of patients with no recordable 
RH meant that the most ‘critical’ of the group were omitted. In addition, there is no long-term 
follow up of these patients to see if their time to peak, in spite of an improved ABI was 
predictive of graft failure. 
 
An earlier study from 1988 identified nine patients from within their cohort who had 
undergone surgical reconstruction; six aorto-femoral bypasses & three femoro-popliteal 
bypasses.  They concluded that post reconstructive reactive hyperaemia values, including time 
to peak, improved in all limbs and in fact ‘normalised’ in reconstructed single level disease 
(Van den Brande and Welch, 1988).  It is not clear whether these differences are attributable 
to the presence of multi-level disease but only single level reconstruction being performed in 
certain cases.  Similar to previous studies in this area, there is an assortment of disease 
severity and also anatomical location and they have not compared their findings to any 
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haemodynamic measures of success.  In addition, the timing of the post-operative studies 
have not been clarified and hence whether this is a short-term or longer-term change. 
 
 
Local Vasoconstrictor Mechanisms and Oedema 
 
Eickhoff and colleagues undertook a lot of work in this area in the 1980’s.  They used the 
Xenon washout technique in ischaemic limbs undergoing revascularisation procedures above 
and below the inguinal ligament, to describe the changes in local vasoconstrictor responses 
(Eickhoff and Engell, 1982a).  The table below summarises their findings, divided by the 
level of reconstruction and the pre-operative presence or absence of vasoconstrictor response.  
All patients are reported to have had clinical improvement and an associated rise in distal 
pressures and normalisation of autoregulation. 
 
 VAR 
Grp Procedure Pre-op Early post-op: 
Day 10 
Late post-op: 
3-6months 
Hyperaemia 
A Infrainguinal Absent Present: NS Present: Sig. Significant 
B Infrainguinal Present No change No change NS 
C Suprainguinal Absent Present: NS Present: Sig. Significant 
D Suprainguinal Present Absent: Sig. Present: Sig. None 
 
Table 11: Summary of findings by Eickhoff and colleagues on the return of VAR and post-operative hyperaemia (elevated 
resting blood flow). Groups A to D delineate the presence or absence of pre-operative VAR and whether the procedure was 
performed above or below the inguinal ligament. NS - Not significant, Sig - Significant.  
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Those with a preserved vasoconstrictor response present at the outset had higher pre-operative 
ankle and toe pressures and therefore by definition, were not critically ischaemic.  Some of 
the patients in Group A who showed absent responses, were only suffering intermittent 
claudication and their pre-operative ankle and toe pressures ranged from 25-80mmHg and 0-
53mmHg respectively.  
 
The post-operative hyperaemia however, correlated with a low or absent pre-operative VAR 
and was therefore greatest in those with the most severe ischaemia at the outset and the lowest 
distal blood pressure (Eickhoff and Engell, 1982a, Jelnes, 1986).  Subsequently, those that 
displayed the greatest change in VAR post-operatively demonstrated the greatest hyperaemic 
response.  This supports the concept of loss of normal small vessel function either from 
ischaemic damage or atrophy, as the cause for hyperaemia although it has not been correlated 
directly with limb oedema per se.  Overall, the study suggests that revascularisation prompts 
normalisation of the auto-regulative mechanism of vasoconstriction in this group of patients, 
which is probably carried out by the arterioles (Eickhoff, 1985, Eickhoff and Engell, 1982a). 
 
In a subsequent study by the same group, postoperative oedema developed after 12/13 
infrainguinal procedures and only 1/17 suprainguinal reconstructions (Eickhoff, 1985).  
Whilst late post-operative improvements in VAR and hyperaemia remained commonplace to 
the most severe disease (rest pain vs. claudication), postoperative oedema appeared to develop 
independently to these and appeared more related to the procedural type.   
 
Furthermore, when the groups when analysed by symptoms irrespective of type of 
reconstruction, the VAR in the rest pain group normalised by the early postoperative period 
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i.e. within 10 days despite persistent hyperaemia.  They dispute pre-capillary resistance as the 
cause of oedema, as this appears to normalise within 10 days. Instead, they consider 
lymphatic damage at the popliteal level as a cause and the hyperaemic response to be related 
to small artery rather arteriolar damage (Eickhoff, 1985).  Of course, whilst flow and 
ischaemia are improved with revascularisation and reperfusion, it does not alter the 
atherosclerosis in the vascular bed beyond the distal anastomosis (Delis et al., 2001).  Others 
feel that the hyperaemia post-operatively is just a reflection of the normalisation of blood flow 
and not a true hyperaemia (Jelnes, 1986). 
 
Delis et al also found that loss of autoregulation is not a permanent feature and can be restored 
following surgical revascularisation.  They used laser Doppler fluxmetry to demonstrate the 
percentage decrease in skin blood flow on sitting was not significantly different between 
normal and patients’, within six days following successful infra-inguinal bypass grafting for 
severe ischaemia (Delis et al., 2001).  In fact, the skin flux during sitting was significantly 
higher in claudicants compared to the post-operative group (p<0.001). There is however no 
indication as to what patients VAR’s were pre-operatively or whether they were troubled with 
lower limb oedema as a consequence of vasoparalysis, at day six post-operatively.  
 
The hypothesis that the vasoconstrictor impairment is functional and flow-dependent, rather 
than as a result of structural damage, is supported by an improvement in VAR at day three 
following aorto-bifemoral bypass.  This was however for non-critical ischaemia, and VAR 
was present in all patients pre-operatively and improvement was seen by a reduction in sitting 
blood-flow from 27% to 45% post-operatively.  This improvement persisted at 45% 28 days 
later (Ubbink et al., 1999).  This may not be representative of the CLI population where 
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ischaemic damage and/or atrophy of cells have been reported (Hillier et al., 1999, Coats and 
Hillier, 2000). 
 
Those patients who displayed oedema post-operatively did not demonstrate return of their 
VAR until 3-6 months following surgery, which at that time corresponded to improvement in 
oedema. An attenuated VAR pre-operatively was also correlated with post-reconstructive 
hyperaemia, or the increase in flow at rest (Eickhoff and Engell, 1982b).  Hyperaemia was 
therefore correlated with severity of ischaemia.  This would reinforce the role of arteriolar 
tone in the development of oedema. 
 
 
Oedema 
 
After successful infra-inguinal surgical revascularisation lower limb oedema is ubiquitous, 
irrespective of pre-operative oedema.  It occurs within the first 48 hours and is both 
troublesome for patient mobility and wound healing. The distribution and nature of the 
oedema is distal and pitting and can last from several weeks to months post-operatively 
(Porter et al., 1972). 
 
This phenomenon is reasoned to be due to an abrupt increase in arterial inflow and systemic 
transmural pressure in the region of >70mmHg into an atrophied system that has lost its 
ability to autoregulate, having become chronically accustomed to low pressures (Eickhoff, 
1985, Eickhoff and Engell, 1982a).  The reduction in capillary resistance is maintained and 
there is a high transcapillary filtration rate and subsequent accumulation of interstitial fluid, in 
keeping with Starlings law. This can further compromise tissue nutrition (Coats, 2003, Coats 
and Wadsworth, 2005). 
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However, oedema formation and post-reconstructive hyperaemia have not always been 
inextricably linked and oedema formation was not correlated with clinical severity of 
symptoms, VAR or ankle pressures, only with the type of surgery, in the study mentioned 
above by Eickhoff (Eickhoff and Engell, 1982b).  Post-reconstructive hyperaemia and oedema 
developed after all femoro-popliteal bypasses, but only after a limited number of aorto-
bifemoral bypasses (Coats, 2003, Eickhoff and Engell, 1982b, Porter et al., 1972).  Similar to 
previous studies, the vasoconstrictor response was absent in the most severe cases until three 
to six months later but this did not equate to post-operative oedema. The difficulty of 
evaluation comes again though where a mixture of disease severity and different anatomical 
procedures within a small cohort muddies the water of interpretation. 
 
Alternatively, lymphatic disruption has been suggested as a contributing factor to oedema 
following inguinal and popliteal dissection where major lymphatics can be found (Eickhoff 
and Engell, 1982b).  Lymphangiograms have demonstrated disruption to superficial inguinal 
lymphatics with contrast extravasation following surgery for femoro-popliteal bypass 
grafting.  The magnitude of disruption has been correlated with the extent of the oedema, 
particularly if the medial superficial nodes are traumatised.  Equally, preservation of 
lymphatic channels appeared to minimise oedema (Porter et al., 1972).  In the event of early 
graft failure, oedema is not observed. This could be because vast transudation of fluid does 
not occur because capillary pressure does not reach a critical level and so fluid can still be 
reabsorbed by lymphatics, albeit if the system has been disrupted.  Furthermore, intact 
lymphatics are able to absorb the increase in filtrate achieved by successful supra-inguinal 
reconstruction (Eickhoff and Engell, 1982b). 
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The fact that it is so unusual to experience similar findings following recanalisation with 
endovascular treatment would support this theory.  However, very often the disease severity is 
not as significant in this patient population as endovascular techniques are less likely to be 
successful in long segment, severely calcified disease. It seems unprecedented though to have 
similar magnitudes of lower limb oedema with other forms of femoral dissection, such aorto-
bifemoral bypass grafting and insertion of cardiac catheters. Post-operative venous 
thrombosis and hypoalbuminaemia are not generally acknowledged as causes of unilateral 
oedema in this situation (Khiabani et al., 1999b, Porter et al., 1972). 
 
Endovascular Techniques 
 
Laser Doppler Fluxmetry and Reactive Hyperaemia 
 
This technique has been used, predominantly in claudicants, who underwent 21 PTA and/or 
mechanical recanalisation for symptom relief of ilio-femoral disease and were compared to 16 
controls that underwent diagnostic arteriography alone (Bongard et al., 1994).  The primary 
aim was to see if endovascular treatment resulted in impaired microvascular haemodynamics 
and tissue oxygenation as a result of infraclinical microemboli, despite an improvement in the 
macrocirculation. 
 
Both groups had a pre-intervention ABPI of 0.7.  In accordance with angiographic 
improvement, all patients experienced an improvement in toe and ankle indices 4-6hours 
following intervention, which remained stable one month later.  However, this did not 
correlate with some of the microcirculatory measures in the treatment arm.  In the PTA group, 
tissue oxygenation (Tcp02) decreased immediately after the procedure compared to pre-
operative levels and to the control group (46mmHg (29-67) and 40mmHg (10-65) vs. 
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46mmHg (26-64) and 46mmHg (29-65), p0.0004), without a corresponding reduction in 
resting rCBV and rLDF readings.    A nutritional index calculated from these latter two 
readings (rCBV/rLDF) suggesting that there was a reduction in nutritional blood flow 
following PTA, correlating with a reduction in Tcp02 readings.  Whilst the skin blood flow 
had not decreased overall, rather the blood flow had been redistributed to sub-papillary plexi, 
consistent with the hypothesis of subclinical micro emboli from the procedure (Bongard et al., 
1994).  These features did begin to show improvement at one month. Of note, there was no 
clinical oedema observed in these patients. 
 
These findings are from patients with claudication and therefore cannot be generalised to the 
CLI population.  Furthermore, the study was mainly adopted for looking at complications 
rather than looking at distal perfusion benefits per sae. 
 
Leonardo at al examined 209 limbs, healthy and PAOD, to record their post-occlusive 
hyperaemia after a three-minute cuff occlusion.   Within this group, four limbs with single-
level stenosis were treated with PTA and their PORH flow patterns returned to the same range 
as healthy subjects with time to peak flux improving from 150.0±47.2 to 55.0±7.0, see figure 
19 below.  They all had simultaneous resolution of their symptoms although it is not clear 
over what time course this occurred (Leonardo et al., 1987). 
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Figure 19: Effects of percutaneous transluminal angioplasty (PTA) on the average pattern of the cutaneous post-ischaemic 
hyperaemia test curve (Leonardo et al., 1987). 
 
The subject group who underwent intervention is undoubtedly very small and they were 
suffering with moderate single-level disease as opposed to critical ischaemia.  The 
angiographic techniques for dealing with complex disease was not available in 1987 when 
this paper was published and the indications and technology are far more advanced now.  In 
the previous paper with a cohort of similar disease severity, a one-minute cuff occlusion did 
not elicit an improvement in PORH response after a haemodynamically and angiographically 
successful PTA, with mean time to peak reactive hyperaemia not changing (10 vs. 9 vs. 12 sec 
before, after and 1 month). (Bongard et al., 1994) These time to peak hyperaemias are very 
short and are not representative of critical ischaemia. 
  
 
Local Vasoconstrictor Mechanisms 
 
In a study of 14 patients undergoing femoro-popliteal angioplasty for stable claudication, 
percutaneous revascularisation significantly improved VAR (55.5%±21.2 from 33.4%±20.2), 
measured by LDF with a probe secured at the tip of the big toe.  The change occurred due to a 
significant reduction in orthostatic blood flow, horizontal blood flow remained unchanged.  
106 
 
The changes persisted at 6 months follow-up although they did not return to the same level as 
healthy age and sex-matched volunteers (68.4% ± 20.5%) (Husmann et al., 2006). 
 
Figure 20: Vasocutaneous autoregulation in controls and in patients with peripheral arterial disease. Decrease in skin blood 
flow on sitting (VAR) in healthy controls compared to patients with stable intermittent claudication before and after femoro-
popliteal angioplasty. *P<.05 versus controls; P<.05 before versus after angioplasty (Husmann et al., 2006). 
 
The ABPI’s similarly increased immediately after the intervention (0.71 (0.52-0.85) to 0.89 
(0.72-1.10)) and remained unchanged during the follow-up, in a similar fashion to VAR.  It 
supports the hypothesis that local vasoregulation is pressure and/or flow sensitive to maintain 
local tissue perfusion (Husmann et al., 2006).  Baseline characteristics in a similar group of 
patients with non-critical disease also demonstrated a highly significant correlation between 
VAR and post-exercise ABPI (Otah et al., 2005). 
 
 
Oedema 
 
Anecdotally, patients who undergo PTA do not tend to experience oedema after the procedure 
and is rarely objectively measured in endovascular studies.  Ray et al specifically measured 
changes in lower limb volume, calculated from calf girth measurements, one day and one 
week following balloon angioplasty in 37 patients undergoing intervention for disabling 
claudication (n=27), rest pain (n=7) and ulceration (n=3).  The calf volume of the treated limb 
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did not increase regardless of anatomical location or severity of disease at one day or one 
week.  However, there was a reduction in the volume of the control leg immediately following 
PTA, suggesting potential fluid redistribution, as this finding was no longer evident one week 
later (Ray et al., 1997b). 
 
Diabetes 
 
Limb salvage and long term patient survival are reduced in the diabetic population compared 
to those without diabetes (Conte, 2010b).  Patients are often younger with co-existing 
coronary artery disease and renal disease. Furthermore, intervention more commonly involves 
infra popliteal and infra-malleolar vessels and the use of short segment grafts and if ulcers are 
present they tend to heal more slowly than patients without diabetes (Akbari et al., 2000, 
Coats, 2003, Lepantalo et al., 2011).  However, there is very little data available on any 
potential changes observed in the microcirculation following revascularisation procedures, 
particularly with regard to diabetes.   
 
Functional ischaemia has been shown to improve, although not to the levels of healthy 
controls, in a study of 13 diabetic patients following femoro-distal bypass using iontophoresis 
and transcutaneous oxygen pressure (Arora et al., 2002).  Four-six weeks following surgery 
all patents had palpable graft pulses. The vasodilatory response to heating and acetylcholine 
both improved from pre-intervention to post-intervention (p<0.05) but were comparable to 
patients with neuropathic disease, not healthy controls.  C-fibre nociception failed to show 
any improvement following revascularisation (Arora et al., 2002).  This is in keeping with 
work by Veves who used TcP02 to demonstrate that reversing hypoxia by revascularising 
extremities of diabetic patients halts the progress of neuropathy, but does not affect 
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neuropathic damage already present (Akbari et al., 1997, Veves et al., 1996).  The persistent 
endothelial dysfunction may explain why some patients have persistent or recurrent tissue loss 
despite a running graft and improvement in the macrocirculation. 
 
1.6 Conclusions 
Critical limb ischaemia is characterised by critically low perfusion pressure to lower limb 
tissues, resulting in loss of small vessel reactivity and autoregulation such that it is unable to 
regulate its nutritive blood supply. Poor oxygenation, tissue loss, ulceration and ultimately 
limb loss ensue.   
 
There are two key therapeutic strategies available to manage CLI; open surgical bypass or 
endovascular recanalisation.  To date, the vast majority of trials have appraised these 
treatments individually, using conventional clinical outcomes including resolution of 
symptoms, prevention of amputation and/or vessel patency, as predictors of long-term 
success. Physiological improvements in haemodynamic markers such as APBI have not been 
shown to have any predictive value in assessment of outcome, with increases in toe pressures 
variably showing a relationship with patency in the short and longer-term.   Changes 
occurring in the microcirculation are generally under utilised as an outcome measure. 
 
From a surgical perspective, reactive hyperaemia time to peak has been shown to normalise 
after treatment and correlate with clinical outcome, but not ABPI, in an unselected group of 
PAOD patients (Van den Brande and Welch, 1988, Wahlberg et al., 1995).  In some studies 
however, patients with the most severe CLI were excluded. Outcomes of other parameters 
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used in measuring reactive hyperaemia have been generally mixed and unreliable. Auto-
regulative control processes such as VAR have improved within days following successful 
surgery, above and below the inguinal ligament and is associated with a significant 
hyperaemia at rest (Delis et al., 2001, Eickhoff and Engell, 1982a).  Whether the presence or 
absence of vasomotor control is linked to the development of post-operative oedema has not 
yet been established.  
 
Such information is only occasionally included in endovascular series and the majority is 
related to functional, rather than critical ischaemia.  There is a reported discrepancy between 
vessel patency and limb salvage, which would seem to confound macrovascular measures but 
associated changes in the microcirculation are seldom described.  Improvement in reactive 
hyperaemia has been shown after PTA, but this was in single level disease (Leonardo et al., 
1987).  Similarly in claudicants, local vasoconstrictor mechanisms improved towards the 
levels of healthy volunteers following femoro-popliteal angioplasty (Husmann et al., 2006).  
A relationship with oedema has never been identified following PTA, regardless of severity of 
disease and flowmotion and corresponding changes in frequencies has not been formally 
assessed in this setting.  
 
It is evident that there is a paucity of data on the effects of treatment on skin circulation and 
studies that do measure microcirculatory outcomes are limited and do not present a 
comprehensive picture, either to compare within treatment or to correlate with clinical 
outcomes.  The BASIL trial went some way to comparing limb salvage and survival in CLI 
but the two treatment modalities were not compared with respect to their perfusion benefits.  
Other studies have used a homogenous patient population, with no focus on CLI.  Certainly, 
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no studies have directly compared treatment effects on basal perfusion, reactive hyperaemia, 
VAR, flowmotion and oedema.  Consequently, it remains unclear whether successful 
revascularisation, by either technique, reverses endothelial dysfunction and the microvascular 
disease process and perhaps those patients who have a poor outcome despite apparently 
satisfactory revascularisation, have persistent microvascular dysfunction. 
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Aim%and%Hypotheses%
!
2.1!Aim!
The aim of this study was to compare open surgical bypass and endovascular treatment in CLI 
using conventional clinical outcomes (limb salvage, patency, symptom relief), haemodynamic 
measures (ABPI, toe and skin pressures), microcirculatory measures (resting flux, RH, VAR, 
flowmotion) and resultant oedema and tissue hardness. 
 
 
2.2!Hypotheses!
It is hypothesised that successful open surgery will lead to superior outcomes compared to 
endovascular techniques with regard to: 
 
1. Clinical -  
• Resolution of symptoms and higher patency rates  
 
 
2. Haemodynamic - 
• A greater increase in ankle, toe and skin pressures 
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3. Microcirculation – 
• There will be a greater reduction in reactive hyperaemia time to peak.  
Consequently one would expect to see other microcirculatory parameters 
improving with a greater increase in resting basal flux, improved regulation of 
local postural vasoconstrictor mechanisms and an associated increase in 
flowmotion related to myogenic and sympathetic control mechanisms 
 
 
4. Oedema – 
• A bigger rise in tissue hardness associated with greater unilateral lower limb 
oedema 
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METHODS 
3.1!Study!Subjects!
Forty patients participated in the study.  All were undergoing treatment for ischaemic rest 
pain, tissue necrosis or gangrene of the lower limb. Patients were recruited from Selly Oak 
Hospital Vascular Department and identified through inpatient or outpatient referral to the 
vascular team. In addition, site-specific application was approved by local Research and 
Design committees, to study patients from Birmingham Heartlands Hospital Vascular 
Department.  
  
Patients, who fulfilled the criteria of Fontaine stage III or IV disease, with multi-level 
atherosclerotic arterial disease requiring infra-inguinal revascularisation with either arterial 
bypass surgery (ABS) or percutaneous transluminal angioplasty (PTA), were invited to take 
part.  Patients who had multiple co-morbidities contributing towards lower limb pathology 
together with single level arterial disease were assessed on the basis of toe pressures 
<30mmHg, or <50mmHg in the presence of ulceration or gangrene, in accordance with the 
Trans-Atlantic Society Committee (TASC) definition of critical limb ischaemia (CLI).  The 
exclusion criteria were clinical evidence of deep venous insufficiency, acute limb ischaemia 
and major limb amputation. In addition, patients who could not tolerate cuff insufflations 
around the calf were excluded for practical reasons.  Patients also requiring concomitant 
treatment of iliac inflow disease were not excluded.  Patients were not retested if they 
required repeat intervention to the same limb for recurrent symptoms. 
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Medical history was documented, including data on concomitant illnesses, previous 
angioplasties or vascular surgeries, for all study participants.  Height and weight were 
recorded using a portable stand-on scale, with an attached height-measuring stand.  Body 
mass index was calculated by the individual’s body mass in kilograms divided by the square 
of his or her height (kg/m2).  
 
The TASC classification of inflow and femoro-popliteal disease has been used to stratify 
patient disease and its pattern.  Pre-intervention imaging to assess the anatomy of disease was 
always with Duplex ultrasound in the first instance, by one of two dedicated vascular 
technicians in the outpatient department.  Their findings were recorded on standardised 
diagrams as seen in Figure 21.  Duplex reports were corroborated with subsequent CT or MR 
angiography, particularly in patients where iliac vessels could not be imaged due to overlying 
bowel gas, or extensive calcification made it challenging to see infrageniculate vessels on 
Duplex. 
 
As an adjunct to TASC, the Nicolson-Simms-Brown index (NSB) was devised as a numerical 
classification of disease severity in the lower limb.  It is derived from the degree and length of 
stenosis as determined by pre-intervention imaging and therefore the higher the number, the 
more severe the disease.   
 
Table 12 below demonstrates NSB calculation. The columns labelled grade and segment are 
completed with values from 0-4 dependent on the grade of the lesion and whether it involves 
all or some of the specified vessel.  The sum of each row is added up and multiplied by a 
factor of 1 to 3 depending on the anatomical impact of the disease, to give a maximum total of 
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108.  The higher the NSB index the greater the burden of disease.  An example is shown in 
Figure 21 below, using the standardised proforma from lower limb ultrasonography. 
 
Nicolson-Simms-Brown Classification: Global index of severity of chronically ischaemic lower limbs 
 
Vessel Grade Severity Multiply Total Max Score  
CIA     3 0 18  
EIA     3 0 18  KEY Grade Severity   
CFA     2 0 12  0 Patent 0   None 
SFA     2 0 12  1 Stenotic <50%  1   Partial 
Pop     2 0 12  2 50-75% 2   Complete 
TPT     1 0 6  3 75-99%  
AT     1 0 6  4 Occluded 
PT     1 0 6  
Pe     1 0 6  
   
0 108  
 
Table 12: The Nicolson-Simms-Brown Classification to classify severity of CLI by grade and segment, giving a total score of 
up to 108.  The greater the total number, the more severe the disease. CIA – common iliac artery, EIA – external iliac artery, 
CFA – common femoral artery, PFA – profunda femoris artery, SFA – superficial femoral artery, Pop – popliteal artery, TPT 
– tibioperoneal trunk, AT – anterior tibial, PT – posterior tibial, Pe – peroneal. 
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Vessel Grade Severity Multiply Total 
CIA  0  0 3 0 
EIA  3  1 3 12 
CFA  2  1 2 6 
SFA  4  1 2 10 
Pop  0   0 2 0 
TPT  0  0 1 0 
AT  0  0 1 0 
PT  4  1 1 5 
Pe  0  0 1 0 
   
33 
 
Figure 21: A schematic representation of a lower limb ultrasound scan used to calculate the NSB index. Using the table 
above, the NSB of the left leg in this patient was calculated as 33. CIA – common iliac artery, EIA – external iliac artery, 
CFA – common femoral artery, PFA – profunda femoris artery, SFA – superficial femoral artery, Pop – popliteal artery, TPT 
– tibioperoneal trunk, AT – anterior tibial, PT – posterior tibial, Pe – peroneal. 
 
The study was approved by the ‘Black Country Research and Ethics Committee’ and 
performed in accordance with the principles of the Declaration of Helsinki. Each patient gave 
written informed consent before any study-related procedure was conducted. (See Appendix 
A) 
117 
 
3.2!Protocol!
The principal aim of this observational study was to ascertain whether there was a 
quantifiable difference in skin blood pressure, flow and vascular reactivity with the extent and 
method of revascularisation of the affected limb.   
 
Revascularisation of an ischaemic limb can be achieved by open surgical or percutaneous 
endovascular techniques.  Surgery uses autologous vein or a prosthetic graft to bypass the 
affected segment/s of diseased vessel, providing a new conduit free from disease.  
Endovascular techniques recanalise diseased vessels in-situ to improve flow to the 
extremities.  Surgical techniques are reported to be more durable in the longer term in 
comparison to endovascular techniques, as canalised vessels have a tendency to re-stenose 
after a period of time.  In order to compare the efficacy of these treatments their outcomes 
need to be objectively measured and compared in the short and longer-term.  
 
Patients were assigned to different treatment groups, on clinical grounds and were not 
randomised.  This was based upon pattern and extent of disease and whether it was amenable 
to endovascular or surgical treatment, patient age and co-morbidities and patient preference.  
In cases of bilateral limb ischaemia, the most severely affected limb (leg one) was treated 
first.  Table 13 below demonstrates the methods of assessment used to ascertain the primary, 
secondary and clinical endpoints. 
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 Method of Assessment 
Primary endpoint  Reactive hyperaemia (RH) - change in time to peak (∆Tp)  
       using laser Doppler flowmetry 
 
Secondary endpoints  Absolute toe pressures & TBPI 
 Skin LDF pressures 
 Lower limb anthropometric volume 
 Tissue depth 
 Tissue tension (Durometry) 
 Laser Doppler flowmetry – basal flux and spectral analysis of basal 
flux (Fourier transformation) 
 Postural Vasoconstriction (PVC) 
 Neurothesiometer: Vibration perception & detection thresholds 
(VPT/VDT) 
 
Clinical endpoints  Absolute ankle pressures & ABPI 
 Patency 
 Symptom relief – complete/partial/none 
 Further intervention/surgery 
 
Table 13: Primary, secondary and clinical study endpoints and their method of assessment 
 
All measurements were taken in the treatment limb and also in leg two, the contralateral limb.  
Each patient was tested on three separate occasions at discrete time points in relation to the 
intervention: 
• Pre-intervention (within 72hours) 
• Post- intervention (within 72hours) 
• Six weeks post-intervention 
In addition, a small sub-group (n=7) were tested at a six-month follow up visit.  
 
All measurements were made at the three-time points specified, except the measurements 
involving cuff insufflations around the calf (reactive hyperaemia, ankle and skin pressures), 
which were not performed immediately post-operatively to avoid inadvertent damage to a 
newly canalised vessel or graft.   
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Testing%procedures%
 
The subjects lay supine in an examining room at Selly Oak Hospital, or as close to supine as 
possible for those that found it difficult medically to lie flat. Shoes and socks were removed 
and the lower limbs exposed from the distal femur with all dressings taken down.  The 
temperature was kept as stable as possible at 22.2±1.3°C because of the importance of 
ambient temperature on skin blood flow. Direct sunlight was avoided and noise and 
interruptions were kept to a minimum.  No medications, including vasoactive drugs, were 
stopped but patients were requested not to smoke.  Resting heart rate was recorded manually. 
Measurements that did not involve the laser Doppler were performed first, allowing time for 
the patient to acclimatise to the environment.  All measurements were performed in both legs 
unless specifically stated; leg one being the most symptomatic.  
 
Anthropometry 
 
Anatomical reference points were marked with a permanent marker pen at the outset to allow 
repeated measures from the same location.  These were 2.5cm proximal to the centre/most 
prominent part of the medial malleolus and 5cm distal to the tibial tuberosity.  
 
 
Figure 22: Reference markings made with a permanent marker 2.5cm proximal to the medial malleolus and 5cm distal to the 
tibial tuberosity 
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Intervention-related changes in lower limb volume were calculated from anthropometric 
measurements of the limb segment.  A tape measure was used to measure circumference, 
starting at the ankle 2.5cm proximal to the centre/most prominent part of the medial malleolus 
and 5cm distal to the tibial tuberosity.  The section length between these two points was 
recorded.  In addition, forefoot circumference was measured around the first and fifth 
metatarsal heads.  Lower limb segment volume was determined using the truncated-cone 
method (Fuller et al., 1999) as follows: 
 
Vs=L/12π(C12 + C1 C2 + C2 2) 
Vs - Segment volume, C1 + C2 - measured circumference at either end of segment of length (L) 
 
  
Figure 23: Measuring the ankle circumference at the pre-defined point 2.5cm proximal to medial malleolus and the length of 
the limb between the two markings. 
 
Tissue Depth 
 
Tissue depth was used as an indirect measure of the distribution of tissue oedema, which may 
be present in the lower limb subcutaneous tissues following intervention and to corroborate 
with lower limb volume.  A portable ultrasound machine, Sonosite 180 with a convex probe 
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was used to measure tissue depth from the skin surface to the fascia in the lower limbs (Figure 
24). 
 
Figure 24: Transverse section demonstrating fascia and underlying muscle of lower leg. Arrow indicates the point of 
measurement at the fascial surface from the skin surface. 
 
The probe was held perpendicular to the skin.  Firstly, in the plane 2.5cm proximal to the 
medial malleolus, the tissue depth was taken just anterior to the medial malleolus.  Secondly, 
in the plane 5cm distal to the tibial tuberosity over the tibialis anterior the tissue depth was 
measured just lateral to the tibia.  Finally, tissue depth in the forefoot was taken over the 
metatarsal heads.  
                       
  
(A)  (B) 
Figure 25: Measurement of tissue depth in the lower limb using a portable ultrasound machine. Depths taken (A) 2.5cm 
proximal and anterior to the medial malleolus and (B) lateral and 5cm distal to the tibial tuberosity. 
 
122 
 
Durometry 
 
A Rex Durometer Hand Model 1600, Type 00 (Rex Gauge Company Inc., Buffalo Grove, IL, 
USA) was used to assess tissue tension in the lower limbs.  Within the context of medicine, 
experience with the Durometer has predominantly been in dermatological conditions such as 
scleroderma to monitor disease progression and also in the assessment of skin changes in 
relation to venous disease (Choh et al., 2010, Kissin et al., 2006).  It has not previously been 
used to assess tissue ‘hardness’, caused by tissue oedema in relation to lower limb 
revascularisation. 
 
Durometry should be performed over areas of soft tissue, not bone, with the instrument being 
gently supported to allow the weight of the instrument (170 gram) to press against the skin. 
Ulcerated areas should be avoided if possible.  With the patient supine, the Durometer was 
rested perpendicular against the skin in two places: 
 
• In the plane 2.5cm proximal to the centre/most prominent part of the medial 
malleolus, lateral to the extensor hallucis longus (EHL) with the patients leg 
slightly internally rotated to keep the Durometer perpendicular 
• In the plane 5cm distal to the tibial tuberosity, over tibialis anterior (TA) with the 
patients leg slightly internally rotated to keep the Durometer perpendicular 
 
With the patient sitting and feet resting flat on the floor, Durometry was measured in the first 
web space of the foot.  This was done at the end of the testing so as not to disturb the supine 
rest period. 
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(A)    (B) 
Figure 26: Measurements taken with the Durometer at (A) the ankle, 2.5cm proximal to medial malleolus and (B) the calf, 
5cm distal to the tibial tuberosity with the leg internally rotated to keep the Durometer perpendicular 
 
 
Measurement of arterial pressures and pressure indices 
 
Pressures were measured in both limbs using a manual non-mercury sphygmomanometer and 
a hand-held 8 MHz Doppler probe. Insonation of the right upper limb was over the radial 
artery for brachial systolic pressure and the posterior tibial (PT), peroneal (PN) and dorsalis 
pedis (DP) arteries for ankle pressures.  The individual pressures of each of the respective 
arteries were recorded.  In addition, ABPI was calculated for each of the three ankle arteries. 
 
A Vascular Assist® portable laboratory (Huntleigh Healthcare, UK) was used to measure toe 
pressures in the great hallux of each foot, using the phlethysmography probe. The second toe 
was used in cases where the first toe was severely ulcerated.  Three measurements were taken 
from each limb and the average reading was used to calculate the TBPI.  
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Figure 27: Measurement of toe pressure at the hallux with the patient supine, using the Vascular Assist® 
 
Laser Doppler Flowmetry  
 
Principles!
 
The Doppler effect was a term coined in 1844 by Johann Christian Doppler, through 
experimentation with the pitch of a moving trumpet and a static observer.  The principles of 
‘Doppler shift’ were swiftly applied to astronomy and later to fields such as medicine and 
engineering, with the development of laser technologies and fibre-optics in the 1970’s.  The 
advent of laser Doppler flowmetry (LDF) has enabled the study of microvascular function in 
humans in many different tissues including skin (Shepherd and O\berg, 1989). 
 
Laser Doppler blood flowmetry utilises the principles of Doppler shift to continuously record 
and measure the dynamics of blood flow, but uses coherent laser light instead of sound.  The 
visible and infrared light emitted by the instrument is monochromatic, so it has very narrow 
range of wavelengths or extremely high frequencies (Fullerton et al., 2002, Shepherd and 
O\berg, 1989).  It is directed to a limited volume of tissue via an optical fibre, or directly 
mounted onto a probe.  As light enters the tissue, the interactions between photons and 
moving red blood cells produce a change in frequency, creating the Doppler shift. The 
magnitude of the shift depends on the velocity of the cells.  
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Figure 28: Schematic diagram of light defusing through vascularised tissue from a laser source and back scattered light 
leaving to return back to a photo detector (Shepherd and O\berg, 1989). 
 
In a true sampling area, the vessels will be of varying size, function, tension, tonicity and 
micro-anatomical orientation relative to the incident and reflected laser light (Fullerton et al., 
2002).  The system is however insensitive to the direction of movement by the random spread 
of blood cell velocities and hence scattered light, so the Doppler shifts attained are distributed 
on a wide bandwidth (Fullerton et al., 2002, Tenland et al., 1983, Vongsavan and Matthews, 
1993).  One or more afferent optical fibres, running in parallel within a single probe, collect 
the light and transmit it back to the monitor where it is converted into an electric signal.  This 
‘flow signal’ is the average frequency shift normalised with respect to the unshifted signal 
from the stationary tissue (Johnson et al., 1984, Kvernebo, 1988). 
 
The speed of light is a constant.  Therefore, if light strikes a stationary object and is reflected 
directly back to a detector, the received light will have the same frequency as the emitted light 
(Shepherd and O\berg, 1989).  Only a minor portion of about 3-7% is reflected back 
(Fullerton et al., 2002).  However, the returning light will impart a Doppler shift if it is 
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reflected back from a moving object such as a red blood cell.  The output signal achieved is 
linearly related to the product of the red blood cell (RBC) velocity and concentrations i.e. 
flow. Additional frequencies and greater amplitudes are generated when there are multiple 
collisions, as a result of a greater number of cells scattering the light (Cracowski et al., 2006). 
 
For the blood flow to influence the laser and its output, the photons must penetrate to the 
depth of tissue blood flow and also return from it.  Most biological structures will scatter 
incident light so only surface layers tend to be easily penetrated anyway.  The penetration of 
laser light into tissues alters depending on its wavelength. Scattering of light in the dermis 
varies inversely with light wavelength; therefore longer wavelengths penetrate the dermis to a 
greater extent than shorter wavelengths (Berardesca et al., 2002).  The vast majority of the 
wavelengths are absorbed by components of the dermis and epidermis are much less than 
those used in laser-Doppler i.e. 660-800nm (Shepherd and O\berg, 1989).  Melanin, however, 
does afford some protection to laser light and reduces its penetration at wavelengths of up to 
1200nm.  Haemoglobin tends to have its peak absorption around 600nm.   
 
There are different methods to determine the depth of LDF measurement, which vary with the 
approaches used and on different tissues and their optical properties. In skin, studies involving 
the increase of blood flow to skeletal muscle by moderate exercise or occlusion techniques do 
not result in a comparable increase on LDF.  This demonstrates that the laser-Doppler is 
specific to superficial tissues and is not affected by blood flow to deeper tissues such as 
muscle, when applied to the skin. (Saumet et al., 1988, Shepherd and O\berg, 1989)  Although 
there is no critical depth of detection of flow, the greatest penetration and measurement depth 
is likely to be no more than 2.0mm with maximum sensitivity around 0.6mm (Saumet et al., 
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1988).  Although the thickness of skin differs with anatomical location, it is in the range of 1-
3.5mm, and this is still deep enough to measure flow in nutritive capillary loops and in the 
subpapillary arterio-venous plexi of the dermis, without contribution from deeper tissues 
(Abularrage et al., 2005, Bircher et al., 1994, Saumet et al., 1988).  
 
In the single-probe technique, the sampling size on the skin is around 1-2mm2 depending on 
probe geometry, and is therefore highly sensitive to variations in dermal perfusion.  Flow 
values obtained should be regarded as relative to that particular region and not extrapolated to 
absolute values (Fullerton et al., 2002).  Relative perfusion values representing total blood 
flow are therefore expressed as arbitrary perfusion units (APU), rather than absolute units.  
This is as a consequence of the heterogeneity of the sample, such that cutaneous blood flow 
cannot be measured relative to the volume or weight of tissue, rather to the product of the 
average concentration and velocities of moving red blood cells in that tissue sample volume. 
Furthermore, the sensitivity to a particular flow rate within a vessel varies according to the 
distance of the vessel in the capillary bed from the probe tip (Cracowski et al., 2006, Fullerton 
et al., 2002, Vongsavan and Matthews, 1993).  
 
PERFUSION OR FLUX = NUMBER OF RBC’s x 
MEAN VELOCITY OF RBC’s 
 
The LDF signal (in volts) should therefore be linearly related to the volume-velocity product 
of the blood, assuming proportionality between RBC number and blood volume.  This will in 
turn, depend on the haematocrit of the sample i.e. the number of moving red blood cells in 
that sample and the volume of capillaries present (Fullerton et al., 2002, Johnson et al., 1984).  
Platelets and leucocytes are suggested to have little impact on the flux derived as they 
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contribute relatively little volume overall (Tenland et al., 1983).  Flow is not age-dependent 
and there are no major differences between sex and racial groups. There is however, 
considerable regional variation due to the lack of uniformity and regional comparisons must 
be made with prudence (Bircher et al., 1994). 
 
Reproducibility!
 
Natural temporal and spatial variations exist in skin blood flow, therefore ‘normal’ values, are 
difficult to describe.  The structural differences in skin blood vessel architecture and the 
dynamic nature of vascular function provide explanation for regional variations in blood flow 
(Abularrage et al., 2005).  However, absolute flux levels can provide a broad overview of 
perfusion levels in any one area. 
 
Baseline blood flow on cuff occlusion, or biological zero, is highly reproducible, with a 
coefficient of variation of 6% (Tenland et al., 1983).  The flux does not actually return to zero 
and is not influenced by perfusion and or limb position (Wahlberg et al., 1990).  It is due to 
non-blood-flow related movements of muscle cells and vessels walls (vasomotion), stagnant 
red blood cells and other molecular movement (Van den Brande and Welch, 1988). 
 
The coefficient of variation of baseline cutaneous blood flow is much higher than provocation 
tests such as post-occlusive reactive hyperaemia (Bircher et al., 1994).  This is due to the site-
specific nature of LDF.  For example, areas such as the forehead, which are known to be 
vascularly dense, have higher baseline flux than other areas such as the sternum. The 
magnitudes of finger and toe pulp LDF readings are similarly reflective of high flow from 
their AV anastomoses and the density of vessels (Jepsen and Gaehtgens, 1995, Schmidt et al., 
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1993).  The site-to-site diversity in morphology of the skin microvasculature is reflected in 
the difficulty in conducting longitudinal LDF studies, due to site-specificity of sampling areas 
with the single-probe technique.  To obtain repeated measures, prudent orientation and 
localisation of the probe is essential (Tenland et al., 1983).  To eliminate spatial variability, 
Lamah and colleagues used micro tattooing and capillaroscopy to look at capillary numbers in 
the dorsum of the foot over the course of one month.  They found very little temporal 
difference between counts (2.4% ± 1.82) although this did not measure capillary flow per se 
(Lamah et al., 2001).  
 
One of the major drawbacks is the unprovoked intra-individual variation between sites and 
even the same site in the same individual after hours, days or weeks (Fullerton et al., 2002, 
Tenland et al., 1983).  This is however, a reflection of the in homogeneity of the skin 
microvasculature. Using a multiple measurement probe can help with standardising results. In 
the present study, a multiple measurement probe was used at the pulp of the great toes. 
 
Technique!
 
Standardisation of equipment, procedures and measuring conditions must be adhered to, to 
reduce the risk of errors being introduced:  
 
Reduce motion artefacts: equipment 
 
The pattern of reflection of coherent light is, in part, dependent on the properties of the 
reflecting surface.  If the surface is stationary this ‘speckle’ pattern will not vary.  As soon as 
the reflecting surface, the laser or the fibre optics leading the laser light to the surface are 
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moved the speckle pattern is also changed, causing movement artefact and subsequent error in 
blood flow signal (Shepherd and O\berg, 1989).  
 
In an effort to reduce this, a number of variables can be controlled including: 
• Reduced fibre size: reducing the diameter of the fibres reduces the motion artefact 
• Mechanical fibre dampening: prevents the fibres from moving too fast or going into 
mechanical oscillations. There are a number of variables including, stabilising the 
fibres in mechanically dead material, the method of coupling between the distal fibre 
end and the tissue and the end-surface quality. 
• Movements at the measured site: this can include tissue movements due to muscles or 
pressure waves in the arterial tree causing pulsating tissue movements.  This is often 
indistinguishable from the part of the signal generated by the flux of RBC’s.  
Nevertheless, mechanically restraining tissues can in itself impair blood flow 
(Shepherd and O\berg, 1989).  In this study probes were repositioned in the same 
location at each time point by concise measurements and for the halluces, centring the 
probe in the middle of the toe pulp. 
 
Reduce motion artefacts: participants 
 
The laser Doppler is very motion sensitive. Even with probes firmly adherent to the skin 
surface, movement artefact cannot be eliminated and non-physiological readings can be 
formed from even the most discrete movements.  Tissue structures besides red blood cells and 
movement of the fibre-optic cables can create Doppler shift and should be kept to a minimum 
to avoid creating signals, which cannot be distinguished from red cell flux (Vongsavan and 
Matthews, 1993).  Ideally, long studies should be avoided where possible. Clearly the heart-
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synchronous LDF signal conducted into the distal tissues under analysis cannot be eradicated 
(Berardesca et al., 2002).  Once the recording is underway, a stable baseline can be achieved 
in 2-3mins (Sundberg, 1984).  Patients were provided with a good explanation of the study 
process so they were aware of what was expected and should increase compliance and 
reduced movement. 
 
Standardise and calibrate 
 
In order to maintain accuracy of measurements methods should be calibrated at regular 
intervals, by comparing them to a standard (Shepherd and O\berg, 1989).  Laser Doppler 
fluxmetry creates a unique difficulty with calibration since flow is spatially variable, it cannot 
be calibrated in absolute terms. Comparison to other methods has been attempted and 
generally, there is good alliance but obtaining a unique ‘calibration factor’ poses a complex 
problem, largely due to the site-specific nature of the LDF signal (Berardesca et al., 2002).  In 
studies assessing a change in the flux from baseline after a physical intervention, the patient is 
able to act as their own control, which can avoid the need for calibration and can in fact make 
results more reliable (Berardesca et al., 2002). 
 
Standardising the laser-Doppler ensures it retains its reproducibility, as flux does not reach 
absolute zero when there is no perfusion present. Instead, Brownian motion of 
macromolecules arising from the interstitial space contributes to the remaining signal when 
red blood cell flow is absent (Cracowski et al., 2006). ‘True zero’ will only be achieved when 
the probe is placed against non-living material where no movements occur, so there will be no 
Doppler shift of the scattered light (Berardesca et al., 2002).  There are several techniques 
used for standardisation and setting the sensitivity of the instrument, but of relevance to this 
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study is the use of a particle suspension as the reference level.  This is a concentrated colloidal 
suspension of latex spheres, specific to the manufacturer that is used to ensure that the probes 
are detecting Brownian motion only, giving a standard motility of 250PU (Shepherd and 
O\berg, 1989, Vongsavan and Matthews, 1993).  
 
Light Source Considerations 
 
The light source, commonly helium-neon (He-Ne) should be stabilised to prevent a high noise 
to signal ratio. The noise can be misinterpreted as blood flow motion, frequently through a 
variation in the temperature and thermal expansion of the laser cavity. 
 
Ambient Light 
 
Interference may be introduced through ambient light, and light bulbs and fluorescent lighting 
are particularly noteworthy due to their fluctuation in intensity at mains frequency 
(Vongsavan and Matthews, 1993).  Although it is suggested that normal, constant levels of 
background lighting should not interfere with readings (Vongsavan and Matthews, 1993).  By 
attaching the probes with an adhesive tape this in itself provided an element of protection 
from external light.  This was applied gently to the skin, as pressure of the probe and tape 
application may reduce blood flow to the area concerned (Berardesca et al., 2002).  
 
Room temperatures 
 
Due to the skins normal thermoregulatory function, neutral room temperatures should be 
maintained to minimise variability from stimulating the microvasculature in extremes of 
temperature.  This is particularly true of the extremities where the greatest numbers of AV 
shunts are present and flow can vary as much as a factor of 100-200 (Shepherd and O\berg, 
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1989).  Stable readings can be achieved with ambient temperatures between 20 and 25°c 
(Bircher et al., 1994).  In this study, the mean ambient temperature was 22.2±1.3°c and was 
maintained by using the same examination room as much as possible. Where patients were 
not mobile enough to be moved to the examination room e.g. immediately post-operatively, 
studies were conducted at the bedside.  Temperatures did not vary greatly between locations. 
 
Position 
 
The subject position should be controlled.  They should be rested supine with the test-site at 
the relative level of the heart, so the microvasculature is not affected by orthostasis. There 
should be 20-30minutes allowed for acclimatisation where the test-site is uncovered 
(Berardesca et al., 2002).  Relaxed experimental settings are also required to prevent 
neurogenic alterations occurring, which can influence the cutaneous vasculature (Orlandi et 
al., 1988).  A small number of patients were unable to lie supine due to medical conditions 
such as congestive heart failure or chronic obstructive airways disease.  In this situation 
patients were raised to the lowest tolerable position, which was never greater than 30 degrees. 
 
Vasoactive Substances 
 
This category includes prescribed medication such as beta-blockers and calcium channel 
blockers that affect vascular tone, in addition to caffeine, nicotine and spicy food which 
should be avoided for 24hours prior to testing. (Berardesca et al., 2002).  The patients’ 
vasoactive medications were not stopped in this study unless it was clinically indicated.  Of 
the 40 patients, 26 were on 1 or more vasoactive medications including beta-blockers, alpha-
blockers, calcium channel blockers and/or angiotensin converting enzyme inhibitors (ACEi).  
The proportions in each group are displayed in Table 18.  This may affect peripheral vascular 
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tone and hence flow, detected by laser Doppler flowmetry readings.  Patients were requested 
not to smoke prior to testing. 
 
Study protocol for LDF 
 
In this study, the laser Doppler was used to measure basal skin blood flow and to quantify 
relative changes in blood flow to challenges perturbing the microcirculation. These were a) 
reactive hyperaemia; b) postural vasoconstriction induced by leg dependency or by sitting.  
 
A 4-channel LDF monitor (MoorLab, Moor Instruments Ltd, UK) was used for simultaneous 
recordings of skin blood perfusion at a sampling rate of 25Hz, across four standardised 
measurement sites: 
i) Pulp of great toe, leg 2 
ii) Pulp of great toe, leg 1 
iii) Forefoot, lateral to EHL, leg 1 
iv) 10cm distal to tibial tuberosity over tibialis anterior, leg 1 
 
A standard calibration (flux standard) of all the probes was made prior to the recordings using 
the recommended solution.  
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Figure 29: The 4-channel Moorlab laser Doppler Flowmetry monitor 
 
The light is delivered to each probe via a flexible optical fibre.  Probe-holder mounts were 
secured to the skin with a double-sided adhesive disc and further secured with tape over the 
probe to the skin.   The skin was shaved or dry skin detached as necessary. The MoorLab 
output i.e. the product of the number of cells and their mean velocity, is represented by ‘flux’. 
Red cell flux was expressed as arbitrary perfusion units (APU).  The Moorlab was interfaced 
to a laptop on Moor software, sampling at 25Hz. Recordings from the 4 different skin regions 
were displayed in real time on the computer screen and flux data was saved in timed sections 
relating to basal skin perfusion, and to baseline and challenge responses (for reactive 
hyperaemia and postural vasoconstriction).  
 
Real-time data recorded in Moorlab was analysed either by dedicated software for Fast-
Fourier transform analysis (Nevrokard) to calculate the spectral components of basal skin 
blood flow, or exported to an excel document for assessment of the microvascular responses 
(see ‘data analysis’). 
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Basal!skin!blood!flow!
 
This was recorded for a period of ten minutes, with patients resting supine.  The data from all 
four channels was then saved as a text file at 10Hz in readiness to analyse the power spectral 
content of different frequency bands.   
 
Two main techniques exist for analysing the spectral content of a signal by transformation 
into a frequency domain (cycles per second) from a time domain. 
1. Wavelet transformation: this takes into account the time component by using an 
adjustable window length (Saumet et al., 1986).  
2. Fast-Fourier transformation (FFT): analysis of longer segments allows better 
resolution of low frequency oscillations (Kvernmo et al., 2003).  This was the 
technique of choice for this study. 
 
In this study FFT was used and analysis was performed with Nevrokard software, utilising the 
Hamming window. The power spectral density was recorded for 5 frequencies, corresponding 
to oscillations in endothelial, neurogenic and myogenic activity, respiratory rate and heart rate 
(Table 14).  The absolute power (AP) of the signal was also recorded so that relative 
contributions for each frequency interval could be calculated. 
 
 
 
 
Table 14: Frequency intervals (Avery et al., 2009, Kvernmo et al., 1999, Tikhonova et al., 2010) 
 
Interval Frequency (Hz) Physiological Origin 
I 0.009-0.02 Endothelial 
II 0.02-0.06 Neurogenic 
III 0.06-0.15 Myogenic 
IV 0.15-0.6 Respiratory 
V 0.6-2.0 Heart rate 
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Postural!Vasoconstriction!(PVC)!!
 
To allow new data to be saved at a rate of 1Hz, a new window was opened in the Moor 
Software. Flux recordings were continued for two minutes with patients in the supine position 
with legs horizontal for baseline analysis (HBF).  Three further sub-intervals were recorded in 
continuity, reflecting different postural manoeuvres: 
 
1. After two minutes, leg one was passively moved to rest in the dependent position, with 
the foot resting flat on a stool at the side of the bed and the knee and hip flexed to 90°.  
The patient remained supine such that the hydrostatic pressure load at the foot, 
approximately 30cm distance below the level of the heart, was 23 mmHg.  Four 
minutes of flux during dependency was then recorded (LBF). 
 
2. Passive return of leg one to the supine position for two minutes of basal flux 
recording. 
 
3. Patients were then positioned upright sitting, with both feet dependent flat on the 
stool. There was around 60-70 cm distance between the probe and the level of the 
heart, increasing hydrostatic pressure at the foot by ~ 55 mmHg (de Graaff et al., 
2003).  Sitting flux (SBF) was recorded for four minutes before patients returned to 
the horizontal position.   
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Figure 30: Demonstrating the patient and probe 
positioning when recording the PVC from (A) 
horizontal, (B) leg drop/dependency and (C) 
sitting. In dependent and sitting positions the foot 
should be supported to allow a 90º bend at the knee 
joint.                          
(C) 
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Figure 31: Timeline of flux recordings for basal flux and postural vasoconstriction. Red boxes represent individual minutes 
used in the analysis; unfilled boxes are stabilisation periods where data is discarded. 
 
Distortion of the flux recordings due to changes in position or erroneous movements were 
marked onto the data sheet at the time of the study.  The data for each second of flux for each 
of the probes were exported to Microsoft Excel as a text file. For analysis, the first two 
minutes of both dependency and sitting recordings were discarded as a stabilisation period 
and flux values over the following two minutes were averaged to calculate LBF or SBF 
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respectively.  Any erroneous values as a result of movement artefact were preferentially noted 
at the time and if required, a further continuous two-minute recording was made.  If values 
were noted to be outliers at the time of analysis in Excel, they were substituted with a value 
calculated from the average of 10 prior values.  Care was taken not to remove physiological 
values. 
 
Once fluxes were calculated for the timed sections of each manoeuvre, the following 
algorithm was used to determine the PVC at each site: 
 
PVC dependency    = LBF/HBFx100 
PVC sitting             = SBF/HBFx100 
 
LBF – leg drop/dependent blood flow, HBF – horizontal blood flow, SBF – sitting blood flow 
 
Therefore, a fall in blood flow on dependency or sitting – postural vasoconstriction - was 
shown as a percentage decrease in flux relative to baseline; a rise in flux on dependency or 
sitting was expressed as a percentage increase.  
 
Reactive!Hyperaemia!
 
On return to the supine position with legs horizontal, after testing for postural 
vasoconstriction, a sphygmomanometer cuff was positioned around each calf, proximal to the 
shin probe on leg one.  The patient was left to rest to allow stabilisation of the LDF recordings 
and two minutes of baseline flux was recorded from the toe probes.  The cuff on leg two was 
first inflated to 50mmHg above brachial systolic pressure and held for 2 minutes.  At this 
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point, the cuff was rapidly deflated and flux recorded for a further 2 minutes.  This exercise 
was then repeated on leg one.  
 
If patients had severely calcified vessels, the cuff was still inflated to 50mmHg above systolic 
pressure and held until the laser flowmetry display dropped to biological zero for the 
appropriate channel/s.  The stopwatch was started at the point at which biological zero was 
achieved and held for two minutes as described.  Typically, it would take approximately 
30seconds to achieve baseline flux in poorly compressible arteries. 
 
 
Figure 32: Typical reactive hyperaemia recording from toe two. Recordings from leg one are included and confirm that flow 
in this limb does not alter with occlusive testing in leg two.  Time ‘0’ represents cuff insufflation. 
 
Data was exported into Microsoft Excel at 1Hz for analysis, to calculate the time to peak 
hyperaemia (Tp), magnitude of the peak (Mp) and area under the curve (AUC) for each 
channel/skin probe for each patient.  
 
Analyses were made relative to cuff release at 0secs, with cuff occlusion occurring between -
120 and 0secs.  The basal flux two minutes prior to RH cuff occlusion (t-180 to -120secs) was 
Fl
ux
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averaged to provide a baseline value, taken to represent 100%.  Thereafter, actual flux values 
were recorded per second and calculated as a percentage of the baseline.  Actual flux values 
were also averaged over ten second periods and expressed as % of baseline. This is 
demonstrated by the Excel Figure 33 below. 
 
 
 
Figure 33: An example of ‘patient 1’ actual flux recording against time in seconds and subsequent analysis. (A) Average 
baseline flux over two minutes prior to cuff occlusion (B) Flux values per second (C) Flux values per second as a percentage 
of baseline (D) Actual flux values over 10sec intervals.  
 
Flux values per second were plotted against time for the entire time to include baseline (2 
min), cuff occlusion (2 min) and reactive hyperaemia on cuff release (2 min). A plot was 
drawn of each patient’s flux against time in seconds to enable the time to peak, magnitude of 
the peak and percentage change from baseline to be visualised.  Any outlying values were 
removed by eye.  For any patient whose flux was continuing to climb at the end of the 
recording, Tp was documented as 120secs. 
(A) 
  (B)   (D)   (C) 
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Figure 34: An example of an XY scatter plot per second, for a patient’s reactive hyperaemia from t -120s (cuff occlusion) to t 
+120s to visualise the time and magnitude of the peak and to identify any outlying values. 
 
 
Calculation of area under the curve was made by the trapezium method (Matthews et al., 
1990) using the 10-second averages (Figure 35): 
 
1) The change in flux relative to baseline was calculated for each 10 sec average. 
2) The increase above baseline was divided by two 
3) Using linear interpolation between 10 sec time points, the difference between fluxes 
was divided by two and added to the first flux value. 
4) All values were totalled to give the total area under the curve 
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ux
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) 
        -120            0                       +120
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                                                                                     (4) 
 
 
Figure 35: A schematic representation of calculating area under the curve using 10sec averages of the change in flux relative 
to baseline (1). The increase above baseline was divided by two (2). Using linear interpolation between 10 sec time points, 
the difference between fluxes was divided by two and added to the first flux value (3). All values were totalled to give the 
total area under the curve (4). 
 
Skin!LDF!Pressures!
 
A method for measuring skin LDF pressure was implemented using the laser Doppler, 
utilising a similar technique described by Castronuovo et al for measuring skin perfusion 
pressure (Castronuovo et al., 1997). However, instead of the laser Doppler probes being 
secured under a cuff at the toe, the cuff remained at the ankle with the LDF probes attached to 
the toe pulps of leg 1 and 2.   
 
The cuff was inflated to 20mmHg above brachial systolic blood pressure to achieve a near 
zero flux.  The cuff was then deflated in 10mmHg stepwise decrements every 5 seconds to a 
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pressure of 50mmHg.  Deflation then proceeded in 5mmHg decrements every 15seconds until 
laser Doppler output decreased for two consecutive pressure values.  The pressure at which 
this first occurs was recorded (Castronuovo et al., 1997).  
 
Neurothesiometer!
 
The Neurothesiometer is an electromagnetic device used to quantitatively measure sensitivity 
to increasing or decreasing amplitudes by the delivery of voltage (O'Neill et al., 2006).  It is 
commonly used in the diabetic population to assess peripheral neuropathy and the risk of 
ulceration, as the vibration threshold reflects the functional integrity of the sensory fibres 
(Goldberg and Lindblom, 1979).  The outcome measures are vibration perception threshold 
(VPT) and vibration detection threshold (VDT).  The VPT is the stimulus amplitude at which 
sensation is felt, as voltage is increased.  Likewise, the VDT is the stimulus amplitude at 
which sensation disappears, as voltage decreases (O'Neill et al., 2006). 
 
In this study, patients remained in a supine position with the foot to be tested in an everted 
position, with the knee slightly flexed. This allowed the Neurothesiometer (Horwell 
Scientific, London, UK) to bear down perpendicular to the medial aspect of the MTH, under 
its own weight.  The Neurothesiometer was applied to the patients’ right hand as a 
suprathreshold stimulus in a symptom free region, so they were able to recognise the ‘normal’ 
sensation first.  With the patients’ eyes closed the Neurothesiometer was then applied to the 
first metatarsal head (MTH) of each foot and the method of limits (Dimitrakoudis and Bril, 
2002) was employed to assess the VPT and VDT. The voltage was dialled at approximately 
1V/second, but with higher VPTs the intensity of the stimulus was increased to within the 
VPT range immediately and then slowed to 1V/second for accurate measurements.  Three 
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readings were taken for each and the average voltage was recorded.  The first reading was 
omitted and repeated if it was clearly erroneous. 
 
The MTH was used as a testing site as it was found to be more sensitive than the pulp of the 
toe, particularly for VDT, during the pilot study (See section 3.3).  There is no clear guidance 
in the literature as to where the ideal location is to place the head of the probe. 
 
3.3!Pilot!study!
Pilot testing was done to determine logistic factors influencing the final protocol.  It focused 
on the use of the Neurothesiometer, the Durometer and the measurement of tissue depth with 
the Sonosite 180.  The day-to-day reproducibility of these techniques was evaluated in 7 
healthy volunteers (2 male and 5 female, aged 23-51 years, median 35 years), on both legs.  
All parameters were assessed during the course of two afternoons, one week apart.  
 
Neurothesiometer 
 
The volunteers were tested using VPT at two different anatomical sites, the pulp of the great 
toe and the medial aspect of the metatarsal head.  There was a lower threshold on the MTH 
than the pulp of the toe for both VPT (3.2 vs. 3.7) and VDT (3.9 vs. 4.2) and anecdotally 
volunteers reported that it was easier to detect a distinct presence or absence of stimulation 
over the MTH compared with the toe pulp, presumably because the stimulus was transferred 
to the underlying bone at the MTH. This was reflected in the lower standard deviation at the 
MTH compared to the toe pulp (VPT 0.8 vs. 1.05 and VDT 0.7 vs. 0.9 respectively).   
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Overall VDT was generally less distinct than VPT and Goldberg also found that the 
variability was significantly less for VPT than VDT. In spite of this the thresholds were 
indisputably coherent and the threshold gap (VPT-VDT) tended to be constant for each site 
(Goldberg and Lindblom, 1979).  It is not possible to comment on false negatives and 
sensitivity, as all volunteers were healthy with no evidence of peripheral neuropathy but based 
on these findings it was elected to tested vibration perception at the MTH.   
 
It may be that the relatively large surface area of the bone at the MTH provides a better 
surface for detection of vibration than the pulp of the toe, which may dampen the signal. 
Furthermore, Armstrong et al considered the value of testing at multiple sites on the foot and 
ankle and felt it was of no considerable practical benefit compared with single site testing 
(Armstrong et al., 1998).  It is also worthwhile to note that some patients included in the study 
had digit amputations and testing at the MTH allowed consistency of the testing site 
throughout the study. At both locations, the neurothesiometer was found to be reproducible on 
a test-retest within acceptable limits of <10% for biological variables. Data are calculated 
based on Hopkins definition of typical error for a test – retest (Hopkins, 2000).  
 
Location  Mean ± SD AUs Typical error  
MTH VPT 3.2 ± 0.7 0.5 
 VDT 3.7 ± 0.8 0.6 
Toe Pulp VPT 3.9 ± 1.3 0.9 
 VDT 4.2 ± 1.1 0.8 
 
Table 15: The reproducibility of the Neurothesiometer in healthy subjects on a test-retest measurement at two different sites 
for VPT and VDT, expressed as typical error (% mean). Data was included from measurements on both legs so n = 14 (7 
individuals) for each site 
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Durometer 
 
The data in the literature are limited with regards to the medical use of the Durometer and 
certainly assessing tissue hardness in the context of revascularisation is a novel approach.  
Lower limb hardness and oedema is potentially subject to change over time in healthy 
individuals, due to changes in tissue osmotic pressure. Variability of lower limb Durometry 
was assessed one week apart at the three described locations at the calf, ankle and foot.  
Within the three locations the Durometer was found to be reproducible on a test-retest.  
 
Location Mean ± SD AUs Typical error  
Calf  36.1 ± 2.7 1.9 
Ankle 38.8 ± 3.1 2.2 
Foot 16.1 ± 2.3 1.6 
 
Table 16: The reproducibility of Durometry in healthy subjects on a test-retest measurement at three different sites, expressed 
as typical error (% mean). Data was included from measurements on both legs so n = 14 (7 individuals) for each site 
 
Tissue Depth 
 
Tissue depth was shown to be greatest at the ankle and lowest at the foot, consistent with the 
presence of subcutaneous tissue.  This was consistent between legs and did not vary over the 
course of time.   
 
Location Mean ± SD Typical error  
Calf  0.32 ± 0.02 0.03 
Ankle 0.41 ± 0.06 0.05 
Foot 0.25 ± 0.03 0.02 
 
Table 17: The reproducibility of tissue depth using ultrasound in healthy subjects on a test-retest measurement at three 
different sites, expressed as typical error (% mean). Data was included from measurements on both legs so n = 14 (7 
individuals) for each site 
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The within-subject variations for all measurements are within acceptable range for typical 
error, confirming that they are precise and reliable tests.  
 
3.4!Data!reduction!and!Statistical!analysis!
Patient%numbers%and%power%calculations%
 
The skin toe pulp reactive hyperaemia was selected as the primary outcome measure of 
microcirculation pre and post-treatment.  Based on published data showing that time to peak 
for RH in CLI patients reduces following successful treatment, a power calculation was 
carried out using the statistical program ‘G power’. Data was used from Wahlberg et al, 1995 
and Ostergren et al, 1988 and the following assumptions were made: 
a) A baseline Tp for CLI of 126seconds (Wahlberg et al., 1995) 
b) A standard deviation of 81sec (Ostergren et al., 1988) 
c) An expected decrease in Tp following treatment of 39sec, giving a post-treatment 
mean Tp of 87sec and a SD of 27sec. (Wahlberg et al., 1995) 
 
This calculates that a total sample size of 38 provides 95% power at the 5% significance level.  
 
Patient%descriptors%
 
Demographic data descriptive of the clinical status of the patient population, including 
presence / absence of risk factors, are presented as numbers, proportions or percentages 
falling into different categories of classification. Physical characteristics at baseline are 
presented as mean values ± standard deviations (SD) to demonstrate variance. Measured 
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variables – pressures, fluxes, anthropometric measurements – are presented as mean values ± 
standard errors (SE). 
 
Statistical%tests%
 
Test!for!normality!of!data!
 
All numerical data for the two treatment groups, Open and Endovascular, were subjected to a 
Kolmogorov-Smirnov test of normality, with the resultant p value required to be > 0.05 for a 
normal distribution to be assumed. All variables were normally distributed apart from the time 
to peak of reactive hyperaemia. Therefore parametric tests were used to make comparisons 
between and within groups and time points for all data except the time to peak values (sec) 
which were log transformed and then subjected to parametric tests, as described below. 
 
Comparisons!preMintervention!within!and!between!treatment!groups!
 
Pre-intervention, data for the Open and Endovascular groups were compared by unpaired t-
test, assuming unequal variances.  
 
Comparisons between leg 1 and leg 2 for anthropometric measures (limb volumes, 
circumferences, tissue depths), Durometry readings, ankle, toe and skin pressures, skin 
perfusion fluxes (basal; oscillatory frequency power) and microcirculatory responses (reactive 
hyperaemia time to peak, magnitude, AUC; postural vasoconstriction) were made by paired t-
test.  
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Changes in flux during reactive hyperaemia or postural vasoconstriction were analysed by 
paired t-test to determine if they were significant. Derived values of time to peak flux, % 
increase in flux for reactive hyperaemia, and % change in flux for postural vasoconstriction 
(leg dependency or sitting) were then compared between open and endovascular groups by 
unpaired t-test. 
 
Anthropometric measures and postural vasoconstriction data were made at different sites on 
the limb and where appropriate, regional comparisons were made between sites by performing 
a two-factor Anova, with treatment group and site as factors. Leg volumes were analysed in a 
two-factor Anova with treatment group and gender as factors.  
 
Relationships between variables such as tissue depth and Durometry reading, between ankle 
or toe pressures and the NSB index of disease severity were analysed by correlation and 
calculation of Pearson’s product moment coefficient.  
 
In pilot studies on a small number of control healthy subjects, typical errors of measurement 
of tissue depth and Durometry measurements were estimated from the standard deviation of 
the difference scores of test-re-test data (Hopkins, 2000).   
  
Comparison!of!treatment!effects!within!and!between!groups!
 
Anthropometric data, ankle pressures, basal skin fluxes and postural vasoconstrictor responses 
were tested pre-, post- and six weeks after intervention.  Repeated measures Anova was used 
to look at differences between interventions over time. 
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All statistical analyses were performed using Statview v5.0 (SAS Institute Inc, NC, USA). A 
p-value <0.05 was considered as statistically significant.  In selected cases, borderline 
significances are also shown. All data will be presented as mean +/- SE. 
 
On occasion, measured variables could not be obtained because patients could not participate 
in all testing sessions following intervention due to graft failure, amputation or mortality. This 
reduced the n numbers below 40, particularly for repeated measures analysis, and lowered the 
power of statistical comparison. This will be highlighted as appropriate. 
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RESULTS 
4.1!Study!cohort!
Table 18 provides demographic data on the patient study group as a whole and for the groups 
divided according to treatment intervention. The most noticeable difference between the 
groups were the numbers, 30 receiving open surgery and 10 receiving endovascular treatment. 
This arose because patients were allocated to the most clinically appropriate intervention and 
during the course of the study there were more patients deemed suitable for open surgery than 
endovascular intervention.  Furthermore, some patients declined to take part in the study, 
either when they were initially approached or failed to return following initial testing pre-
intervention.  More of these patients were in the endovascular group (open 6: endovascular 
11).  Any significant differences in characteristics between the treatment groups that are 
pertinent to likely treatment effects will be pointed out.  
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ALL PATIENTS 
(n=40) 
OPEN  
(n=30) 
ENDOVASCULAR 
(n=10) 
Number 40 (100) 30 (75) 10 (25) 
Age (yrs) 72 (r52-92) 70 (r 52-89) 76 (r 59-92) 
Gender (M:F) 26:14 (65:35) 21:9 (70:30) 5:5 (50:50) 
BMI (kg/m2) 27 (r16-44) 27 (r16-44) 25.9 (r19-30) 
 
Resting heart rate (bpm)  
 
72±3 
 
69±3 
 
80 ± 6 
Brachial systolic blood pressure 
(mmHg) 
 
151±4 
 
154±3 
 
142 ± 10 
 
TASC (femoro-popliteal): 
     
A 0 (0) 0 (0) 0 (0) 
B 10 (27) 3 (10) 7 (70) 
C 9 (23) 7 (23) 2 (20) 
D 21 (53) 20 (66) 1 (10) 
Inflow disease 9 (23) 9 (30) 0 (0) 
 
Fontaine: 
      
III 23 (58) 19 (63) 4 (40) 
IV 17 (43) 11 (37) 6 (60) 
       
 
Risk Factors: 
      
Cholesterol 33 (83) 27 (90) 6 (60) 
Hypertension 32 (80) 24 (80) 8 (80) 
Smoker (current or ex) 36 (90) 29 (97) 7 (70) 
Diabetes 16 (40) 12 (40) 4 (40) 
IHD 19 (48) 13 (43) 3 (30) 
TIA or CVA 8 (20) 8 (27) 0 (0) 
Dialysis 4 (10) 2 (7) 2 (20) 
 
Medications: 
      
Beta blocker 10 (25) 8 (27) 2 (20) 
Ca2+ channel antagonist 13 (33) 10 (33) 3 (30) 
Vasodilators 5 (13) 3 (10) 2 (20) 
ACEi/AT2 blockers 18 (45) 13 (43) 5 (50) 
Diuretics 19 (48) 15 (50) 4 (40) 
Aspirin/Clopidogrel 36 (90) 29 (97) 7 (70) 
 
Table 18: Demographics of the patient study group as a whole and divided into the two intervention groups.  Figures in 
parentheses represent the proportions within each group of the specified factor. IHD – Ischaemic heart disease, TIA – 
Transient Ischaemic Attack, CVA – Cerebrovascular Accident. Values are reported as mean ± SE. 
 
Physical%characteristics%
 
The mean age of all study participants, 72 ± 11(SD) years, included a small number of very 
elderly patients but the age ranges of the two treatment groups were similar (Table 18). 
Overall there was a preponderance of male over female patients (26:14), reflecting the 
154 
 
distribution of vascular disease in this age of population. With the disparity in numbers 
between the treatment groups, this M:F ratio was maintained in the open group but was equal 
in the endovascular group. Any potential influence of gender balance on measured variables 
will be indicated where appropriate. For example, although the height (170 ± 2cm, mean ± 
SEM) and weight (80 ± 3.7 kg) for the open group tended to be greater than for the 
endovascular group (height 160 ± 3cm, weight 68 ± 4.1kg) because of more men in the 
former, values of BMI for the two groups were similar (open: 27 ± 1.1, endovascular: 25 ± 1.0 
kg/m-2). 
 
Disease%classification%
 
There were however, evident differences in disease status between the two groups at the 
outset. When disease was categorised using the Fontaine classification, there were 
proportionately more open patients fulfilling Fontaine III criteria and more endovascular 
patients with Fontaine IV disease.  
 
Likewise, with the TASC classification there was a difference across the categories with 
>65% of open patients in class D and 70% endovascular patients in class B. There was no 
correlation between increasing TASC classification, which is defined by disease morphology 
and increasing Fontaine classification, which is based upon patient symptoms.  For example, a 
patient with peripheral ulceration satisfying Fontaine criteria IV may have less anatomical 
disease present than a patient with rest pain, Fontaine III.  This may be due to other co-
existing conditions that predispose ulceration, despite a lower vascular disease burden. 
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A new descriptive index of disease severity based on length and degree of stenosis, the NSB, 
was used to discriminate better between the groups. For all patients, the numerical values 
obtained increased with an increasing femoro-popliteal segment TASC classification (p0.03 
ANOVA). Similarly, when inflow disease was present in the iliac vessels, a significantly 
higher NSB index was recorded (inflow disease 55.9±4.2 AU, no inflow disease 31.7±2.2, p 
<0.0002).  
 
 
 
Figure 36: Femoro-popliteal segment TASC classification and its relationship to the NSB index of the most symptomatic 
limb 
 
Thus, the NSB index correctly matched with disease severity. It also distinguished the 
difference in disease status between the treatment groups, being significantly greater in the 
open group (40.1±3.2 AU) compared to the endovascular group (25.7±3.2 AU) reflecting the 
anatomical severity of the disease in the former. 
 
With regard to other factors impacting upon critical limb ischaemia and disease status, there 
were more patients with hypercholesterolemia in the open group and a higher proportion of 
smokers, current or ex. There were similar numbers of hypertensives and diabetics in each 
group but a larger proportion of patients with renal failure requiring dialysis in the 
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endovascular group.  There were more patients in the open group with symptomatic disease in 
other vascular beds, including CVAs and ischaemic heart disease (Table 18).   
 
So, overall disease severity was greater in the open group with a higher TASC classification 
and a greater percentage of patients with inflow disease.  This also correlated with greater 
symptomatic systemic vascular disease in this group. 
 
4.2!Haemodynamic!Evaluation!
 
Pre-intervention, brachial systolic blood pressures were slightly higher in the open compared 
to the endovascular group (154 ± 3 vs.142 ± 10mmHg, NS) but this difference was not 
significant.  Both groups had similar consumption of vasoactive medications for hypertension.  
More patients were on anti-platelet agents in the open group (97%) compared to the 
endovascular patients (70%), which may be due to the higher incidence of IHD in this group 
(Table 18). Likewise, resting heart rates in the two groups were not different (open 69 ± 3, 
endovascular 80 ± 6 beats.min-1, NS).  Overall, the cardiovascular status of these two groups 
was similar. 
 
Ankle%Pressures%
 
Ankle-brachial pressure index (ABPI) is widely accepted as a useful tool to screen for the 
presence of haemodynamic disease in the lower extremity arteries. Pressures were measured 
at the posterior tibial (PT), dorsalis pedis (DP) and peroneal (PN) arteries of both legs and the 
ABPI was calculated for each individual ankle vessel.  
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In leg one (the worst affected and scheduled for intervention), absolute ankle pressures for all 
patients were significantly lower in the open group compared to the endovascular group for 
the PT and PN vessels, and DP values also tended to be lower in the open group (Figure 37a). 
However, the variance of pressure measurements within the endovascular group especially 
was large due to the presence of several abnormally high readings, greater than systolic 
pressure, as a result of vessel calcification. As this renders ABPIs uninterpretable, these 
outliers were removed and figure 37b shows that whilst the open group still tended to have 
lower ankle pressures, there were no statistical differences between the two groups.  
 
a)       b) 
  
Figure 37: Absolute ankle pressure in leg one pre-intervention, divided by open and endovascular a) in all patients and b) 
after removing outliers.  Values are mean ± SE. Posterior tibial (PT), Peroneal (PN) and Dorsalis pedis (DP) vessels. * 
p<0.05 between groups. 
 
The impact of variable ankle pressures on ABPIs is shown in Table 19 below. Inclusion of all 
patient values resulted in significantly higher ABPIs in the endovascular than open group 
(Table 19a) whereas removal of the outliers abolishes this difference (Table 19b). The 
pressure in the dorsalis pedis vessel tended to be higher than the PT and PN vessels in both 
groups, but this was not significant. 
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Table 19: Average pre-intervention ABPI for each vessel in leg 1 for open and endovascular groups for all patients and after 
removal of outliers. Values are mean ± SE. Artery abbreviations as in Figure 37.  * p<0.05, NS non-significant between 
groups. 
 
The same applied to ankle pressure measurements made on the contralateral leg (leg 2, least 
affected and remaining untreated), as vessel calcification was usually present bilaterally.  
Absolute pressures (Figure 38a) and indices (Table 20a) were higher in the open than 
endovascular group when including all patients but the difference was abolished on removal 
of the outliers, except for the peroneal artery index which remained significantly higher in the 
endovascular group. This is often the worst affected ankle vessel of the 3 in PVD, particularly 
in diabetic patients.  The greatest effect of removing outliers was seen in the endovascular 
group, as there were proportionately more patients with falsely elevated ABPIs in this group.    
 
 
 
 
 
 
 
 
 
 
 All  Outliers removed  
Index Open (n=30) Endo (n=10) Open (n=28) Endo (n=7) 
PT  
 
0.35 ± 0.8 0.93 ± 0.34    * 0.25 ± 0.05  0.30 ± 0.11  (NS) 
PN 
  
0.23 ± 0.05 0.81 ± 0.31    * 0.23 ±0.05 0.39 ± 0.12  (NS) 
DP 
 
0.45 ± 0.09 0.86 ±0.29  (NS) 0.30 ± 0.05 0.45 ± 0.08  (NS) 
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a)       b) 
  
  
Figure 38: Absolute ankle pressure in leg two pre-intervention, divided by open and endovascular a) in all patients and b) 
after removing outliers.  Values are mean ± SE. Artery abbreviations as in Figure 37.  * p<0.05 between groups. 
 
 
Table 20: Average pre-intervention ABPI for each vessel in leg two, divided by open and endovascular for all patients and 
after removal of outliers. Values are mean ± SE. Artery abbreviations as in Figure 37.   * p<0.05, NS non-significant between 
groups. 
 
Comparison of Figures 37a and 38a shows that ankle pressures in leg one were significantly 
less than the respective pressures in leg two pre-intervention, reflecting the most symptomatic 
leg in both groups.  
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 All  Outliers removed  
Index Open (n=30) Endo (n=10) Open (n=28) Endo (n=7) 
PT  
 
0.62 ± 0.07 1.19 ± 0.29    * 0.55 ± 0.05 0.67 ± 0.14  (NS) 
PN 
  
0.50 ± 0.08 1.25 ± 0.27    * 0.45 ± 0.07 0.75 ± 0.07    * 
DP  
 
0.65 ± 0.07 1.23 ±0.27     * 0.60 ± 0.05 0.74 ±0.07   (NS) 
Vessel 
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Toe%Pressures%
 
Although small vessels in the foot may be calcified in patients with CLI, it is rare for pedal 
vessels to be significantly calcified and absolute toe pressure measurements therefore remain 
a reliable indicator of the severity of disease, even in patients with non-compressible ABPIs 
(Dattilo and Casserly, 2011).  Consequently, all patient data were included.  
 
Figure 39 shows that there was no significant difference between the absolute toe pressures 
between groups in either leg one or leg two.   In leg one, the mean values were 15 ± 4 mmHg 
in the open group and 24 ± 7 mmHg in the endovascular group. As such they fall below 30 
mmHg, consistent with a diagnosis of CLI, whereas for leg two, the values were above this 
level (open 55 ± 6 mmHg; endovascular 65 ± 12 mmHg). Likewise, there were no significant 
differences in toe pressure indices between groups in either leg one (open 0.10±0.02; 
endovascular 0.15±0.05) or leg two (open 0.39±0.04; endovascular 0.47±0.07). 
 
 
Figure 39: Average toe pressures in leg one and two pre-intervention, divided by open (n=30) and endovascular (n=10). 
Values are mean ± SE. Mark sigs * p<0.0001 between legs. 
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Skin%LDF%Pressures%
 
Measurements were made using the laser probe on the great toes of respective legs. A rise in 
LDF above baseline, with reducing cuff pressure around the calf, indicated return of 
perfusion. Both groups had similar pressures at the outset in leg one and leg two.  The 
pressure in leg two was significantly greater than in leg one for both groups, as expected. 
 
Pressure (mmHg) Open (n=30) Endo (n=9) 
Leg 1 47.8 ± 5.4 54.0 ± 10.0          (NS) 
Leg 2 94.6 ± 5.9 * 91.8 ± 15.0 *       (NS) 
 
Table 21: Average pre-intervention skin LDF pressures (mmHg) for leg one and two, for open and endovascular groups.  
Values are mean ± SE. NS non-significant between group; * p<0.05 between legs 
 
 
Ankle, toe and skin pressures in leg one were significantly less than the respective pressures 
in leg two pre-intervention, reflecting the most symptomatic leg in both groups.  
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4.3!Assessment!of!lower!limb!oedema!
Lower%limb%anthropometry%
 
Measurements were made of the volume of the lower limb segment (knee to ankle) to provide 
baseline data from which to assess whether treatment affects limb swelling and oedema. The 
mean limb volumes of leg one and two were significantly different between groups at 
baseline, with the open group having larger average volumes. Since the open group included a 
higher proportion of males than in the endovascular group, and males in general have larger 
limb size than females, a two-factor Anova was carried out to examine the effects of gender 
and group on volume. This showed that it was gender, the preponderance of men in the open 
group that significantly influenced volume (p=0.02) rather than treatment group per se 
(p=0.10). 
 
 
 
 
Table 22: Average pre-intervention limb volume (Lq) for leg 1 and 2, for open and endovascular groups. Values are reported 
as mean ± SE. * p<0.05 between groups. 
 
As an assessment of oedema due to CLI, leg one volume (ml) was graded with TASC 
classification, higher mean values occurring with TASC D (1630) > C (1490) > B (1410). 
(Figure 40) The same was also true for leg two, but there was no significant difference 
between the legs.  There were similar proportions of males and females in each TASC group 
(Females A0%, B29%, C29%, D43% vs. males A0%, B23%, C19%, D58%)  
 
Limb Volume (ml) Open (n=30) Endo (n=10) 
Leg 1 1620 ± 0.07 1302 ± 0.12  * 
 
Leg 2 1620 ± 0.08 1330 ± 0.10  * 
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Figure 40: Point chart of average lower limb volume (ml) in leg one pre-intervention compared to TASC classification. 
 
There was no correlation between and lower limb volume and foot circumference pre-
intervention and the disease severity, as indicated by NSB index (Figure 41).  
 
  
  
Figure 41: Pre-intervention a) limb volume of leg one and b) foot circumference and their relationship to the NSB index of 
the most symptomatic limb. 
 
Tissue oedema was also evaluated in the forefoot by circumferential measurements. At 
baseline there were no group differences in circumference of the forefoot in leg one (Open 
23.6 ± 0.3, Endo 23.5 ± 0.7cm, NS) or leg 2 (Open 23.7 ± 0.4, Endo 23.2 ± 0.7cm, NS). 
Although this contrasts with findings for lower limb segment volume, it is not surprising 
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given that tissue composition at the forefoot is less dependent on subcutaneous adipose and 
hence less subject to gender influences.  
 
However, ultrasound measurement of tissue depth from skin surface to fascia, to assess 
subcutaneous oedema, did not detect any baseline differences between groups at any site in 
either leg one or leg two. When subdivided by gender, there was a tendency for females to 
have greater tissue depths than males at all 3 regions but this was not statistically significant.  
There was no difference in tissue depth between leg one and two in any region pre-
intervention. 
 
Table 23: Average pre-intervention tissue depth (cm) for leg one and two, divided by open and endovascular.  Values are 
mean ± SE. 
 
Consequently, the relationship between tissue depth at calf and ankle and the leg volume for 
all patients (not subdivided into open and endovascular groups) was not very close pre-
intervention, as shown by figure 42a below.  The correlation coefficients are 0.43 and 0.32 
respectively, although there is a relationship between the two variables, p<0.001.  Foot 
circumference against tissue depth also demonstrated a relationship, p<0.001 although this 
was not a strong correlation r20.2. (Figure 42b)  
 
 
Tissue depth (cm) Open (n=30) Endo (n=10) 
 Leg 1 Leg 2 Leg 1 Leg 2 
Tibial tuberosity 0.36±0.04 0.34±0.04 0.30±0.04 0.32±0.04 
Medial malleolus 0.65±0.07 0.59±0.08 0.63±0.11 0.54±0.10 
Forefoot 0.57±0.07 0.51±0.06 0.55±0.09 0.48±0.08 
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(a)           (b) 
  
 
Figure 42: Tissue depth at the calf and ankle against leg volume for all patients (a) and tissue depth in the forefoot against for 
circumference (b).  Values are mean ± SE. Artery abbreviations as in Figure 37. 
 
 
There was an initial difference in lower limb volume between groups, which is gender related 
and was not dependent on differences in subcutaneous fat.  There was a tendency for higher 
TASC classifications to have greater limb volume. 
 
 
Durometry%
 
Durometry measurements have been shown to be a sensitive indicator of tissue hardness and 
can demonstrate changes over time (Choh et al., 2010, Kissin et al., 2006).    
                                                             
Tissue hardness was greatest at the ankle and least at the forefoot but there were no 
differences between the treatment groups in Durometry values at any of the 3 defined 
locations in either leg.  There were no differences in tissue hardness between the genders or 
between leg one and leg two at the calf and the ankle. However, forefoot tissue hardness in 
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leg one was significantly greater than in leg two. As tissue depth in this region was similar 
between the legs, this indicates greater ‘turgor’ in the more symptomatic leg. 
 
Durometry Open (n=30) Endo (n=10) 
 Leg 1 Leg 2 Leg 1 Leg 2 
Tibial tuberosity 39.1±1.05 37.0±5.70 36.1±2.03 37.0±2.28 
Medial malleolus 45.1±1.40 44.6±1.54 43.9±2.46 40.1±2.13 
Forefoot 29.8±2.01 26.3±1.76  † 27.2±3.09 23.6±3.23  †† 
 
Table 24: Average pre-intervention tissue Durometry for leg one and two, for open and endovascular groups. Values are 
mean ± SE. †p<0.05, †† p<0.01 between leg one and leg two. 
  
Tissue hardness was similar between the two groups at all three points.  The forefoot in the 
symptomatic limb displays greater skin turgor than the contralateral foot.    
 
Overall, anthropometrical measurements showed a greater limb volume in patients with more 
severe disease and in the male population.  This was not related to an increase in 
subcutaneous tissue depth or an increase in tissue hardness in the limb.  At the forefoot, 
circumference and tissue depth were not increased but skin hardness is greater in the 
symptomatic limb. 
 
Healthy!volunteers!
 
Using data from our 4 healthy control subjects, Durometry was inversely related to tissue 
depth at the ankle and the calf. (Figure 43) That is, the greater tissue depth, the less the tissue 
hardness. Eight data points have been used in total from the mean of 2 measurements for each 
person and using separate data from each leg.  This goes against the notion that Durometry 
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increases with tissue depth, but this will depend on what the tissue depth is due to i.e. soft fat 
or hard oedema.  
 
 
Figure 43: The relationship between average lower limb tissue depth (cm) in 4 healthy volunteers in both legs, compared to 
Durometry readings at the same location: calf, ankle, foot. 
 
4.4!Microcirculation!of!the!lower!limb!skin!pre!treatment!
Basal%flux%
 
Although LDF measurements of flux cannot be taken as absolute values, they do give an 
indication of perfusion levels in the different regions of the lower limb in the patients. For the 
shin and the foot, regions of hairy/non-glabrous skin, perfusion was higher in the 
endovascular than the open group (Figure 44), although this difference was only significant at 
the foot (49.5±6.9 vs. 24.6±2.45, p0.004). For toe 1 in leg 1, a glabrous region where arterio-
venous anastomoses are prevalent, perfusion was similar between treatment groups but for toe 
2 of the untreated leg, perfusion was significantly higher in the open than the endovascular 
group (111.8±17.9 vs. 57.7±14.5, p0.02).  
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Figure 44: Basal flux for shin, foot and toes for each open (n=30) and endovascular (n=10). Values are means ± SE. *Foot 
p0.004, toe 2 p0.02. 
 
In terms of actual flux, values tended to be lower prior to cuff inflation in the endovascular 
than the open group, and this was the case for both legs (Table 25).  
 
Reactive%Hyperaemia%
 
The ability of the skin microcirculation of the toes to display reactive hyperaemia, following a 
two-minute arterial occlusion, was assessed using Laser Doppler flowmetry. As described in 
‘methods’ section, Laser Doppler fluxes are measured in arbitrary units rather than absolute 
values because of the variability of tissue volume and micro vessel numbers detected by the 
probe. Reactive hyperaemia was therefore quantitatively measured using three parameters 
derived from the flux signal: 
 
1. Time to peak (Tp) 
2. Magnitude of the peak (Mag) 
3. Area under the curve (AUC) 
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Actual flux units and/or percentage change in flux from baseline express a change in flux.  
 
The figure below demonstrates the reactive hyperaemia curve from the four healthy control 
subjects and the shape of a typical response following cuff occlusion, up to 50seconds post 
cuff release.  The average time to peak was 32.8±4.1sec, with a peak percentage change in 
magnitude of flux 372.2±96.9%.  
 
 
 
 
 
 
 
 
Figure 45: Time course of reactive hyperaemia as a percentage change in flux from baseline for healthy controls.  Values are 
means ± SE for 10s average values.  Arterial occlusion commenced at t = -120s and the cuff was released at t = 0s. Brownian 
motion prevents the flux going to absolute zero when the cuff is inflated. 
 
With regards to the treatment groups, Figure 46 illustrates the time course of the flux signal in 
Toe 1 for both groups pre-intervention, expressed as actual flux (Figure 46a) and as % change 
from baseline (Figure 46b). 
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Figure 46: Time course of 
(a) actual flux and (b) flux 
expressed as % of baseline 
for open group (n = 29, 
blue line) and endovascular 
group (n = 9, red line) for 
the toe of the most 
symptomatic leg. Values 
are means ± SE for 10s 
averaged values. Arterial 
occlusion commenced at t 
= -120s and the cuff was 
released at t = 0s. 
Brownian motion prevents 
the flux going to absolute 
zero when the cuff is 
inflated. 
 
 
 
 
 
In comparison to the control subjects, neither group showed any great degree of hyperaemia 
in toe 1, and flux values of many individuals hardly reached baseline levels by the end of the 
2 min post-occlusion observation period (Figure 46a). The peak magnitude of toe one post-
occlusion response was not different between the groups whether expressed as actual flux or 
relative to baseline (Table 25), but it was significantly lower than that in toe two in the open 
group, consistent with being the limb with worse perfusion.  The AUC was significantly 
different between groups at the outset, with the open group not achieving a flux above 
baseline and hence a negative AUC in leg 1. (Figure 47)  There were no significant 
differences between the groups in leg 2. 
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Figure 47: Area under the curve for reactive hyperaemia in leg 1 pre-intervention, in open (blue) and endovascular group 
(red).  Values are means ± SE.  
 
 Open (n= 29) Endo (n=9 ) 
 Toe 1 Toe 2 Toe 1 Toe 2 
Baseline flux (APUs) 22.9 ± 3.3 95.5 ± 15.9† 
p<0.001 
15.2 ± 2.1 50.1 ± 13.0† 
p0.03 
Peak flux magnitude 
(APUs) 
32.0 ± 4.5 159.8 ± 19.2† 
p<0.001 
29.6 ± 4.8 108.5 ± 21.3† 
p0.03 
Peak flux magnitude  
(% baseline) 
150.0 ± 14.2 306.7 ± 80.0† 
p0.05 
196.8 ± 20.1 264.4 ± 60.5 
Time to peak 
magnitude (sec) 
100 ± 4* 
p0.003 
82 ± 5 69 ± 9 63 ± 12 
Area under the curve 
(APU’s) 
-34.0 ± 18.9* 
p0.01 
251.0 ± 76.2† 
p0.0007 
56.1 ± 19.0 179.3 ±84.5 
Table 25: Average pre-intervention LDF recordings for toe one and two, for open and endovascular groups.  Actual flux 
“units” are recorded as ‘Arbitrary Perfusion Units’ (APU’s) for baseline flux and peak flux magnitude. The percentage values 
are relative to baseline, which is 100%. Values are mean ± SE. †p value  between toe 1 and toe 2. * p value  between open 
and endovascular. 
 
Pre-intervention there was a significant difference between groups in toe 1 average time to 
peak due to a slower response in the open than endovascular group (Table 25) most likely 
because of the poorer perfusion pressures in the former. These data contrast markedly with 
reactive hyperaemias in the control group of 4 healthy volunteers with normal pressures 
(ABPI 1.06±0.05) in whom peak magnitude reached 372±96.9% of baseline and times to peak 
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were 32.8±4.1sec. Although this is not age-matched data, it is consistent with data in the 
literature of age-matched individuals (36.1±4.25) (Van den Brande and Welch, 1988). 
 
It was of interest to note that in toe two of both groups in the present study, times to peak 
were similar to those in toe one despite toe pressures being significantly higher in leg two.  
 
In CLI, the hyperaemic response was flatter, delayed and prolonged compared to the rapid 
rise in flow seen in healthy individuals.  This was most marked in the symptomatic leg, 
compared to the contralateral limb.  The response in leg two however was also dampened in 
contrast to a healthy limb. 
 
Vasoconstrictor%mechanisms%
 
In CLI peripheral microvessels show a compensatory dilatation and a loss of local regulatory 
control mechanisms, characterised by impaired myogenic and sympathetic neural constriction. 
The normal postural vasoconstrictor response to leg dependency (myogenic) or sitting 
(neurogenic/sympathetic) is usually absent.  
 
Figure 48a shows the changes in skin perfusion during leg dependency for 3 sites on the most 
symptomatic leg one – shin, foot dorsum and toe. Constriction was only evident in the 
endovascular group where flow decreased by 15% (NS), 26% (p=0.02) and 17% (NS) for the 
three sites respectively. In the open group, constriction was only evident in the foot (10% 
decrease, p=0.05) while flow increased slightly at the shin and toe. Thus the open group 
showed greater impairment of the myogenic constrictor response than the endovascular group, 
consistent with their worse pressures and basal perfusion.   
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Figure 48b shows the changes in skin perfusion when patients assumed the sitting position 
from lying supine. In this situation, the hydrostatic pressure load would be expected to 
increase by ~ 40-60mmHg in a normal circulation and elicit a constrictor response at the toe 
(~50% flow reduction, De Graaf et al. 2003).  
 
     a)                                                                                          b) 
  
                     Shin             Foot            Toe 1                 Shin             Foot           Toe 1           Toe 2 
 
Figure 48: Change in skin perfusion from horizontal to (a) leg dependency in shin, foot and toe 1 and (b) sitting in shin, foot, 
toe 1 and toe 2 for each open (n=30) and endovascular (n=10). Horizontal flux is 0% with an increase in flux seen as a rise 
above baseline and constriction or reduction in flux is seen as a fall below baseline. Values are means ± SE. *p0.05, **p0.02 
***p0.003. 
 
On moving to a sitting position, the decrease in skin perfusion in the endovascular group was 
graded according to the site. It was greatest at the shin (40%), less at the foot (20%) and 
absent at the toe of leg 1 (5%). In the open group, there was no change in perfusion at the 
shin, a modest decrease at the forefoot and no change at the toe. For the toe of leg two, 
significant constriction was seen on sitting (~40%) and there was no difference between the 
treatment groups.  Thus, postural alteration demonstrated greater impairment in the VAR of 
the open group in comparison to those undergoing endovascular treatment given their more 
-50
-40
-30
-20
-10
0
10
20
30
LD VAR Shin LD VAR Foot LD VAR Toe1 LD VAR Toe2
-50
-40
-30
-20
-10
0
10
20
30
Sit VAR Shin Sit VAR Foot Sit VAR Toe1 Sit VAR Toe2
Endovascular
Open
 
    *      
          ** 
%
 C
ha
ng
e 
in
 fl
ux
 
          ***  
    *            **                 ***  ** 
  
174 
 
pronounced reduction in flow with sitting.  This was consistent with greater compromise of 
the microcirculation in the former. 
 
Skin perfusion did not reduce in line with a postural vasoconstrictor response in CLI.  The 
endovascular group kept a modest response compared to the open group. Postural 
vasoconstriction was most evident at the foot. 
 
Frequency%analysis%of%microvascular%oscillations%
 
A Fast Fourier Transform power spectral analysis of the Laser Doppler flux signal from toe 
one was carried out to examine whether the microvascular controls relating to myogenic, 
neurogenic and endothelial mechanisms would be altered by treatment.  
 
The total power pre-intervention was not different between the two groups (open: 
206.2±28.9nu endovascular: 159.9±20.8nu, NS) and therefore the power ascribed to the five 
different frequency bands is expressed as a proportion of the total. Both groups displayed 
similar distributions of power in each band at the outset (Figure 49). The majority of power 
was displayed from the heart rate and respiration. Frequencies of myogenic origin showed 
least power.  
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It is not possible to comment on whether the distribution is representative of any impairment 
in CLI as there is no comparable data examining the toe in CLI with FFT and age-matched 
controls.  However, below is the control subject data from the pilot study (non age-matched) 
expressed as percentage power (Figure 50).  Compared to the CLI patients there is a similar 
power ascribed to endothelial and neurogenic frequencies but myogenic and respiratory 
frequencies are considerably lower, with the difference being ascribed to a greater percentage 
power of heart rate.  Presumably this reflects the elastic nature of healthy vessels and the 
unobstructed transmission of flow to the peripheries. 
 
 
 
 
Figure 49: Fast Fourier Transform power spectral 
analysis of Laser Doppler flux, expressed as % of 
total power for open group (n = 30, blue) and 
endovascular group (n = 10, red) for the toe of the 
most symptomatic leg. Values are means ± SE. 
The frequency and origin ascribed to the 
bandwidths are displayed below. 
Origin Band Frequency % Power 
Endothelial VVVLF 0.009-0.02 O 14.8±2.9 
E 16.3±4.2 
Neurogenic VVLF 0.02-0.06 O 16.4±2.3 
E 17.3±4.2 
Myogenic VLF 0.06-0.15 O 11.7±1.4 
E 10.3±2.8 
Respiratory LF 0.15-0.6 O 19.3±2.6 
E16.9± 3.8 
Heart rate HF 0.6-2.0 O 37.7 ±3.8 
E 39.2±5.4 
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Origin Band Frequency % Power 
Endothelial VVVLF 0.009-0.02 17.6±6.5 
Neurogenic VVLF 0.02-0.06 18.1±3.4 
Myogenic VLF 0.06-0.15 5.8±2.7 
Respiratory LF 0.15-0.6 5.0±1.3 
Heart rate HF 0.6-2.0 57.8±9.0 
  
Figure 50: Fast Fourier Transform power spectral analysis of Laser Doppler flux, expressed as % of total power for the 
healthy control group. Values are means ± SE. The frequency and origin ascribed to the bandwidths are displayed above. 
 
The actual power attributed to each of the microvascular controls is shown below (Figure 51).  
There were no significant differences between the groups for any of the power bands. 
 
 
 
 
Figure 51: Fast Fourier Transform power spectral analysis of Laser Doppler flux, expressed as actual power for open group 
(n = 30, blue) and endovascular group (n = 10, red) for the toe of the most symptomatic leg. Values are means ± SE.  
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4.5!Treatment!effects!
Clinical Outcomes at six-weeks after Intervention 
 
Out of 36 patients tested at six weeks, 21 (58%) of vessels remained patent. The proportion of 
patency was considerably higher in the open (73%) than in the endovascular group (20%). 
This was linked with the presence of tissue necrosis, which occurred in only a third of the 
open group but in two thirds of the endovascular group (Figure 52a). Patency did not 
associate with symptom relief, which was similar in both groups (Figure 52b). The success of 
the open intervention was also evidenced by the necessity for re-intervention/operation, which 
was required in 5 out of 26 in the open group, with 2 patients requiring operative 
reintervention twice following initial surgery.  All but one of the endovascular group required 
repeat endovascular reinterventions.  There were 5 wound infections in the open group.  
 
Within 30 days of intervention, 3 patients in the open group died of cardiac causes one of 
which died following limb amputation after an unsuccessful bypass procedure; they had NSB 
scores ranging from 24 to 64.  There were no immediate deaths in the endovascular group.  
One further patient in the open group underwent amputation; they had an NSB score of 56. 
 
a)                                                                            b)                                                                 c) 
   
Figure 52. Percentage of patients within open (blue) and endovascular (red) groups a) experiencing none (N), partial (P) or 
complete (C) symptom relief, b) with presence of tissue necrosis at six weeks, c) requiring re-intervention.  
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Consistent with patency, the vast majority of patients in the open group became ‘unclassified’ 
(U) by femoro-popliteal TASC criteria at six-weeks, as radiological evidence of significant 
disease was no longer present.  A small number of patients in this group had minor stenoses in 
their graft and four patients had significant occlusions at six-weeks. On the other hand, in the 
endovascular group the distribution of classification changed from predominantly ‘B’ pre-
intervention to a mixture from A to D inclusive and 2 patients with no evidence of disease 
radiologically (Figure 53). 
 
a) b) 
  
c) d) 
  
Figure 53: TASC classification by absolute numbers in the open group (blue) a) pre-intervention and b) at six weeks and in 
the endovascular group (red) c) pre-intervention and d) at six weeks. 
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Supporting the evidence that the surgical invention was successful at improving disease status 
was the highly significant decline in the novel NSB index from pre-intervention to six-weeks 
in this group with a reduction of 25 ± 3 AU (p<0.0001).  In the endovascular group the 
reduction of 7 ± 3 AU was less marked (p<0.03), but the pre-intervention score was already 
lower than in the open group.  
 
 
Figure 54: Mean ± SE values for NSB index pre-intervention and at six-weeks post-intervention for open (n=26) and 
endovascular (n=10). ** p<0.0001, * p<0.05. 
 
 
Haemodynamic%evaluation%after%treatment%
Ankle!pressures!
 
Figure 55 shows ankle pressures for the PT, DP and PN arteries pre-intervention and 6 weeks 
later. Both groups showed significant increases, the magnitude being similar with either 
intervention for each artery (PT: Open 70 ± 12, Endo 76 ± 25 mmHg; DP: Open 53 ± 3, Endo 
46 ± 22 mmHg; PN: Open 71 ± 11, Endo 56 ± 27 mmHg) with no significant difference 
        Pre            Six 
* 
** 
 
 
N
SB
 
 
180 
 
100
110
120
130
140
150
160
170
pre_VAD_SBP post_VAD_SBP six_VAD_SBP
100
110
120
130
140
150
160
170
pre_VAD_SBP post_VAD_SBP six_VAD_SBP
PT
0
50
100
150
m
m
H
g
between treatment effects. However, there was greater variation in the pressure increase 
achieved in the endovascular than open group, as demonstrated by the large variance. 
 
  
Figure 55.  Ankle pressures ± SE for posterior tibial (PT), dorsalis perdis (DP) and peroneal (PN) arteries pre-intervention 
(open columns) and six weeks after surgery (open: blue and endo; red). Values are means ± SE. 
 
 
Systolic blood pressures decreased within 72 h of intervention, most likely due to residual 
effects of surgery and medication, but had recovered to pre-invention values by 6 weeks 
(Figure 56 a and b).  
 
         Open            Endo  
 
 
 
 
 
 
Figure 56.  Brachial systolic blood pressure ± SE at the three-time intervals; pre-intervention, post-intervention and at six 
weeks for a) open and b) endovascular groups. Values are means ±SE. *p<0.05 over time.  
 
In keeping with absolute pressures, the ankle pressure indicies have increased from pre-
intervention to six-weeks in both intervention groups (Table 26). 
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 Open (n = 25) Endo (n = 7) 
 Pre Six weeks Pre Six weeks 
PT Pressure 
      Index 
40.0 ±7.97 
0.26 ±0.05 
110.2 ±10.7  
0.69 ±0.07 † 
49.4 ±17.7 
0.30 ±0.11 
125.1 ±15.4  
0.80 ±0.08 † 
DP Pressure 
      Index 
63.5 ±13.8 
0.40 ±0.08 
116.2 ±10.9  
0.73 ±0.07 † 
79.6 ±10.4 
0.51 ±0.06 
125.1 ±17.1  
0.79 ±0.09 † 
PN Pressure 
      Index 
43.0 ±8.9 
0.27 ±0.06 
114.6 ±10.3  
0.72 ±0.06 † 
68.3 ±18.9 
0.44 ±0.13 
124.0 ±16.6  
0.78 ± 0.08 † 
 
Table 26: Absolute ankle pressure and indices by vessel for leg 1 open and endovascular, pre-intervention and at six weeks. 
Values are means ± SE. †p value  p<0.001 between pre-intervention and six weeks.  
 
 
In leg 2, ankle pressures and indices (Table 27) showed no significant change over time.  
 
 Open (n = 25) Endo (n = 7) 
 Pre Six weeks Pre Six weeks 
PT Pressure 
      Index  
93.8 ±11.1 
0.61 ±0.08 
115.3 ±11.9 
0.73 ±0.08 
100.3 ±20.2 
0.67 ±0.14 
126.9 ±13.4 
0.81 ±0.09 
DP Pressure 
      Index 
96.0 ±11.2 
0.63 ±0.08 
121.0 ±11.3 
0.76 ±0.08 
111.6 ±8.7 
0.74 ±0.07 
120.9 ±15.3 
0.75 ±0.06 
 
PN Pressure 
      Index 
80.3 ±13.6 
0.53 ±0.09 
102.0 ±14.1 
0.65 ±0.09 
113.4 ±9.3 
0.75 ±0.07 
128.3 ±13.9 
0.82 ±0.07 
 
 
Table 27: Absolute ankle pressures and indices by vessel for leg 2 open and endovascular, pre-intervention and at six weeks. 
Values are means ± SE. 
!
Toe!Pressures!
 
Figure 57 below illustrates the actual (a) toe pressures (b) ankle pressures recorded at the toe, 
recorded in leg 1 over time.  Both groups showed increased pressures after intervention but 
whereas in the open group, toe pressures were elevated immediately post- and increased 
further after six weeks (p<0.05), increases in the endovascular group were not evident until 
after six weeks and were not deemed significant.  
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After six weeks, the magnitude of increase in the toe pressure (38.5 ±4.6mmHg) in the open 
group was significantly greater than in the endovascular group (17.5 ±6.7mmHg). The 
magnitude of increase in the ankle pressure recorded at the toe was similar in the two groups 
(open 46.9 ±5.3mmHg, endovascular 56.3 ±4.3mmHg).   
  
   
Figure 57: a) toe pressures pre-, post- and six weeks after intervention in open (blue) n=25 and endovascular (red) n=9 
groups; b) ankle pressure recorded at the toe pre-intervention and six-weeks. Values are means ±SE. *p<0.05, ≠ p < 0.1 > 
0.05 over time. 
 
No significant changes were observed in toe pressures in leg two in either group but the slight 
drop immediately post-intervention mirrored that in systolic blood pressure, indicating a 
systemic effect.  Likewise, skin LDF pressures of leg two were unaltered. 
 
 Open (n = 24) Endo (n = 7) 
 Pre Post Six weeks Pre Post Six weeks 
Toe 2 59.4 ±6.6 42.4 ±7.1 57.1 ±5.9 65.1 ±11.6 54.7 ±11.5 67.2 ±9.6 
Skin 
Pressure 
Toe 2 
95.1 ±6.0 
 
 101.2 ±6.7 97.1 ±17.7  115.4 ±21.1 
 
Table 28: Absolute toe pressures for leg 2 open and endovascular pre-, post- and six weeks. Skin pressures in leg 2 pre-
intervention and at six weeks. Values are means ± SE.  
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Relationship%of%pressure%changes%to%intervention%clinical%outcome%
 
Increases in ankle pressure above pre-intervention values tended to be greater in patients with 
patent than non-patent vessels (Table 29). This was however, significant only for the posterior 
tibial artery in the open group, although this was the commonest site of distal anastomosis in 
the crural vessels for bypass.  Increases in toe pressures were also significantly higher in those 
with patent than non-patent vessels for all patients in the open group.  
 
 ALL PTS Open only Endo only 
Patent Yes No Yes No Yes No 
 
Patency 21 / 36 15 / 36 19 / 26 7 / 26 2 / 10 8 / 10 
 
Δ  PT mmHg 84±11 (21) 37±16 (15) ** 84±12 (19) 23±22 (7) ** 81±53 (2) 50±23 (8) 
Δ  DP mmHg 60±14 (21) 42±21 (15) 62±15 (19) 21±26 (7) 47±19 (2) 62±32 (8) 
Δ  PN mmHg 79±12 (21) 69±23 (15) 80±41 (19) 73±34 (7) 69±41 (2) 65±34 (8) 
Δ  Average 
ankle mmHg 
74±8 (21) 49±16 (15) ≠ 
 
75±9 (19) 39±21 (7) * 
 
66±38 (2) 59±25 (8) 
Δ  Toe 1 
mmHg 
54±8 (19) 6±9 (15) *** 52±8 (18) 5±12 (7) ** 96 (1)  8±15 (8) 
Δ  Skin 
mmHg 
75±8 (21) 11±14 (14) *** 79±7 (19) -13±18 (7) ** 39±45 (2)  34±18 (7) 
 
Table 29. Changes in ankle, toe and skin pressures in relation to patency at six weeks. ≠ p < 0.1 > 0.05, * p<0.05, ** = 
p<0.01, *** p<0.0001 for patent vs. non-patent.  
 
Toe 1 pressure and skin LDF pressure in toe 1 correlated significantly with a change in NSB 
from pre-six weeks for the open group. A similar but much weaker relationship was observed 
in the endovascular group due to low numbers.  
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            a)                                                                                                 b) 
  
Figure 58. Change in a) toe pressure and b) skin LDF pressure at the toe in the open group (blue) and endovascular (red) 
group, against change in NSB index value from pre-intervention to six weeks.  
 
 
Open surgery gave better outcome than endovascular in terms of patency at six weeks with a 
concomitant rise in ankle and toe pressures. Toe and skin pressures related to NSB index 
better than conventional ankle pressures.  
 
 
Oedema,%limb%volumes%and%Durometry%
 
In the open group, leg one volume increased immediately post-intervention, as did ankle 
tissue depth. After six weeks, increased leg one volume was associated with greater tissue 
depth at both ankle and calf, indicative of oedema. This response was delayed in the 
endovascular group as limb volume and ankle tissue depth increased only after six weeks, but 
this was not significant.   Overall limb 1 volume increased by a mean of 11.9% from pre-six 
weeks.  The mean difference in limb volume between leg one and two at six weeks was 
0.13L, which is also an 11.9% increase in the mean volume of leg one compared to leg 2. 
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a)                                                                                                                  b) 
  
Figure 59: Change in leg volume in a) the open group (blue) and b) endovascular group (red), against change in tissue depth 
from pre-, to post- to six-weeks. Values are means ±SE. 
 
Foot circumference increased immediately post-intervention in the open group without 
change in tissue depth, suggesting circumferential fluid accumulation/oedema.  After six 
weeks this was normalised. There was no significant change in either measure in the 
endovascular group.  
 
a)                                                                                                                  b) 
  
Figure 60. Change in foot circumference in a) the open group (blue) and b) endovascular group (red), against change in tissue 
depth from pre-, to post- to six-weeks. Values are means ±SE. 
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In the open group increases in ankle and calf tissue depth at six weeks and in foot 
circumference post-intervention were associated with higher values of Durometry. There were 
no significant changes in Durometry over time in the endovascular group.  
 
a)                                                                                                                  b) 
  
 
Figure 61. Change in Durometry in a) the open group and b) endovascular group from pre-, to post- to six-weeks. Values are 
means ±SE. 
 
 
Irrespective of intervention group, a relationship between tissue depth and Durometry reading 
was only evident for the foot (p<0.001), with a correlation coefficient of 0.2 and 0.49 pre-
intervention and six-weeks respectively.  There was no relationship at the ankle (p0.07) or 
calf (p0.52), suggesting the most distal tissues accumulate fluid and have increasing tissue 
tension/hardness. Perhaps this is due to the foot being a smaller soft tissue compartment and 
having greater hydrostatic forces.  In the open group at the calf and the ankle, the tissues get 
harder but do not change significantly in depth.  
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a)                                                                                                             b) 
  
 
c)                                                                                                        
 
 
Figure 62. Change in Durometry against 
tissue depth in the open and endovascular groups in 
the a) calf b) ankle and c) foot from pre-
intervention to six-weeks. 
 
 
 
 
 
For Leg 2, volume, foot circumference, tissue depths and Durometry at all regions did not 
change over time (Table 30).  
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 Time Open Endovascular 
Leg 2 volume (mls) 
 
Pre 
Post 
Six 
1623 ± 81 
1618 ± 82 
1628 ± 82 
1332 ± 104 
1276 ± 101 
1324 ± 102 
Leg 2 foot circumference (cms) 
 
Pre 
Post 
Six 
23.7 ± 0.4 
23.9 ± 0.4 
23.4 ± 0.4 
23.2 ± 0.7 
23.0 ± 0.6 
23.2 ± 0.6 
Leg 2 foot depth (mms) 
 
Pre 
Post 
Six 
0.52 ± 0.05  
0.50 ± 0.05 
0.47 ± 0.06  
0.48 ± 0.08  
0.59 ± 0.07 
0.51 ± 0.10  
Leg 2 ankle depth (mms) 
 
Pre 
Post 
Six 
0.59 ± 0.07 
0.59 ± 0.07  
0.57 ± 0.07  
0.54 ± 0.10   
0.49 ± 0.09  
0.58 ± 0.10  
Leg 2 calf depth (mms) 
 
Pre 
Post 
Six 
0.33 ± 0.04  
0.33 ± 0.04  
0.37 ± 0.05 
0.32 ± 0.04  
0.31 ± 0.04  
0.33 ± 0.04  
Leg 2 foot Durometry (AUs) 
 
Pre 
Post 
Six 
26.3 ± 1.8  
27.2 ± 1.6  
25.9 ± 1.9 
23.6 ± 3.2  
25.7 ± 3.4  
22.4 ± 2.4  
Leg 2 ankle Durometry (AUs) 
 
Pre 
Post 
Six 
44.6 ± 1.5  
43.8 ± 1.1  
42.7 ± 1.3  
40.1 ± 2.1  
41.3 ± 1.6 
40.3 ± 2.4  
Leg 2 calf Durometry (AUs) 
 
Pre 
Post 
Six 
39.1 ± 1.0  
42.6 ± 1.0  
39.1 ± 0.9  
37.0 ± 2.3  
37.4 ± 2.0  
37.7 ± 1.9  
 
Table 30. Change in leg volume, foot circumference, tissue depths and Durometry in leg 2 from pre-, to post- to six-weeks. 
Values are means ±SE. 
 
Comparing anthropometrical measures against patency between pre-intervention and six, 
there was only a significant relationship between patency and change in Durometry at the 
foot, p0.02 suggesting that increasing tissue hardness at the foot may be predictive of vessel 
patency. 
 
Overall, oedema was more apparent in the open group than the endovascular group. Post-
operative onset of unilateral limb oedema and increased Durometry at the foot could be 
indicative of early success of operative intervention.  
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Skin%microvascular%perfusion%%%
Basal!flux!
 
Laser flowmetry is not an absolute measure of skin blood flow; it is defined in arbitrary flux 
units, and is usually used to examine changing flows in response to provocations that elicit 
microvascular reactivity. However, it can also indicate trends for changes in levels of basal 
perfusion and on that basis, comparisons were made between different regions of skin on the 
leg and foot before and after the two treatment interventions. These are shown in the Figure 
below as absolute flux for shin, foot and toe of leg one (a, b & c). Figure 63 shows the 
absolute flux and the change in flux for the toe of leg two. 
 
In leg one, all three regions tended to show increased perfusion immediately post-
intervention, although this was not significant in the endovascular group, nor at the foot in the 
open group.  It was most noticeable in the toe of the open group (p<0.05). After six weeks, 
perfusion had returned to pre- levels in the toe, with slightly higher flux in the shin and foot of 
the open group only.   
 
a)                                                                 b)                                                                  c) 
   
 
Figure 63: Change in basal perfusion in the open group (blue) and endovascular group (red) at pre-intervention, post-
intervention and at six-weeks at a) shin, b) foot, c) toe 1. *p<0.05 over time. Values are means ±SE.  
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In leg two, toe perfusion decreased considerably in the open group from pre- to post-
intervention but this was not significant (p=0.06) and changes in endovascular were non-
significant.  
 
  
 
Figure 64 a) Actual flux in the open group (blue) and endovascular group (red) at pre-intervention, post-intervention and at 
six-weeks in toe 2 and b) change in basal perfusion in the open group (blue) and endovascular group (red) from pre-post 
intervention and from -intervention and at six-weeks in toe 2 
 
 
Overall, there was a transient improvement in the shin and toe 1 perfusion that did not persist 
beyond the immediate post-intervention period and returned to pre-intervention levels by six 
weeks.  In toe 2 the open group showed a non-significant decrease in basal flux, which may 
have been due to the effect of steal, consistent with the literature (Saucy et al., 2006).  
 
Reactive!Hyperaemia!
 
Prior to intervention, the reactive hyperaemic response in leg 1 in both open and endovascular 
groups was very poor, in many cases with failure to attain basal perfusion levels during the 2-
minute post-occlusion period. Six weeks after intervention, there was a substantial 
improvement in response in the open group but not in the endovascular group (Figure 65 a 
and b). This change was evident in the average time to peak response, which, although 
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significantly longer in the open group at the outset, had significantly shortened after six weeks 
by 41±5sec from pre-intervention in this group (Table 31).  Contrary to this, endovascular 
time to peak did not change over this time period (14±10sec, NS). Whereas the time course of 
the reactive hyperaemia was improved in the open but not the endovascular group, the 
magnitude of the peak flow, either in actual flux units or as a percentage change at peak, did 
not demonstrate consistent changes. In toe one of the open group, it increased following 
treatment, almost reaching significance (p=0.07) but there was no change in peak magnitude 
in the endovascular group. 
     a)                                                                                              b) 
  
Figure 65: Average percentage change in flux from baseline during reactive hyperaemia 1 for a) open and b) endovascular 
patients’, pre and six weeks post intervention.  Values are means ±SE. 
 
Side Variable Intervention Pre-intervention Six-weeks 
Toe 1 Time to peak 
hyperaemia (sec) 
Open 
 
Endo               
100  ± 4  
                         ] * 
69  ± 9 
59  ± 7   ** 
 
55  ± 10  
Toe 1 Magnitude of 
hyperaemia 
(% increase in flux) 
Open 
 
Endo               
150.0  ± 14.2 
                          
196.8  ± 20.1 
204.9  ± 20.7     ≠ 
 
194.6  ± 45.4  
Toe 1 Area under the curve 
(APU’s) 
Open 
 
Endo               
-34.0 ± 18.9 
                         ] *         
56.1 ± 19.0 
342.1 ±39.7  ** 
 
284 ± 72.6 * 
 
Table 31: Average time to peak, magnitude of hyperaemia and area under the curve in toe one for open and endovascular. 
*p<0.05, **p<0.001, ≠ p < 0.1 > 0.05.  Values are means ±SE. 
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It was interesting to note that intervention in leg 1 also had an effect on the reactive 
hyperaemia response of leg two in the open group. The magnitude of the response (3-fold 
increase in perfusion from baseline compared to <1-fold in leg 1) was unaffected, but the time 
to peak was significantly shortened by 20±5sec, as seen in leg 1. This is illustrated in Figure 
66 and Table 32. There were no changes in the endovascular group.  
 
     a)                                                                                              b)  
  
 
Figure 66: Average percentage change in flux from baseline during reactive hyperaemia 2 for a) open and b) endovascular 
patients’, pre and six weeks post intervention. Values are means ±SE. 
 
Side Variable Intervention Pre-intervention Six-weeks 
 
Toe 2 Time to peak 
hyperaemia 
(sec) 
Open 
 
Endo 
82  ± 5 
                          
63  ± 12 
62  ± 5.5  * 
 
57  ± 9     
Toe 2 Magnitude of 
hyperaemia 
(% increase in flux) 
Open 
 
Endo 
306.7  ± 80.0 
                          
264.4  ± 60.5 
329.2  ± 41.1     
 
438.8  ± 154.2  
Toe 2 Area under the 
curve (APU’s) 
Open 
 
Endo 
247.8 ± 90.8 
 
179.3 ± 84.5 
283.0 ± 55.1 
 
237.6 ± 62.9 
 
Table 32: Average time to peak and magnitude of hyperaemia in toe two for open and endovascular. *p<0.05.  Values are 
means ±SE. 
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The area under the curve was the only parameter that significantly changed in the 
endovascular group from pre-intervention to six-weeks (p0.01). Whilst the change was not as 
great as in the open group (p<0.001), they had significantly better hyperaemia at baseline.  
There was no change in the AUC in leg 2. 
 
 
Figure  67: Average change in area under the curve during reactive hyperaemia for open n=24 (blue) and endovascular  n=8 
(red) patients’, pre and six weeks post intervention. Values are means ±SE. 
 
The change in time to peak in leg one correlated well with the change in toe pressure between 
pre-intervention and six-weeks, particularly in the open group (p0.04).  Similarly, time to 
peak shortened with an improvement in NSB over the six weeks, although this correlation 
was not significant in the open group (p0.11) and the changes in NSB were less marked in the 
endovascular cohort. (Figure 68)  There was no correlation between change in time to peak 
and average change in ankle pressures (p0.2). 
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     a)                                                                                                    b) 
  
Figure 68: Relationship between change in time to peak and a) change in toe pressures and b) change in NSB between pre 
and six-weeks for toe 1, divided by open and endovascular. *p<0.05. 
 
Following open surgery, the time course of reactive hyperaemia was improved.  This was not 
seen in the endovascular group, although their AUC had significantly improved and their 
time to peak was better at the outset.  This is associated with a concomitant improvement in 
NSB and toe pressure, particularly in the open group.  
 
 Postural%vasoconstriction%&%local%microvascular%reactivity%
 
In healthy individuals assumption of upright posture induces a reduction in skin perfusion of 
around 60%, a vasoconstriction that is lost in CLI (Eickhoff and Henriksen, 1985).  This is 
due to combination of myogenic constriction and a local sympathetic neural veno-arteriolar 
constrictor response. Lowering the leg of the supine patient below heart level tested the 
myogenic component of postural vasoconstriction response. This increases the hydrostatic 
pressure load by less than 25 mmHg, which is the threshold for triggering the local 
sympathetic neural veno-arteriolar response (reference). The VAR response was tested by 
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measuring skin perfusion on assumption of the sitting position, in which the hydrostatic 
pressure load exceeds the 25mmHg threshold. 
 
Leg!dependency!
 
Pre-intervention, all regions – shin, foot and toe of leg one, toe of leg two – failed to show 
postural vasoconstriction to leg dependency (Table 33).  Immediately post-intervention, 
responses had not changed. However, after six weeks, vasoconstriction had been restored to 
some degree in the shin and the foot in the open group while there was no improvement in the 
endovascular group (Figure 69). In toe 1 of the open group there had been some improvement 
in vasoconstriction in the open group, although this was not significant. In toe two of the 
untreated leg, absence of vasoconstriction pre-intervention was converted to some constrictor 
response after six weeks in both open and endovascular groups however this did not reach 
statistical significance.  
 
SITE  PRE-INTERVENTION POST-INTERVENTION SIX-WEEKS 
 
Shin Open 
Endo 
111.8 ± 8.4 
88.3 ± 8.4 
101.1 ± 8.5 
97.6 ± 9.5 
81.6 ± 3.0*(pre-six) 
85.5 ± 8.5 
Foot 
 
Open 
Endo 
81.2 ± 6.1 
79.4 ± 11.5 
93.3 ± 10.0 
83.8 ± 8.6 
60.6 ± 2.8*(pre & post-six) 
78.2 ± 5.8  
Toe 1 
 
Open 
Endo 
104.7 ± 13.2 
87.1 ± 14.8 
122.6 ± 16.3 
97.0 ± 7.4 
84.3 ± 9.1≠ (pre-six) 
90.8 ± 11.0 
Toe 2 Open 
Endo 
101.7 ± 3.6 
112.2 ± 11.7 
113.3 ± 8.6 
112.6 ± 13.3 
92.3 ± 5.0 
82.9 ± 7.4 
 
Table 33: Flux on leg dependency in open and endovascular groups’ from pre-, to post-intervention to six weeks. Expressed 
as a change from baseline (=100).  Values are means ±SE. *p<0.05, ≠ p < 0.1 > 0.05over time. 
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Figure 69: Change in myogenic PVC with leg drop from pre- to post-intervention and from post- to six weeks in the open and 
endovascular groups by location (shin, foot, toe 1, toe 2).  Values are means ±SE. *p<0.05 over time.  
 
 
 
Sitting!
 
Pre-intervention, sitting induced VAR-mediated vasoconstriction in the foot of both open and 
endovascular groups, and in the shin of the endovascular group. Six weeks after intervention, 
the VAR was restored in all regions of the treated leg in the open group but in the 
endovascular group remained static in the foot, absent at the toe and was considerably further 
impaired in the shin. In toe two of the untreated leg, the vasoconstrictor response seen at 
baseline was unchanged after intervention.  
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SITE  PRE-INTERVENTION POST-INTERVENTION SIX-WEEKS 
 
Shin Open 
Endo 
98.3 ± 7.4 
70.2 ± 5.9 
125.5 ± 13.8 
87.4 ± 14.9 
80.7 ± 8.3*(post-six) 
125.6 ± 22.2 
Foot 
 
Open 
Endo 
72.4 ± 6.8 
75.8 ± 10.8 
96.3 ± 8.5 
80.2 ± 15.7 
52.2 ± 2.3*(pre & post–six) 
78.6 ± 8.0  
Toe 1 
 
Open 
Endo 
99.9 ± 11.0 
96.6 ± 16.4 
117.5 ± 16.2 
95.4 ± 16.4 
80.3 ± 7.8*(post-six) 
100.3 ± 18.0 
Toe 2 Open 
Endo 
62.6 ±8.4  
68.3 ±8.4 
121.9 ± 39.4 
60.9 ± 19.0 
69.0 ± 6.6 
79.9 ±20.9 
 
Table 34: Flux on sitting in open and endovascular groups from pre-, to post-intervention to six weeks. Expressed as a change 
from baseline (=100).  Values are means ±SE. *p<0.05. 
 
 
  
  
 
Figure 70: Change in sympathetic VAR with sitting from pre- to post-intervention and from post- to six weeks in the open 
and endovascular groups by location (shin, foot, toe 1, toe 2).  Values are means ±SE. *p<0.05 over time. 
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relationship where the greater the percentage-change in myogenic FFT, the greater the 
negative difference constriction on dependency. The only region that showed a relationship 
was in toe 1, although this was weak (R2 0.11). All other regions did not show any significant 
relationships.  On changing position to sitting, hydrostatic pressure should be greater than the 
threshold for VAR and subsequently elicit a change in sympathetic frequencies, as seen on 
FFT.   There were no correlations seen between sympathetic frequencies and VAR at any 
location. 
 
FFT%analysis%
 
The actual power ascribed to each of the microvascular controls did not alter significantly 
following treatment. The power ascribed to heart rate and respiratory frequencies remained 
unchanged in both the open and endovascular groups.  There was a tendency for myogenic, 
sympathetic and endothelial frequencies to reduce in the open group but these were not 
significant (endothelial 0.08).  The open group had a higher power in myogenic frequency 
post-operatively and at six weeks compared to the endovascular group.  
 
   
 
Figure 71: Actual power in the 5 frequency bands pre-, post- and six weeks after intervention, divided by open (blue) and 
endovascular (red). Values are means ±SE. 
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The most noticeable change when comparing the FFT as a percentage of total power was the 
increase in heart rate from pre-post and post-six weeks, although this only reached 
significance in the open group (Table 35).  In-keeping with the literature, this is likely to 
reflect better transmission of cardiac output along the length of less disease vessels (Rossi et 
al., 2005, Rossi et al., 2008).  
 
FREQUENCY  PRE POST SIX-WEEKS 
 
Endothelial Open 
Endo 
16.0 ± 3.2 
16.2 ± 4.7 
7.6 ± 1.2* (pre-post) 
9.2 ± 2.8 
9.9 ± 2.1 
10.3 ± 4.1 
Sympathetic 
 
Open 
Endo 
17.5 ± 2.6 
17.6 ± 4.7 
11.4 ± 2.0 
8.5 ± 2.4 
13.6 ± 2.4 
11.3 ± 3.7  
Myogenic 
 
Open 
Endo 
11.1 ± 1.5 
10.8 ± 3.0 
11.0 ± 2.0 
7.2 ± 1.4 
10.2 ± 1.6 
7.0 ± 1.3 
Respiratory 
 
Open 
Endo 
18.0 ± 2.6 
17.8 ± 4.1 
16.4 ± 2.1 
18.8 ± 4.8 
11.6 ± 1.8* (pre-six) 
18.0 ± 3.6 
Heart Rate Open 
Endo 
37.4 ± 4.2 
37.7 ± 5.8 
53.7 ± 4.5* (pre-post) 
56.3 ± 7.1 
54.7 ± 4.8* (pre-six) 
53.3 ± 8.2 
 
Table 35: Fast Fourier Transform power spectral analysis of Laser Doppler flux, expressed as % of total power for open 
group (n = 26) and endovascular group (n = 9) from pre-, to post-intervention to six weeks in toe 1. Values are means ± SE. 
*p<0.05. 
 
 
 
In summary, both surgical and endovascular treatment for critical limb ischaemia elicited a 
change in haemodynamic, anthropometrical and microvascular measures to a differing 
degree.  Whilst symptoms were similarly improved across both groups, vessel patency was 
superior in the open group, which was reflected in the lower reintervention rate. The 
anatomical severity of the disease, described by the NSB correlated with an improvement in 
toe and skin perfusion pressures in the open group only, despite an increase at six weeks in 
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these outcomes in the endovascular group.  Ankle pressures and indices improved by a 
similar magnitude in both groups, although this was only related to patency in the open 
group.   
 
Measures relating to limb oedema show that this is more apparent in the open group, with 
increasing leg volume and tissue depth immediately post-intervention and at six weeks, with a 
transient increase in foot circumference. Tissue depth tended to be associated with an 
increase in Durometry but this difference was only significant at the foot. The endovascular 
group did not exhibit any significant change in anthropometry or Durometry.  
 
From a microvascular perspective, there was only a transient improvement seen in the shin 
and toe 1 perfusion in the open group that did not persist beyond the immediate post-
intervention.  In toe 2 the non-significant decrease in basal flux in the open group may have 
been due to the effect of steal.  What was much clearer was the significant decrease in time to 
peak and the increase in area under the curve with reactive hyperaemia in the open group.  
The magnitude of the peak was not helpful in delineating a change.  The VAR showed 
evidence of vasoconstriction only in the open group with restoration in the shin and foot on 
leg dependency and in toe 1 only with assuming the sitting position. Toe 2 exhibited no 
change.  This showed a degree of correlation with myogenic control, which was greater in the 
open than the endovascular group. 
 
Whilst, endovascular intervention provides symptom relief at least in the short term, it did not 
provoke the same microvascular restoration that surgery appeared to and therefore may not 
offer a longer-term solution to improving the microcirculation.  
201 
 
4.5!SixGmonth!follow!up!data!
Seven patients were followed up after 6 months, 6 from the open group and 1 after 
endovascular treatment. (3 further endovascular patients were offered 6 month follow up; one 
had died of unrelated causes and 2 declined).  The patient demographics were similar to the 
study cohort overall, bar a smaller percentage of six-month follow up patients with 
hypertension. (Table 36) 
 
Variable All Patients Follow-up Range SE 
Age (yrs) 72 70 59-82 3.3 
Gender M:F (%) 65:35 71:29   
BMI (kg/m2) 27 29.3 23.2-43.7 2.7 
Cholesterol (%) 83 86   
Smoker: Y or ex (%) 90 100   
Hypertension (%) 80 57   
Diabetes (%) 40 29   
Dialysis (%) 10 14   
 
Table 36: Patient demographics for the six-month follow up group compared to the total study cohort. 
 
Two out of seven patients (1 open, 1 endovascular) had further intervention during the time 
period. Of the remaining 5 patients, 4 whose grafts were patent six weeks after intervention 
were still patent after six months and were still pain free, unclassified according to TASC and 
reduced from Fontaine 3 or 4 pre-intervention to 1.  
 
NSB and Pressures  
 
The improvement in NSB index at six weeks was maintained at six months (Figure 72). 
Despite this, there was regression of the increases in DP and PN artery ankle pressures in the 
treated leg with values at six months returning to pre-intervention levels (Figure 73). 
Likewise, toe and skin pressures in leg 1 reverted to pre-intervention levels.  
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Figure 72: Change in NSB index from pre-intervention, six weeks to six months a) for individual patients and b) overall. 
 
a)                                                                    b)                                                                 c) 
   
 
Figure 73: Change in a) ankle pressures in leg 1 b) toe pressures and c) skin LDF pressures recorded at the toe in both legs 
from pre-intervention, six-weeks and six months. Values are means ±SE. 
 
Pressures in toe 2 (untreated leg) did not show significant changes from 6 weeks to six 
months.  
 
Anthropometry and Oedema 
 
In the treated leg, the increase in limb volume after six weeks was associated with greater 
tissue depths at the ankle and calf indicative of tissue oedema. Some changes had begun to 
recover by six months, with a significant decrease in calf tissue depth (p0.05), implying 
resolution of oedema.  By six months, ankle tissue depth remained unchanged from post-
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intervention. In the foot, tissue depths and circumference were not significantly different from 
pre-intervention values.  Volume and tissue depths in leg 2 did not change.   
 
a)                                                                                                    b) 
 
 
 
Figure 74: Change in a) limb volume and tissue depth at the ankle and calf in leg 1 b) foot circumference and tissue depth in 
leg 1, pre-intervention, six-weeks and six months. Values are means ±SE. 
 
Durometry at the calf did not change significantly between six weeks and six months.  The 
tissue depth appeared to improve prior to an improvement in Durometry with tissues still 
remaining hard, but this did not worsen.  
 
 
Figure 75: Change in Durometry in a) leg 1 and b) leg 2, from 1- pre-intervention, 2- six-weeks and 3 - six months. Values 
are means ±SE. 
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The Durometry in the calf of leg 2 did increase at six months in this cohort (p0.05), this was 
unrelated to leg volume and tissue depths, which were not altered from six weeks to six 
months.  It is unclear for the cause of an isolated rise in calf Durometry. 
 
 
Skin Microvascular Perfusion and Reactivity%
Basal!Skin!Perfusion!
 
The basal skin perfusion did not change significantly from six weeks to six months in either 
leg 1 or leg 2.  In fact, despite the temporary post-operative increase seen at the foot and the 
toe in the open group (see treatment effects), the basal flux did not change significantly from 
pre-intervention to six-weeks and six-months and suffered large variability. 
 
Reactive!Hyperaemia!
 
The time to peak of the reactive hyperaemia response, which at six weeks had decreased 
significantly from pre-intervention, worsened by six months and was no longer significantly 
shorter in either limb.  
 
Figure 76: Change in reactive hyperaemia time to peak in leg 1 and leg 2, from 1- pre-intervention, 2- six-weeks and 3 - six 
months. Values are means ±SE.  
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Postural!Vasoconstriction!
 
Interestingly, the recovery of myogenic vasoconstriction in the treated leg during limb 
dependency continued at six months at the toe but reverted in the foot (p0.05).  Veno-
arteriolar constriction during sitting was unchanged between six weeks and six months at the 
toe and the foot, and there were no changes in the untreated leg two toe responses.  
 
a)                                                                                                      b) 
  
 
Figure 77: Leg 1 percentage change in flux a) on leg dependency and b) on sitting at the shin, foot and toe 1- pre-
intervention, 2- six-weeks and 3 - six months. Values are means ±SE. 
 
FFT!
 
In contrast to the data at six weeks, there were some considerable changes in flowmotion by 
six months from pre-intervention.  All of the lowest frequencies (endothelial, sympathetic and 
myogenic) significantly reduced their actual power over this time (p0.05).  Respiratory rate 
and heart rate remained unchanged. 
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a)                                                                   b)                                                                 c) 
 
Figure 78: Actual Power of a) endothelial, b) sympathetic and c) myogenic frequencies from pre-intervention, to six-weeks 
and six-months. *p0.05.  Values are means ±SE. 
 
Frequency Pre Six Weeks Six Months 
Respiratory 34.7±9.8 16.2±4.8 31.5±8.0 
Heart Rate 58.62±4.9 65.5±6.2 58.5±5.3 
 
Table 37: Actual Power of respiratory and heart rate frequencies from pre-intervention, to six-weeks and six-months.  Values 
are means ±SE 
 
 
A small number of patients were followed up at six months, predominantly from the open 
group.  Despite maintenance of the NSB index, all measured pressures had reduced again by 
6 months and rather surprisingly the time to peak hyperaemia also reduced to pre-
intervention levels.  Oedema appears to be resolving by this stage although the tissues in the 
calf still remained tense.  Alongside this, myogenic vasoconstriction continued to improve in 
all but the foot and sympathetic constriction had not deteriorated from six weeks, but equally 
showed no signs of improvement. Changes in flowmotion, corresponding to endothelial, 
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sympathetic and myogenic frequencies under basal conditions had continued to reduce over 
time and did not appear to relate to improvements in PVC. The microcirculation has suffered 
a long period of atrophy prior to treatment and its function does not return to normal levels 
and further declines by six-months, evidenced by the poor haemodynamic and 
microcirculatory parameters.  
 
4.6!Diabetes!data!
PreMintervention%
 
There were 12 diabetics in the cohort who underwent open surgery. They were a mixture of 
insulin dependent (4), tablet (2) and diet controlled (6).  The male to female preponderance 
was 5:7.  They were compared to 18 non-diabetics who had also undergone surgical 
revascularisation. Unless mentioned, comparisons are based on 12 diabetics and 18 non-
diabetics.   
 
There was no difference between the NSB scores between diabetics and non-diabetics at the 
outset (39.9±4 vs. 41.7±4 respectively), but there were significantly more diabetics with class 
IV disease (50%) compared to those without diabetes (28%).  
 
Pressures%
 
As anticipated, there was no difference in the average toe pressures between groups (17±6 vs. 
14±5). APBI was not significantly higher in the diabetic population, despite the expected 
consequences of mediocalcinosis (Figure 79).  
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Figure 79: Average pre-intervention ankle brachial pressure index divided into diabetic (red) or non-diabetic (blue) groups. 
Values are means ±SE.  p0.12 %
 Neuropathy%
 
Neuropathy was assessed using a neurothesiometer on the metatarsal head of the great toe.  
Both VPT and VDT were assessed.  If patients could not feel the vibration at 50V this was 
assigned the value of 50 to allow quantitative comparison.  There was no significant 
difference between diabetic and non-diabetic groups.  In addition, there were no significant 
differences between leg 1 and leg 2 readings. 
 
Neurothesiometer Diabetic (n=8) Non-Diabetic (n=10) 
VPT (v) 31.4 ± 5.3 28.9 ± 5.3 
VDT (v) 29.4 ± 5.7 26.4 ± 5.5 
 
Table 38: Neurothesiometer values for vibration perception and detection thresholds in diabetics and non-diabetics pre-
intervention.  Values are means ±SE 
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Microcirculation%
Basal!Flux!
 
The basal flux was not shown to be different from non-diabetic patients at baseline across any 
of the four sites, despite diabetics usually having greater total blood flow due to autonomic 
neuropathy and the presence of significant AV shunts. 
 
Reactive!Hyperaemia!
 
Reactive Hyperaemia time to peak, magnitude of peak and AUC were no different between 
the groups at the outset (Figure 80).  
 
a)                                                                                            b) 
  
Figure 80: Reactive hyperaemia a) time to peak and b) magnitude of the peak in diabetics n=11 (red) and non-diabetics n=18, 
(blue) groups. Values are means ±SE.  
 
Postural!Vasoconstriction!
 
Myogenic constriction does not show any attenuation in the diabetic group pre-intervention  
(Table 39).  There is a tendency for flow to increase on dependency at the toe more than non-
diabetics but there was greater variation in flow as seen by larger SE’s. 
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Site Diabetic Non-Diabetic 
Shin 111.8 ±12.3 107.8 ± 8.6 
Foot 82.1 ± 6.9 88.6 ± 9.1 
Toe 1 122.4 ± 18.9 101.5 ± 15.7 
Toe 2 104.2 ± 5.6 103.6 ± 4.8 
 
Table 39: Percentage change in flow with leg dependency in diabetics and non-diabetics pre-intervention in leg 1 and 2.  
Values are means ±SE 
 
Testing VAR did not elicit a difference in sympathetic constriction at any site compared to 
non-diabetics but there was a similar tendency for increased flux in toe 1 (Table 40).  
Site Diabetic Non-Diabetic 
Shin 96.1 ±10.0 96.7 ± 8.7 
Foot 72.0 ± 8.0 83.3 ± 10.1 
Toe 1 121.9 ± 20.0 94.4 ± 9.7 
Toe 2 56.3 ± 8.1 74.2 ± 12.0 
 
Table 40: Percentage change in flow with sitting in diabetics and non-diabetics pre-intervention in leg 1 and 2.  Values are 
means ±SE 
 
Flowmotion!
 
There was no correlation between sympathetic FFT and VAR at the toe.  Similarly, FFT pre-
intervention was similar between the two groups across all frequency bands (Figure 81). 
 
 
 
 
 
 
 
Figure 81: FFT analysis pre-intervention in diabetics (red) and non-diabetic (blue) groups. Values are means ±SE.  
 
 
 
0
10
20
30
40
50
60
70
80
90
En
do
 P
re
.2
Sy
m
p 
Pr
e.
2
M
yo
 P
re
.2
R
es
p 
Pr
e.
2
H
R
 P
re
.2
Yes
No
Endo      Symp     Myo       Resp         HR 
A
ct
ua
l P
ow
er
 
Frequency Band 
211 
 
It was previously suggested that systemic pressure had an influence on endothelial activity in 
the diabetic population. There was no correlation identified between ABPI and endothelial 
activity on FFT.  
 
Treatment%Effects%
 
In the six weeks following intervention, there were two deaths in the diabetic group and one 
amputation, two of which had had redo-surgery prior to these events.  There were also two 
further diabetic patients requiring major surgical reintervention for graft failure.  In the non-
diabetic group there was also one death, one amputation and 3 patients requiring redo-surgery 
during this time period. 
 
The average change in NSB was the same between diabetics and non-diabetics (24±4 vs. 
26±5), suggesting that resolution of disease was similar.   Consequently, symptom relief was 
also comparable across the groups (Table 41). 
 
Symptom Relief Diabetic  (n=10) Non-Diabetic (n=16) 
Complete 6 (60%) 10 (63%) 
Partial 3 (30%) 5 (31%) 
None 1 (10%) 1 (6%) 
 
Table 41: Symptom resolution in diabetics and non-diabetics from pre-intervention to six weeks in leg 1 in absolute numbers 
and percentages. 
 
Pressures!
 
The change in pressure measurements between pre-intervention and six-weeks was not 
statistically different between groups (Table 42). 
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Variable Diabetic (n=9-10) Non-Diabetic (n=16) 
Δ Ankle Pressure 
(mmHg) 
52.4 ± 7.1 73.5 ± 13.7 
Δ Toe Pressure 
(mmHg) 
24.2 ± 10.7 46.6 ± 10.5 
Δ Skin LDF Pressure 
(mmHg) 
54.9 ± 19.9 54.3 ± 12.7 
 
Table 42: Average change in ankle, toe and skin pressures in diabetics and non-diabetics from pre-intervention to six weeks 
in leg 1.  Values are means ±SE 
 
Neurothesiometer!
 
There was an improvement in neurothesiometer VPT and VDT readings from pre-intervention 
to six-weeks (21.0±3.8 and 19.1±3.7) but this was not dependent on diabetic status.  
Furthermore, an improvement in neurothesiometry did not correlate with patency.  Readings 
from leg 2 changed by less than 1volt on average after treatment. 
!
Microcirculation!
 
Basal Flux 
 
The basal flux did not change over time at the shin or the foot in leg one, nor was it different 
between groups. At the toe,  there was a signifcant increase in post-intervention flux at the toe 
in non-diabetics but this was not signifcantly different between groups. 
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a)                                                                   b)                                                                c) 
   
Figure 82: The change in basal flux (APU’s) over time in the a) shin, b) foot and c) toe 1 divided by diabetics n=9 (red) and 
non-diabetics n=15 (blue). Values are means ±SE. 
 
 
In toe 2, there was a tendency for basal flux to be higher in the diabetic group (p0.07).  By 
six-weeks the flux was similar in both groups (Figure 83). 
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Figure 83: The change in basal flux (APU’s) over time in toe 2 divided by diabetics n=13 (red) and non-diabetics n=20 
(blue). Values are means ±SE.  
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Reactive Hyperaemia 
The reactive hyperaemia response measured by change in the time to peak was not affected by 
diabetes (p0.09).  There was a trend however for the diabetics to have a slower time to peak 
compared to non-diabetics (Δ20.1±14.6 vs. 48.7±9.0). The change in AUC was the same 
between the two groups (Figure 84). 
 
 
 
Figure 84: The change in area under the curve over time in diabetics n=9 (red) and non-diabetics n=15 (blue). Values are 
means ±SE.  
 
 
Postural Vasoconstriction 
Myogenic constriction improved from pre-intervention to six-weeks at the shin and from post-
intervention to six-weeks at the foot in non-diabetics (p0.05), but there was no significant 
difference between the two groups overall. Whilst there was no significant change in flux over 
time at the toe, there was a tendency for the diabetic group to have a smaller myogenic 
response to dependency at the toe (p0.06).  
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a)                                                                    b)                                                                c) 
 
  
Figure 85: The change in flux with leg dependency over time in the a) shin, b) foot and c) toe of leg one, divided by diabetics 
n=9 (red) and non-diabetics n=15 (blue). Values are means ±SE.  
 
Sympathetic vasoconstriction was evident from post-intervention to six-weeks in both groups 
in the foot (p0.05).  At the shin, these changes were only seen in the diabetic group, contrary 
to the findings with leg dependency. In toe 1, the diabetic group started off with a higher flux 
pre-intervention, but neither group improved over time.  The changes did not differ 
significantly between groups at any location. 
 
   
Figure 86: The change in flux with sitting over time in the a) shin, b) foot and c) toe of leg one, divided by diabetics n=9 (red) 
and non-diabetics n=15 (blue). Values are means ±SE. 
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Flowmotion 
Flowmotion remained unchanged for both groups from pre-intervention to six weeks. 
Endothelial activity did not change over time but there were large variances, particularly in 
the non-diabetic group. (Figure 87)   
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rate, divided by diabetics (red) and non-diabetics (blue).  Values are mean ±SE. 
The diabetic cohort had similar severity of disease anatomically to the non-diabetics but 
suffered with more tissue necrosis.  The ankle, toe and skin pressures were not different 
between groups and changes were similar following treatment.  Neuropathy was evident in 
both groups and equal in both legs. Improvements were no more apparent in diabetics.  The 
basal flux and FFT did not change over time with treatment.  Reactive hyperaemia time to 
peak shortened with treatment with a non-significant trend for diabetics to have a longer time 
to peak.  There were no evident differences in postural vasoconstriction between groups.  
Overall, this small cohort of open surgical diabetic patients does not show significant 
differences in outcome measures to those without diabetes. 
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Figure 87: Change in actual flux over time for the 5 frequency bands corresponding to 
endothelial, sympathetic, myogenic, respiratory and heart rate, divided by diabetics (red) 
and non-diabetics (blue).  Values are mean ±SE. 
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DISCUSSION%
 
This study set out to show that microvascular control mechanisms would be enhanced 
following open surgery, to a greater extent than is seen with endovascular treatment and that 
this would be supplemented with a concomitant improvement in clinical and haemodynamic 
parameters.   
 
I have objectively shown that skin microvascular perfusion and reactivity is improved after 
open bypass surgery and patients undergoing endovascular recanalisation do not display these 
findings to the same degree.  This was demonstrated in a number of ways: 
 
• Basal flux: a transient increase in basal perfusion post-operatively in the open group 
only, most significantly at the toe pulps. 
 
• Reactive hyperaemia: a significant shortening of the time to peak from pre-
intervention to six-weeks and an almost significant increase in peak magnitude, seen 
only in the open group.  There was also an improvement noted in the hyperaemic 
response of toe 2 in the surgical group, which was not seen in the endovascular cohort. 
 
• Postural Vasoconstriction: the myogenic component of PVC improved significantly 
at six weeks at the shin and the foot in the open group, but not in the endovascular 
group.  There had been some improvement at the toe in the surgical group but this was 
not significant.  The sympathetically mediated VAR remained impaired in the 
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endovascular group at six weeks but was restored in all regions of the treated limb in 
the open group.  Vasoconstriction in the contralateral limb remained unchanged in 
both groups. 
 
• Flowmotion at rest: Significant increases are seen both post-intervention and at six 
weeks in the heart rate frequency in the open group only, reflecting improved 
peripheral transmission of cardiac output.   
 
The microvascular changes observed in the open group correlated with greater vessel patency 
(73%) and improvements in both NSB and TASC criteria.  Interestingly, the magnitude of 
improvement in ankle pressures was similar between both groups.  Equally, they both 
displayed significant increases in toe pressures by six weeks, but the magnitude of 
improvement was significantly greater in the open group, with both parameters improving 
within 72hrs following intervention.  The magnitude of increase in skin pressure recorded at 
the toe with the laser Doppler was similar between the two groups.  
 
Oedema was inferred through increases in lower limb volume and tissue depth at the calf and 
ankle at six weeks in the open group.  There were no significant changes seen in the 
endovascular cohort.  Interestingly, foot circumference increased significantly immediately 
following surgery as well but had returned to pre-intervention levels by six weeks. The 
Durometry or tissue hardness had increased in association with tissue depth immediately post-
operatively in the open group and correlated well with vessel patency (p0.02).  Endovascular 
intervention did not elicit these changes.   
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The Literature 
 
Clinical!and!Macrocirculatory!Outcomes!!
 
From a clinical perspective regardless of intervention group, the vast majority of patients had 
gained partial or complete resolution of their symptoms by six weeks (85%).  The CLI 
population is a very morbid group and is highly associated with cardiovascular events, even 
greater than symptomatic coronary artery disease (Conte, 2010c).  Their 30 day mortality rate 
in this study was 7.5% overall, with all deaths cardiac-related in the open group. This is in 
contrast to the BASIL trial where mortality between the two groups was equal at 30 days. 
That said there were unrelated deaths in the endovascular group by six months that equalized 
the mortality by group.  
 
Surgical revascularisation was performed with autologous vein in all cases, which has 
consistently been shown in the literature as the best available conduit.  This was invariably 
LSV but on some occasion supplementary arm vein was utilized.  Twelve bypasses were to 
crural vessels of which, some were complex composite sequential bypasses to more than one 
outflow vessel, with 10 below knee and 4 above knee infra-inguinal grafts.  All had common 
femoral endarterectomies and 2 had concomitant iliac procedures performed.  Patency at 6 
weeks was 73%, with 5 patients requiring major reinterventions for revisions, extensions or 
surgical thrombectomy in the immediate post-operative period.  Two patients had amputations 
within 30 days.   Approximately 25-30% of autologous vein grafts will suffer stenosis in the 
first year but there is no data specifically quoting patency rates after six-weeks and many will 
exclude grafts that stenose within the first 30 days (Dick et al., 2011).  
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The majority of endovascular procedures were sub-intimal balloon angioplasties ± stent 
insertion, performed on both SFA and crural vessels with high immediate technical success 
but six-week patency rates were 20%, similar to the patency rates reported at 1 year for CLI-
related occlusions (Kandarpa et al., 2001).  The low rates are a consequence of having diffuse, 
calcified occlusive disease with compromised distal vasculature.  This would correlate with 
Met who found a significant discrepancy between vessel patency (50%), limb salvage rates 
(80-90%) and clinical success (50-70%) in functional and critical limb ischaemia patients, 
demonstrating that patency does not correlate with symptom relief (Met et al., 2008).  This 
also extends to 5 years where there is an almost 60% difference in primary patency rates and 
limb salvage (Kudo et al., 2005).  Our vessel patency was significantly lower than this but our 
limb salvage and symptom relief were comparable despite being solely based on CLI patients. 
This again highlights how challenging this group is to treat given that outcomes have not 
changed significantly, despite significant advances in endovascular technologies since Met’s 
paper.  Furthermore, most of the endovascular patients had class IV disease, which has an 
inferior outcome to class III disease for infrapopliteal angioplasty (Dorros et al., 2001).  The 
number of segments treated and the most distal vessel treated are also known to significantly 
affect primary and secondary patency rates, but not clinical outcome or limb salvage (Kudo et 
al., 2005).  
 
Ankle Pressure/ABPI   
 
Ray et al suggested that ABPI is not considered to be a sensitive indicator of predicting 
success and patency/clinical outcome in the longer term (Ray et al., 1997a).  This is consistent 
with our findings that there is no correlation between conventional ABPI and patency, despite 
an improvement in distal pressures from pre-intervention to six weeks.  Consequently it 
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affords no prediction for graft closures within six weeks of intervention. Similarly we were 
unable to demonstrate a correlation between ABPI and change in the NSB index indicating 
the severity of any residual disease following treatment. It certainly does not deduce those 
who will need an amputation and those who will not.  It has been quoted that ABPI is 
expected to increase by 0.15 following open or endovascular intervention, usually within 7 
days but can be up to 1 month (Husmann et al., 2006, Jelnes, 1986).   In both intervention 
groups the ABPI rose by a similar magnitude and this was by more than a mean of 0.15 in 
each vessel by six weeks.  Nevertheless, it does not relate to outcome. 
 
ABPI does not provide information on the nutritive blood supply in the microcirculation and 
highlights that outcome cannot be predicted solely by macrocirculatory parameters if there is 
a discrepancy between macro- and microcirculatory function.  Bongard demonstrated this 
incongruity by measuring a fall in TcP02 and LDF after angioplasty, but an increase in the 
ABPI (Bongard et al., 1994).  
 
Toe and Skin LDF Pressures 
Toe and skin LDF pressures reflect the perfusion pressure in the smaller vessels of the foot 
and seem to be a much better indicator of patency by six weeks (p<0.01).  Saucy et al found 
that successful surgical revascularisation was associated with a rise in toe pressures from 21-
40mmHg immediately post-operatively and similar values were found in this study, with a 
continued increase in the open group at six-weeks (Saucy et al., 2006).  Ray did not find toe 
systolic pressures of <30mmHg to predict clinical improvement, having just 55% sensitivity 
and 27% specificity.  However, this was at six months following revascularisation and we 
found a similar trend with toe pressures dropping to near pre-intervention levels at this stage, 
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even with 86% patency (29% having had reintervention to achieve secondary patency). The 
mean six-month value was above the critical level of 30mmHg, which has been found to 
predict foot viability and no patients had clinically critically ischaemic limbs at this stage. It 
seems that the window to predict patency in relation to pressure changes is prior to six 
months.  This may be a reflection of persistent underlying microcirculatory dysfunction, even 
with initial post-operative normalization of arterial pressures. 
 
Previously, skin perfusion pressures have been shown to correlate highly with toe systolic 
pressures in the limbs of diabetics and non-diabetics (Tsai et al., 2000).  In our study, as well 
as correlating with patency (change in skin LDF pressure 78±8 vs. 11±14mmHg), skin LDF 
pressures were also shown to correlate with a change in the NSB index over the same time 
period.  This is in keeping with SPP being able to detect the severity of disease, although this 
was as a diagnostic tool rather than at follow up from an intervention (Castronuovo et al., 
1997).  At absolute pressures below 30mmHg, ulceration has been shown to be significantly 
less likely to heal than those with a perfusion pressure greater than this. From our data, a 
change in skin LDF <30mmHg appears predictive of non-patency although numbers are small 
and this is a relative change rather than an absolute change. Perfusion pressures following 
treatment are greatly under utilized particularly in view of its predictive value in diagnosing 
CLI and predicting limb salvage and ulcer healing.  A Japanese group measured SPP before 
and after endovascular recanalisation but improved SPP values are compared to the presence 
of a wound blush and not patency per se and therefore it is difficult to interpret and compare 
in this context.  Given that wound blush was predictive of limb salvage it would suggest that 
SPP is also related to limb salvage and could be a useful marker but the study was not 
powered with this in mind (Utsunomiya et al., 2012). 
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Microcirculation%
 
Basal Flux 
 
Resting or basal flux using LDF is reduced in severe ischaemia at the foot and in the toe 
(Bongard and Fagrell, 1990, Saucy et al., 2006).   Following surgical intervention, this 
parameter has been shown to increase considerably, although it is subject to noticeable 
overlap (Wahlberg et al., 1995).  Laser Doppler Imaging similarly displays a global increase 
in flow ten days following surgery, with a simultaneous reduction in flow on the untreated 
side (Saucy et al., 2006).  Our cohort exhibited similar findings with an increase in basal 
perfusion by day 3 (post-intervention) and a non-significant decrease in the basal flux of toe 2 
(p0.06). By six-weeks basal perfusion in toe 1 had returned to pre-intervention levels but 
remained elevated at the foot and the shin.  Toe 2 maintained it’s post-operative flux at six-
weeks.  Lamah et al suggested that in CLI whilst there are fewer capillaries present 
anatomically, a much higher proportion of these are perfused.  This may explain why the flux 
returns to baseline levels by six weeks, if the capillary numbers return to ‘normal’ and flux 
remain constant. 
 
Reactive Hyperaemia 
 
Reactive hyperaemia offers a quantitative global assessment of the microvascular function of 
a limb, with the time to peak providing the commonest and most discriminatory method of 
assessment.  It has been shown to correlate with disease severity because the pressure lost 
across a stenosis or occlusion causes a delay in the time to peak hyperaemia, or it may even be 
abolished all together in severe disease.  The configuration of the traces themselves can be 
characteristic of certain disease patterns and there are many parameters described in an 
attempt to quantify them for comparison.  For example, ‘double-humped’ curves were 
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described by Kvernebo who suggested that this was due to the presence of a significant 
arterial pressure gradient, which became more pronounced with more significant gradients.  
They measured the fdiff (the difference between the flux value of the first peak and the 
minimum flux value between the two curves) to try to assign a value to it for comparison, but 
this was not shown to have any discriminatory value (Line et al., 1996).  In our experience, 
these types of curves are typically seen in diabetics, dialysis dependent patients or the very 
elderly with severe mediocalcinosis where the vessels are stiff and non-compliant giving rise 
to sudden movement on release of the cuff, which is detected by the Laser Doppler as an 
initial artifact peak and a subsequent peak related to flow transmission.  This artifact was not 
used as the reading for time to peak in this study.  (Figure 88 a and b)  Furthermore, the 
period of occlusion prior to cuff release at time 0 shows that it is very difficult to compress 
these vessels and you would expect to see a disproportionately high ABPI in these patients.   
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         a) b) 
  
         c) d) 
  
 
 
Figure 88: Examples of individual reactive hyperaemia curves from the toe of the most symptomatic leg.                               
a) Diabetic patient, b) dialysis dependent diabetic, c) severe ischaemia with calcified disease, d) severe ischaemia with no 
peak above baseline. Values are means ± SE for 10s averaged values. Arterial occlusion commenced at t = -120s and the cuff 
was released at t = 0s. 
 
In many cases basal perfusion was not attained during the two-minute post-occlusion period.  
Figure 88 c and d demonstrate patients with particularly severe disease where a peak 
hyperaemia is not achieved, as they do not go above baseline.  Patient c had extensive disease 
and subsequently died.  Patient d later required an amputation.  In a study by Ubbink et al, 
absent reactive hyperaemia was one variable used in predicting amputation in addition to 
capillary density values of <20mm2, TcpO2 <30mmHg, giving a specificity of 87% and 
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predictive value of 73% for amputation (Ubbink et al., 1999).  In a healthy patient there is a 
smooth ephemeral rise to a peak within 50seconds and this was seen in our control patients.   
 
Because reactive hyperaemia represents the vascular resistance of the limb as a whole, the 
time to peak is not affected by the positioning of the probe above or below the stenosis.  
However, the positioning of the probe in relation to the cuff has been shown to affect the time 
to peak and consequently we ensured this was standardized for every hyperaemia tested (Line 
et al., 1996).  The site of measurement was always from the toe, which would also have 
provided higher peak flux values than other sites due to the high number of AV anastomoses 
(Kvernebo et al., 1989).  In terms of attempting to distinguish curve patterns based on 
anatomical location of disease, this was not possible in the small numbers present in each 
group.  Furthermore, many of the studies use high pressure ~300mmHg for 3minutes 
occlusion time.  In this study we used a 200mmHg for 2 minutes, which allowed successful 
discrimination without putting the patient through further discomfort from increasing 
ischaemic times. 
 
Following treatment, the time to peak in the open group changed significantly (p<0.001), 
consistent with Wahlberg’s findings, but this was not seen in the endovascular group.  The 
six-week time to peak was similar between the two groups (59±7 open vs. 55±10 
endovascular) but the initial times to peak were significantly different from the outset (100±4 
open vs. 69±9 endovascular), suggesting more severe disease in the open group.   The 
magnitude of the peak did not change significantly over time, consistent with findings in the 
literature, which have not found this parameter to be highly discriminatory.  The area under 
the curve is not a commonly reported measure for comparison of hyperaemic responses.  In 
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this study there was a significant rise confirming that flow rose above baseline, which was not 
seen in the open group pre-intervention and rarely in the endovascular group.  It reflected time 
to peak in the open group but was the only measure in the endovascular group that changed 
significantly.  It seems to detect subtler, insidious rises in flow above baseline than a one-off 
peak reading.   However, this time of response is not the ‘normal’ reactivity of a vessel, which 
is better reflected by a combination of a sharp rise and a large area under the curve. 
 
Interestingly, the time to peak in toe 2 of the open group was also significantly shortened.  
Whilst this has not been specifically noted by previous studies, other parameters suggestive of 
improved flow have been shown in the contralateral limb, such as an increase in basal flux 
and improved postural vasoconstriction.  This may be as a consequence of systemic increases 
in vasodilator metabolites or a heightened response from local reflexes such as myogenic or 
sympathetic pathways.     
 
A significant relationship was found between the change in time to peak and the change in toe 
pressures in the open group (p0.04).  Although many authors have concluded that reactive 
hyperaemia is more discriminatory than ABPI and can distinguish clinical improvement 
regardless of ABPI, the time to peak has not been correlated with changes in toe pressures 
before.  It would seem logical that this would be more consistent given that it takes account of 
small vessels changes in addition to the macrocirculation.  The results achieved following 
endovascular treatment have varied with regards to time to peak but have not tended to 
involve critically ischaemic patients.  Leonardo reports a significant improvement in time to 
peak flux returning to 55±7sec with single-level PTA, whereas Bongard did not elicit an 
improvement in response at all despite haemodynamically and angiographically successful 
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procedures (Bongard et al., 1994, Leonardo et al., 1987).  It is difficult to comment given that 
the study populations are different, but our endovascular group had the same mean time to 
peak at six weeks (55±10sec) as Leonardo’s group, although this was not significantly 
different from the outset, but the majority of the endovascular patients did not achieve patency 
by his time (80%). 
 
Postural Vasoconstriction 
 
Patients suffering with CLI have regional passive dilatation of distal small vessels in an 
attempt to compensate for poor flow.  Subsequently there is greater perfusion during 
dependency compared with the supine position, with flow increasing by 28% in dependency 
in limbs that suffer with rest pain (Eickhoff and Engell, 1982b).  This increased flow is 
greatest at pulp of toe compared with the foot and/or the ankle predominantly due to the 
presence of AV shunts and also its most distal positioning (Khiabani et al., 2000a).  
 
Delis found that VAR with sitting improved within 6 days following surgery for severe 
ischaemia. In our surgical cohort, whilst there were improvements in VAR seen at all three 
locations, they were only significant from post-intervention to six weeks at the shin and toe 
and from pre-intervention to six-weeks at the foot and hence there was no improvement in the 
immediate post-operative period.  Similarly after leg dependency and initiation of the 
myogenic reflex, constriction improved at the foot and the shin, with the toe showing a non-
significant tendency to improve over this time.  There was no real change identified 
immediately post-operatively. Eickhoff and colleagues showed that a low or absent pre-
operative VAR was only significantly improved 3-6months after surgery if clinical 
improvement was evident (Eickhoff and Engell, 1982a), which is more in keeping with the 
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findings from our cohort.  They suggested that the time taken to show improvement would be 
more suggestive of loss of normal small vessel function from ischaemic damage or atrophy, 
rather than as a functional consequence that is flow dependent and hence more likely to 
recover quicker (Eickhoff and Engell, 1982a). 
 
Return of vasoconstriction was not seen in the endovascular group.  In a small study of 
claudicants that had undergone angioplasty, orthostatic blood flow at the toe improved 
equating to an overall improvement in VAR.  However, there was already some evidence of 
postural vasoconstriction at the outset making it difficult to compare the two groups, as this 
was not evident in our cohort pre-intervention. In contrast to the findings following surgery, it 
has been proposed that the change in VAR are pressure and flow sensitive due to their 
correlation with an increase in ABPI (Husmann et al., 2006).  Our endovascular group did 
show some improvement in their ABPI of >0.15 but there was no associated improvement in 
VAR and therefore does not support this suggestion.  It is likely that patients with functional 
ischaemia do not have loss of small vessel function and therefore postural vasoconstriction 
may recover more quickly as a consequence of increased pressure and flow.  
 
Flowmotion 
 
The rhythmical variation in blood flow is composed of oscillations of differing frequencies 
and amplitudes. Over time these oscillatory wave patterns have evolved to describe specific 
mechanisms of regulatory control processes.  However, the description and frequency of the 
bands, the method of analysis and the units reported differ, making it difficult to directly 
compare like for like.   
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Following periods of ischaemic stress in claudicants the power bands ascribed to endothelial, 
sympathetic and myogenic control were blunted compared to controls although flowmotion 
was preserved, if not amplified, in the same group under resting conditions using wavelet 
analysis (Rossi et al., 2005, Rossi et al., 2008).  This was not however the case in CLI, where 
the same frequency bands were found to be reduced at rest (Anvar et al., 2000b).  On 
comparison of our pre-intervention data with our healthy controls (not age-matched) a similar 
percentage power was seen for endothelial and neurogenic frequencies, although myogenic 
was lower in the control group.  This was attributed to a reduction in frequency associated 
with heart rate in the CLI group, which was also seen by Rossi, even in functional ischaemia, 
as a consequence of reduced transmission of cardiac output to the peripheries.    
 
Unfortunately there are no studies that have used FFT to examine the distribution of 
frequencies at the toe in CLI or to compare changes following a treatment intervention.  This 
study showed that microvascular controls do alter after treatment with more power ascribed to 
heart rate, particularly in the open group, and respiratory frequencies remaining unchanged in 
both groups, as expected.  In the lower frequency ranges, there is a tendency for endothelial, 
sympathetic and myogenic to fall but this is not significant.   It may be that basal conditions 
are not sufficient to highlight changes in flowmotion and it requires a period of physiological 
demand to demonstrate differences.  This study did not identify a significant correlation 
between a change in postural vasoconstriction and FFT myogenic or sympathetic power.  
Consequently, it is difficult to know if flowmotion has a role in improving PVC after 
treatment, or whether the relationship is not evident from FFT readings that have been taken 
during basal conditions, rather than under conditions of stress. 
 
231 
 
Oedema 
 
There is controversy around the cause for post-surgical oedema and how intimately resolution 
of oedema may be associated with the return of PVC.  The phenomenon of post-intervention 
oedema is seen in 65-100% of successful femoro-popliteal bypass reconstructions (Eickhoff 
and Engell, 1982b), but is not encountered in endovascular patients and consequently it is 
rarely objectively recorded in this group.  In our experience oedema is not seen in the 
endovascular group, as measured by limb volume and tissue depth.  Ray also found that calf 
volume of the endovascularly treated limb did not increase regardless of disease severity at 
day one or one week following intervention (Ray et al., 1997b). 
 
The surgical group remains thought provoking and certainly in our surgical cohort, limb 
volume and tissue depth increased in the immediate post-operative period and persisted at this 
level at six weeks.  Calf tissue depth did increase further by six weeks but this did not impact 
on limb volume.  Autoregulation of postural vasoconstriction in this group did not show signs 
of improvement until six weeks, by which point oedema had plateaued.  It would be 
consistent with a picture of persistent vasomotor paralysis, together with an increase in 
systemic arterial pressure favoring oedema formation early post-operatively.  
 
Counter arguments to the cause of oedema formation have been related to surgical trauma and 
inguinal lymph node disruption.  All patients in the surgical cohort underwent surgery at the 
inguinal region but lymph node disruption was not assessed in this study.  Is has been 
suggested that the magnitude of disruption is correlated with the extent of oedema, although 
some oedema was still present even if lymph nodes were preserved (Porter et al., 1972).  
Equally, if there is early surgical graft failure oedema is not observed, which is counter-
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intuitive, however they suggest that this may be due to such low capillary perfusion pressures 
that excess filtrate can be absorbed adequately even in atrophic beds.  Eickhoff also studied 
PVC in surgical patients and whilst they too did not see the return of autoregulation until 3-6 
months, they did not find this correlated with the presence or resolution of limb oedema, 
suggesting that this appears independently to PVC post-surgery (Eickhoff and Engell, 1982b).  
 
Durometry 
 
Durometry was initially described for its use in industry but it has been used in medical 
specialties to assess tissue tension.  This has predominantly been in the field of dermatology 
(Kissin) but it has also been reported in identification of skin changes in venous disease 
(Choh).  It has not been used in critical limb ischaemia and hence there is no data in this area. 
 
We found the increase in ankle and calf tissue depth at six weeks was also associated with an 
increase in Durometry, in contrast to healthy controls that displayed lower levels of tissue 
tension with increasing tissue depth.  Whereas the controls have healthy, compliant and elastic 
tissues with supple subcutaneous tissues, the vascular patients typically have pitting oedema 
with ‘water logged’ skin, which is much less compliant and has evidently higher readings of 
tissue tension. 
 
Interestingly, it was just the tissue depth of the foot compartment that correlated with 
Durometry readings.  It is likely that smaller compartments become ‘harder’ because fluid 
accumulates within the fascial planes, which are more rigid in smaller areas and subject to 
increasing hardness with much more ease.  This also had a relationship with patency (p0.02), 
where higher Durometry readings correlated with patency.  It is difficult to identify a cut-off 
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value that identifies patent from non-patent, as anecdotally patients who had the most severe 
disease at the outset seemed to have tenser lower limb tissue compartments. Nevertheless, it 
may be interesting to prospectively look at whether foot Durometry could be predictive of 
successful revascularisation in the early post-operative period. 
 
SixMMonth!Data!
 
Unfortunately by six months, pressure indices and reactive hyperaemia had reduced to pre-
intervention levels, although this did not correlate with a decline in patency and NSB index.  
The patients’ symptoms had not deteriorated and therefore one can assume that the transient 
rise in pressure was sufficient to deal with the metabolic demands of the tissue.  Beyond the 
immediate post-operative period there is no comparison in the literature on which to relate our 
finding of a return of pre-intervention time to peak. 
 
The vasoconstrictive mechanisms had maintained some improvement, alongside resolving 
oedema.  Even at six months this has still not returned to even pre-intervention levels.  
Eickhoff suggested that constrictive mechanisms should be present within 3-6mths following 
surgery in those where it was previously absent (Eickhoff and Engell, 1982a).  Whilst we 
have not demonstrated normalization, there has been ongoing improvement in this time.  The 
timings of improvement are contrary to Delis who demonstrated normalization of VAR within 
6 days of surgery (Delis et al., 2001).  They do not however, comment on pre-operative VAR 
to assess existing pre-operative function.  Our findings do not show early return of VAR and 
hence is not in accordance with the theory that VAR is purely a physiological mechanism 
related to flow. Furthermore power in endothelial, sympathetic and myogenic frequencies 
have a declining pattern and do not show signs of improvement by this time. 
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The outcomes at this stage following treatment are not favorable towards the microcirculation 
regaining normal function.   
 
Diabetes!
 
Diabetic patients are commonplace in vascular clinics, carrying significant risk for lower limb 
amputation.  Many studies in the literature exclude diabetic patients due to their complex 
microvasculature but we felt they were worth special consideration and separate analysis. 
 
Diabetic feet are particularly prone to wounds from minor trauma and this was evidenced by 
the propensity to present with ulceration as opposed to rest pain (50% vs. 28%).  Peripheral 
neuropathy (DPN) is present in over a quarter of patients with diabetes (Parry, 1999) and is a 
causal factor for ulceration.  In some cases this may mean that there is relatively less 
macrovascular compromise to cause symptoms and signs consistent with CLI, but in this 
cohort the NSB was the same in both groups suggesting that the anatomical profile of disease 
was equally severe in each group.  Neuropathy was clearly seen in the diabetic cohort with 
mean VPT and VDTs of approximately 30volts, with scores of >25v known to significantly 
increase the risk of developing an ulcer (Abbott et al., 1998, Young et al., 1994).  In the non-
diabetic group mean VPT and VDT were not significantly different from the diabetic group 
suggesting that ischaemic neuropathy plays a large role in these patients.  Neuropathy scores 
also improved equally between groups with treatment suggesting that there is no sensory 
regeneration in diabetic neuropathy over and above that related to ischaemia.  Equally, if there 
had been an improvement in autonomic neuropathy then you perhaps would have expected to 
see basal flux reduce significantly in the diabetic group, which did not occur.  It does reduce 
at the toe from post-intervention, but no more so than in the non-diabetic group.  It may be too 
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early at six-weeks to expect significant changes in neurological function.   Toe two in the 
diabetics showed a persistently elevated basal flux compared to that in non-diabetics, perhaps 
consistent with systemic disturbance in microcirculatory flow.  Typically the literature does 
not suggest there is any difference in resting basal flow between patients with diabetes and 
PVD (Forst et al., 1998).  
 
The diabetic circulation cannot initiate hyperaemic responses to increasing metabolic 
requirements such as infection or necrosis, partly because they already have an over perfused 
skin circulation due to neuropathic changes.  As a result there was a trend for a reduced 
reactive hyperaemia time to peak (Δ20.1±14.6 vs. 48.7±9.0) but this was not significant, 
perhaps because of the small numbers involved.  Jaffer found that the time to peak was 
significantly impaired compared to controls, but there was no comparison made following 
treatment.  The coexistence of diabetes and peripheral vascular disease have not been shown 
to further impair reactive hyperaemia (Schramm et al., 2006), which is shown from the pre-
intervention being similar, but following treatment an evident difference remains.  
 
Sympathetic vasoconstriction or VAR is reported to be attenuated in diabetics.  (Belcaro et al., 
1992, Cacciatori et al., 1997)  We found no significant differences in vasoconstriction, at any 
of the locations, although there was a tendency for diabetics to have an inferior myogenic 
response at the toe (p0.06).  Changes were not evident during sitting between groups either, 
suggesting that diabetes does not cause further deterioration in PVC over and above CLI.  
Flow increased by a mean of 23% from horizontal in the diabetic group. This is also 
consistent with failure for sympathetic and myogenic vasomotion to improve with treatment. 
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There is little data on diabetic microcirculatory changes following treatment, not least because 
they tend to be excluded from such studies.  TcPO2 is the most commonly used parameter that 
has identified changes after intervention and found that vasodilatory responses do not return 
to those of a healthy individual, suggesting persistent endothelial dysfunction.  This 
conclusion is compatible with our findings, with a functioning graft or recanalised vessel not 
being sufficient. This is reflected by a further 3 limb amputations in the diabetic group 
compared to one in the non-diabetic group by 12 months.  
 
Limitations!
 
The natural history of CLI is distinct from the broader PAOD group and consequently it is 
important to consider them as separate entities for data comparison, although this can be 
challenging.  Existing literature is often retrospective, comparing one single treatment and 
utilizes inconsistent definitions giving rise to broad cohorts, not specifically ‘critical’ patients.  
Certainly much of the work that has been used to compare the outcomes from this study has 
included data from non-critical ischaemia, which are not representative of outcomes for CLI.  
 
In addition, it is paramount to delineate a causal link between symptoms and vascular status, 
but the interplay of patient co-morbidities can heavily influence vascular status, making 
inclusion/exclusion of critical status difficult.  Whilst the BASIL trial has been a cornerstone 
in this field as the only RCT, it exemplifies the challenges of cohort definitions and trial 
designs. Given this spectrum of ‘CLI patients’, Wolfe attempted to further stratify critical 
ischaemia into high and low risk groups, essentially representative of what is clinically critical 
and severe.  They found that only 5% of patients in the high-risk group survived with an intact 
limb unless they had a surgical intervention, compared to 27% in the lower risk group (Wolfe 
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and Wyatt, 1997).  Whilst the outcomes are very poor in both there is a clear distinction and 
this is a very useful tool to improve sensitivity and specificity of outcome even within the 
umbrella term of CLI. 
 
Recently, the Society for Vascular Surgery has undertaken an initiative to define set measures 
and outcomes from interventions ‘objective performance goals’ (OPG’s) to try and stratify 
future research and allow comparability to better appraise interventions and their outcomes.  
These have largely been based on regression models of available data for evaluation of non-
randomised trials for comparison of new treatments (Goodney et al., 2011).  Whilst this has 
not been widely applied, initial experience using the Vascular Study Group of New England 
(VSGNE) data to validate the approach has shown OPG’s to be representative of safety and 
efficacy outcomes.  The 1039 lower extremity bypass operations for CLI, using autogenous 
vein, were divided into high clinical risk (age >80yrs and tissue loss) and high anatomical risk 
(infrapopliteal target artery) and conduit high risk (lack of single segment greater saphenous 
vein).  The primary efficacy endpoint of freedom from any major adverse limb event or post-
operative death within the first year was similar between the two datasets (77% OPG, vs. 74% 
VSGNE) suggesting that the OPG’s should be used as a standard format to compare outcomes 
from trials (Goodney et al., 2011).  Whilst essential to improve methodology, large patient 
numbers will be needed in trials to adequately adjust for subgroup analysis.   
 
Furthermore, there is no single outcome measure that defines the failure or success of a 
procedure and the timing and severity of representation will be different (Conte et al., 2009).  
Statistically, analysis of time-to-event of composite end points considers treatment efficacy 
based on the aggregate of multiple important outcome measures (Subherwal et al., 2012).  
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Whilst there are a number of advantages with this commonplace technique, Conte and 
colleagues suggested that it is not providing a comprehensive picture predominantly because 
only the initial event during the trial is considered for statistical analysis and does not assess 
the cumulative burden of multiple recurrences or procedures on the patient (Conte et al., 2009, 
Subherwal et al., 2012).  An innovative approach is the ‘global rank method’ of analysis, 
which permits consideration and capture of all recurrent events rather than just the initial one, 
by using a hierarchical method of scoring the outcome events (Subherwal et al., 2012).  By 
analysing the study outcomes in this way, the results should encompass a more 
comprehensive picture of both favorable and unfavorable outcomes.  
 
Outside of generic CLI methodology difficulties, the greatest challenge with this study was 
the patient numbers, predominantly the disparity between numbers in each intervention group.  
Power calculations calculated that a sample size of 38 would provide approximately 95% 
power at the 5% significance level for the primary endpoint Tp reactive hyperaemia.   Whilst 
total numbers were 40 this was further reduced on occasions if measured variables could not 
be obtained in all testing sessions, due to patient drop out in the event of amputation or 
mortality, particularly for repeated measures analysis.  Whilst this has been highlighted 
appropriately throughout the study, is does make data analysis difficult and conclusions 
guarded.  Greater than 50 patients appeared very achievable at the outset based on the work 
performed by the unit on an annual basis.  However, there were a large number of patients 
particularly in the endovascular cohort that declined to take part.  The main reason for this 
was not wanting to return to the hospital for repeat testing if this was not part of their routine 
clinical follow up, particularly as many of them already had extensive co-morbidities and 
poor mobility.  Surgical patients were already inpatients during the post-operative phase and 
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were therefore happier to comply with the trial design.   This adversely affected the number of 
patients in each group (open vs. endovascular) and hence they were not equally shared 
between the two treatment modalities.       
 
The trial was an observational study.  The BASIL study had already highlighted the 
challenges and complexities associated with an RCT, particularly in this field, and their study 
population was just 10% of the total number of critically ischaemic patients treated during this 
time as they were required to be in equipoise regarding the best treatment.  This study could 
not have been further limited by smaller patient numbers and was designed to observe the 
changes that occurred in the microcirculation with different treatments in day-to-day vascular 
practice and not necessarily those that were in treatment equipoise. 
 
The follow up from this study was six weeks, which was the routine follow up at this hospital 
following a surgical or endovascular treatment.  A smaller cohort was followed up for six 
months with the aim of assessing longer-term outcomes.  Ideally follow up would be for a 
minimum of one year and in the light of BASIL two years would have been preferable, but 
this was not feasible in the time allowed for the study.  
 
Supplementing current clinical practice with assessment of the microcirculation would need to 
offer additional insight into patient outcomes.  Based on the findings from this study, reactive 
hyperaemia would be the best measure to use as it offers an instant snapshot of the status of 
the limb with a quantitative Tp output.  It also provides additional information through 
‘eyeballing’ the shape of the curve, which is difficult to quantify but does appear to have 
some discriminatory value and needs further analysis in future work.  The test itself is non-
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invasive, quick to perform and practical in a clinical setting.  It is much less time-consuming 
than other methods such as TcP02.  It has been shown to be a valid assessment of the global 
status of the limb and changes are evident by the typical post-operative surgical review of six-
weeks.  Unlike some other microcirculatory measures such as baseline flux and FFT it gives a 
robust distinction and is not subject to significant overlap.   Furthermore, measuring 
Durometry in the immediate post-operative period, particularly in the foot, appears to offer a 
quick, indirect measure of perfusion.  Its association with patency requires further research to 
see if this could be a valid tool. 
 
This study has prospectively assessed CLI patients at a single centre undergoing treatment for 
infrainguinal disease.  It has clearly defined patient demographics and treatment approaches.  
It has highlighted shortcomings in the available literature with regards to the lack of 
microcirculatory outcome measures and direct comparisons between treatments.  It has also 
used novel techniques of measuring oedema and reperfusion changes that can be quickly, 
cheaply and non-invasively applied to a clinical setting. It represents a useful analysis of 
microcirculatory changes, which can be applied to future work.  
 
 
 
 
 
 
 
Word count: 47,664 
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Reperfusion as A Marker of Success Of distal 
Revascularisation (RAMSOR study) 
Consent Form (Version0.2, 5th January 2009) 
 
Authorisation and Signatures 
 
I, _____________________________________, have been invited to participate in a study (The 
RAMSOR study), looking at blood vessel reactivity and skin perfusion in patients who require treatment 
in the form of surgery or endovascular techniques for chronic critical limb ischaemia, under the direction 
of Mr Simms, in which I voluntarily consent to take part. 
 
 
a. The implications of my voluntary participation in this study, its nature, the 
duration, the purpose, the methods and means by which it is to be conducted, 
and the hazards which may be expected have all been explained to me by 
Miss Anna Nicolson. 
 
b. I have read and understood all the written materials that have been provided 
to me describing this study and its potential risks and benefits. 
 
c. I have been given an opportunity to ask any questions I wish concerning the 
procedures, and all such questions have been answered to my complete 
satisfaction.   
 
d. I understand that my participation in this study is voluntary and that I am free 
to withdraw at any time, without giving reasons, and without my medical care 
or legal rights being affected.  
 
e. I agree to allow authorised personnel to examine my medical records and 
understand that this will be done in the strictest confidence. 
 
f. I agree to allow authorised personnel to inform my GP about my participation 
in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date_______________________ 
 
 
___________________________  ___________________________ 
Patient signature    Patient name (Printed) 
 
___________________________  ___________________________ 
Doctor signature    Doctor name (Printed) 
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Reperfusion as A Marker of Success Of distal 
Revascularisation: ‘The RAMSOR study’ 
Pre-intervention Protocol (Version0.4, 19h December 2008) 
 
Date ________________     ID ________________ Patient 
undergoing:  Open surgery   Endovascular  
 
Inclusion and Exclusion Criteria 
CCI fulfilling TASC criteria (Fontaine stage III/IV)   YES/NO 
Iliac/femoral/popliteal/crural disease    YES/NO 
Amputee         YES/NO 
Evidence of chronic venous insufficiency on duplex  YES/NO 
Clinical evidence of motor or sensory neuropathy   YES/NO 
 
Patient Demographics 
ID   -   Diabetic   YES/NO 
D.O.B   -   Hypertensive  YES/NO 
Gender  -   Hypercholesterolaemia YES/NO 
BMI (kg/m2)  -   Smoker   YES/NO/EX 
TASC Classification-   Tissue loss   YES/NO 
Fontaine stage -   Level of occlusion  I/F/P/C 
Mean stenosis -   Numerical index 
 
Room temperature (°c)  ________ Resting heart rate (bpm) ________ 
NB Leg 1 = study limb   Leg 2 = contralateral limb 
 
Patient lying supine and rested.  
Check patient can rest leg over edge of couch comfortably with minimal 
movement. 
 
Anthropometries (lower limb volume & mean muscle mass): 
Measurements (cm) using a standard tape measure in leg 1: L/R 
- Forefoot circumference (1st-5th Metatarsals)     _________ 
- Circumference 2.5cm above medial malleolus (MM)   _________ 
- Circumference 5cm below tibial tuberosity (TT)   _________ 
- Section length between MM & 5cm below TT     _________ 
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Measurements (cm) using a standard tape measure in leg 2: L/R 
- Forefoot circumference (1st-5th Metatarsals)     _________ 
- Circumference 2.5cm above medial malleolus (MM)   _________ 
- Circumference 5cm below tibial tuberosity (TT)   _________ 
- Section length between MM & 5cm below TT     _________ 
 
Tissue Tension/Durometry (arbitrary comparative scale)  
Hold perpendicular to skin. Average of four readings over soft tissue. 
Tissue ‘hardness’ in leg 1: 
- Dorsum of forefoot medial to EHL    _________ 
- 2.5cm above and medial to medial malleolus  _________ 
- 5cm below an medial to tibial tuberosity  _________ 
 
Tissue ‘hardness’ leg 2: 
- Dorsum of forefoot medial to EHL    _________ 
- 2.5cm above and medial to medial malleolus  _________ 
- 5cm below an medial to tibial tuberosity  _________ 
 
Tissue depth using Sonosite 180 Ultrasound machine (cm) 
Depth of tissue down to fascia in leg 1: 
- Middle of dorsum of forefoot    _________ 
- 2.5cm above medial malleolus    _________ 
- 5cm below tibial tuberosity     _________ 
 
Depth of tissue down to fascia in leg 2: 
- Middle of dorsum of forefoot    _________ 
- 2.5cm above medial malleolus    _________ 
- 5cm below tibial tuberosity     _________ 
 
Systolic brachial blood pressure (mmHg)    _________ 
Absolute ankle pressure (mmHg) 
Use the highest reading in each leg for ankle brachial index calculation 
 - Leg 1 posterior tibial _________ dorsalis pedis _________ 
- Leg 2 posterior tibial _________ dorsalis pedis _________ 
Ankle brachial index (ratio)      
 -Leg 1          _________ -Leg 2  _________ 
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Absolute toe pressure with vascular assist device (mmHg) 
 -Leg 1          _________ -Leg 2  _________  
 
Toe brachial index (ratio) 
-Leg 1          _________ -Leg 2  _________ 
 
Skin perfusion pressure with vascular assist device (mmHg) 
- Leg 1         _________ 
- Leg 2              ________ 
 
Laser Doppler Fluxmetry (arbitrary comparative scale) 
Ensure smooth surface and shave hair as necessary & attach probes with 
adhesive sticker and tape. Ensure probes are in correct channels. 
 
Three probes on leg 1:   One probe on leg 2: 
- Pulp of great toe (multisite probe) - Pulp of great toe (multisite   
- Middle of dorsum of forefoot   probe) 
- 15cm below tibial tuberosity 
  
Patient lying supine and rested 
Baseline reading 10 minutes Save data for FFT analysis 
     
Patient to stay lying supine  Baseline reading 2 minutes 
Drop leg over the edge of the couch Leg drop – 4mins reading 
 
Patient to sit upright with foot resting on level 
Sitting – 4mins reading  VAR = (HBF-SBF)/HBF x 100 
 
Patient to lie supine and attach pneumatic cuff around ankle of leg 1 
Baseline reading 2 minutes 
 
Reactive hyperaemia (RH): 2 minute occlusion with pneumatic cuff 
around ankle, 50mmHg above systolic brachial pressure ________  
Measured as the time to peak flux (sec) after release of cuff. 
 
Attach pneumatic cuff around ankle of leg 2 
Baseline reading 2 minutes and repeat RH in leg2   
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Reperfusion as A Marker of Success Of distal 
Revascularisation: ‘The RAMSOR study’ 
Post-intervention Protocol (Version0.3, 6h January 2009) 
 
Date ________________     ID ________________ Patient 
undergone:  Open surgery   Endovascular  
 
Room temperature (centigrade)  _________________________ 
 
Patient lying supine and rested.   Check patient can rest leg over edge of 
couch comfortably with minimal movement. 
 
Anthropometries (lower limb volume & mean muscle mass): 
Measurements (cm) using a standard tape measure in leg 1: L/R 
- Forefoot circumference (1st-5th Metatarsals)     _________ 
- Circumference 2.5cm above medial malleolus (MM)   _________ 
- Circumference 5cm below tibial tuberosity (TT)   _________ 
- Section length between MM & 5cm below TT     _________ 
 
Measurements (cm) using a standard tape measure in leg 2: L/R 
- Forefoot circumference (1st-5th Metatarsals)     _________ 
- Circumference 2.5cm above medial malleolus (MM)   _________ 
- Circumference 5cm below tibial tuberosity (TT)   _________ 
- Section length between MM & 5cm below TT     _________ 
 
Tissue Tension/Durometry (arbitrary comparative scale)  
Hold perpendicular to skin. Average of four readings over soft tissue. 
Tissue ‘hardness’ in leg 1: 
- Dorsum of forefoot medial to EHL    _________ 
- 2.5cm above and medial to medial malleolus  _________ 
- 5cm below an medial to tibial tuberosity  _________ 
 
Tissue ‘hardness’ leg 2: 
- Dorsum of forefoot medial to EHL    _________ 
- 2.5cm above and medial to medial malleolus  _________ 
- 5cm below an medial to tibial tuberosity  _________ 
249 
 
Tissue depth using Sonosite 180 Ultrasound machine (cm) 
Depth of tissue down to fascia in leg 1: 
- Middle of dorsum of forefoot    _________ 
- 2.5cm above medial malleolus    _________ 
- 5cm below tibial tuberosity     _________ 
 
Depth of tissue down to fascia in leg 2: 
- Middle of dorsum of forefoot    _________ 
- 2.5cm above medial malleolus    _________ 
- 5cm below tibial tuberosity     _________ 
 
Systolic brachial blood pressure (mmHg)    _________ 
Absolute toe pressure with vascular assist device (mmHg) 
 -Leg 1          _________ -Leg 2  _________  
Toe brachial index (ratio) 
-Leg 1          _________ -Leg 2  _________ 
Skin perfusion pressure with vascular assist device (mmHg) 
- Leg 1         _________ 
- Leg 2              ________ 
 
Laser Doppler Fluxmetry (arbitrary comparative scale) 
Ensure smooth surface and shave hair as necessary & attach probes with 
adhesive sticker and tape. Ensure probes are in correct channels. 
 
Three probes on leg 1:   One probe on leg 2: 
- Pulp of great toe (multisite probe) - Pulp of great toe (multisite   
- Middle of dorsum of forefoot   probe) 
- 15cm below tibial tuberosity  
 
Patient lying supine and rested 
Baseline reading 10 minutes Save data for FFT analysis 
     
Patient to stay lying supine  Baseline reading 2 minutes 
Drop leg over the edge of the couch Leg drop – 4mins reading 
 
Patient to sit upright with foot resting on level 
Sitting – 4mins reading  VAR = (HBF-SBF)/HBF x 100 
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Reperfusion as A Marker of Success Of distal 
Revascularisation: ‘The RAMSOR study’ 
Six Weeks Post-intervention Protocol (Version0.3, 6h January 2009) 
 
Date ________________     ID ________________  
Patient undergone:  Open surgery   Endovascular  
   
Room temperature (centigrade)  _________________________ 
 
Patient lying supine and rested.   Check patient can rest leg over edge of 
couch comfortably with minimal movement. 
 
Anthropometries (lower limb volume & mean muscle mass): 
Measurements (cm) using a standard tape measure in leg 1: L/R 
- Forefoot circumference (1st-5th Metatarsals)     _________ 
- Circumference 2.5cm above medial malleolus (MM)   _________ 
- Circumference 5cm below tibial tuberosity (TT)   _________ 
- Section length between MM & 5cm below TT     _________ 
 
Measurements (cm) using a standard tape measure in leg 2: L/R 
- Forefoot circumference (1st-5th Metatarsals)     _________ 
- Circumference 2.5cm above medial malleolus (MM)   _________ 
- Circumference 5cm below tibial tuberosity (TT)   _________ 
- Section length between MM & 5cm below TT     _________ 
 
Tissue Tension/Durometry (arbitrary comparative scale)  
Hold perpendicular to skin. Average of four readings over soft tissue. 
Tissue ‘hardness’ in leg 1: 
- Dorsum of forefoot medial to EHL    _________ 
- 2.5cm above and medial to medial malleolus  _________ 
- 5cm below an medial to tibial tuberosity  _________ 
 
Tissue ‘hardness’ leg 2: 
- Dorsum of forefoot medial to EHL    _________ 
- 2.5cm above and medial to medial malleolus  _________ 
- 5cm below an medial to tibial tuberosity  _________ 
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Tissue depth using Sonosite 180 Ultrasound machine (cm) 
Depth of tissue down to fascia in leg 1: 
- Middle of dorsum of forefoot    _________ 
- 2.5cm above medial malleolus    _________ 
- 5cm below tibial tuberosity     _________ 
 
Depth of tissue down to fascia in leg 2: 
- Middle of dorsum of forefoot    _________ 
- 2.5cm above medial malleolus    _________ 
- 5cm below tibial tuberosity     _________ 
 
Systolic brachial blood pressure (mmHg)    _________ 
Absolute ankle pressure (mmHg) 
Use the highest reading in each leg for ankle brachial index calculation 
 - Leg 1 posterior tibial _________ dorsalis pedis _________ 
- Leg 2 posterior tibial _________ dorsalis pedis _________ 
Ankle brachial index (ratio)      
 -Leg 1          _________ -Leg 2  _________ 
 
Absolute toe pressure with vascular assist device (mmHg) 
 -Leg 1          _________ -Leg 2  _________  
 
Toe brachial index (ratio) 
-Leg 1          _________ -Leg 2  _________ 
 
Skin perfusion pressure with vascular assist device (mmHg) 
- Leg 1         _________ 
- Leg 2              ________ 
 
Laser Doppler Fluxmetry (arbitrary comparative scale) 
Ensure smooth surface and shave hair as necessary & attach probes with 
adhesive sticker and tape. Ensure probes are in correct channels. 
 
Three probes on leg 1:   One probe on leg 2: 
- Pulp of great toe (multisite probe) - Pulp of great toe (multisite   
- Middle of dorsum of forefoot   probe) 
- 15cm below tibial tuberosity 
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Patient lying supine and rested 
Baseline reading 10 minutes Save data for FFT analysis 
     
Patient to stay lying supine  Baseline reading 2 minutes 
Drop leg over the edge of the couch Leg drop – 4mins reading 
 
Patient to sit upright with foot resting on level 
Sitting – 4mins reading  VAR = (HBF-SBF)/HBF x 100 
 
Patient to lie supine and attach pneumatic cuff around ankle of leg 1 
Baseline reading 2 minutes 
 
Reactive hyperaemia (RH): 2 minute occlusion with pneumatic cuff 
around ankle, 50mmHg above systolic brachial pressure ________  
Measured as the time to peak flux (sec) after release of cuff. 
 
Attach pneumatic cuff around ankle of leg 2 
Baseline reading 2 minutes and repeat RH in leg2 
     
 
USS – Patent vessel/graft      YES/NO 
 
 
Further intervention/surgery required   YES/NO 
 
 
Symptom relief - Complete  Partial  None 
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Introduction 
 
Thank you for reading this leaflet.  This 
hospital is undertaking a study to 
observe the changes in tissue perfusion 
(skin blood flow) and blood vessel 
reactivity, in patients with chronic 
critical ischaemia (CCI) of their lower 
limb (leg) and observe the effect 
treatment (surgical or x-ray guided 
method) has on these.   
 
This is an invitation to patients such as 
you to consider joining this study.  If 
there is anything you do not 
understand, or you have any other 
questions, your doctor or research 
investigator will be able to discuss this 
with you or you can contact us directly 
(see below for details). 
 
 
 
Background Information 
 
What is Chronic Critical Ischaemia?  
 
CCI is a condition resulting from 
narrowing or blockage of the major leg 
vessels (arteries) that supply oxygen-
rich blood to the legs. When this blood 
supply is severely reduced for a period 
of time, the tissues such as skin become 
ischaemic (oxygen starved) and can 
become gangrenous. 
 
 
What are its symptoms? 
 
Patients develop pain in their foot when 
they are resting, particularly in bed at 
night time.  Ulcers and gangrene of the 
tissues can develop and do not heal 
because the blood supply is poor. 
 
 
How is it treated? 
 
Treatment is aimed at relieving the pain 
and healing the ulcers.  In order to do this 
the blood supply in the legs needs to be 
improved (‘Revascularisation’). Also 
factors that we know cause, and worsen 
this condition should be improved such 
as smoking, high cholesterol and high 
blood pressure.   
 
 
What is Revascularisation? 
 
Revascularisation refers to the process of 
improving the blood supply (flow) to the 
affected limb by either increasing flow in 
the native artery using endovascular 
techniques like angioplasty (balloon 
inflation to stretch the arteries) or 
surgically bypassing the blocked artery. 
 
 
How do I know which Revascularisation 
Procedure is right for me? 
 
The choice of procedure (surgery or 
endovascular) is determined on an 
individual basis depending on the type, 
size and position of the blockage/s in the 
artery and the general health of the 
patient.  Your doctor will discuss your 
treatment options with you. 
 
 
How does revascularisation affect blood 
flow in the skin and vessel reactivity? 
 
By improving the blood flow in the big 
arteries in the leg, the blood flow in the 
skin of the foot and vessel reactivity 
should also improve and therefore reduce 
pain and improve ulcer healing.  It is not 
clear from studies if the improvement in 
blood supply is directly linked to the 
extent of revascularisation. 
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 The RAMSOR Study 
 
What is the research study about? 
 
This is an observational study of 
patients who require intervention 
(surgery or endovascular) to treat 
their CCI. It is looking at whether or 
not skin blood flow and vessel 
reactivity improve, and by how much, 
after treatment and comparing this to 
the type of blockage that you have in 
your blood vessels. 
 
It is being performed at Selly Oak 
Hospital or Birmingham Heartlands 
Hospital where you will be having 
your treatment. 
 
 
What will I have to do? 
 
To carry out the study we need 
individuals like you, who are having 
a revascularisation procedure.  We 
would require you to undergo 
measurements on three separate 
occasions during your treatment at 
hospital: 
 
1. On the day before or the day of 
your treatment. 
2. On the day after your treatment. 
3. Six weeks after your treatment, at 
your routine clinic appointment. 
 
The measurements will take 
approximately one hour and will be: 
 
- Blood pressure in your arm, ankle 
and toe, using a pneumatic blood 
pressure cuff. 
 
- Limb circumference using a tape 
measure. 
 
- Limb ‘hardness’ using a gauge that 
rests on the skin. 
 
 
- Limb tissue depth using an ultrasound 
(jelly) scan. 
 
- Skin blood flow using a laser Doppler.  
This will involve putting four small 
sticky probes onto your legs, below 
your knee.  This will be connected to a 
computer to allow measurements to be 
continuously visualised.  The blood 
flow will be measured with you in the 
lying and sitting position.  There will 
also be a blood pressure cuff inflated 
around the ankle for a two-minute 
period to measure vessel reactivity on 
visit 1 and 3.  This may result in a 
feeling of fullness in the foot but should 
not cause pain.  This test will not 
damage your blood flow. 
 
All of the measurements will be taken 
whilst you are lying comfortably on a 
couch/bed, with the exception of part of 
the laser Doppler test where you will be 
required to sit for ten minutes. 
 
There will be no tests requiring any 
physical exertion and no invasive tests 
such as blood taking will be performed. 
 
What are the benefits? 
 
Although this study may be of no 
personal benefit to you, we hope to 
gain a better understanding of what 
happens to patients’ skin blood flow 
when they have a revascularisation 
procedure.  We hope this will aid 
doctor’s decision-making in future 
management of this condition.   
 
 
What are the risks? 
 
There are no adverse risks to taking 
part in this study.  The only burden is 
the time taken to participate in the 
study. 
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What happens if I change my mind during the 
study? 
 
You can withdraw from the study at any time 
and this will not affect your future management 
in any way.  If you want to withdraw, please 
speak to one of the doctors listed below. 
 
 
Your decision 
 
You may want to think a little bit longer or 
discuss it with a relative before deciding whether 
or not you will take part in the study.  If you 
decide to join we will inform your GP and send 
them information about the study. 
 
 
 
 
Investigators 
 
Miss Anna Nicolson 
Vascular Research Fellow 
University Hospital Birmingham 
Tel: 0121 627 1627 
 
Mr Malcolm Simms 
Consultant Vascular Surgeon 
University Hospital Birmingham 
Tel: 0121 627 8534 
 
 
Independent Person 
 
Patient Advice and Liason Service (PALS) 
Officer 
Selly Oak Hospital 
 
 
Heartlands Hospital 
 
 
  
What if I do not want to take part? 
 
If you decide not to take part in the 
study this will not affect any treatment 
you will receive. 
 
 
What happens to the information? 
 
The identity of the volunteers in the 
study will be kept strictly confidential.  
Only after statistical analysis will we be 
able to say if we have identified 
differences between different groups of 
patients. 
 
 
What happens at the end of the study? 
 
We hope to publish the results in 
medical journals to enable other doctors 
to learn from our findings.  This may 
help the treatment of others in the 
future.  You will receive a copy of the 
result and your identity will be 
anonymous in these publications.   
 
 
What happens if I have more 
questions or I do not understand 
something? 
 
If you would like further information, 
please speak to one of the doctors or 
the independent person listed below. 
 
 
What happens now if I decide to take 
part? 
 
If you decide to take part, please let one 
of the doctors looking after you know.  
Alternatively, the lead researcher will 
contact you after you have had chance 
to read this information to see if you 
have any questions and if you are 
willing to take part.  You will then be 
asked to sign a form to say you consent 
to taking part in the RADAR study. 
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Vascular Department ‘S block’, 
Selly Oak Hospital, 
Raddlebarn Road, 
Selly Oak, 
Birmingham. 
B29 6JD 
 
 
 
 
 
Dear Dr______________, 
 
Reperfusion as A Marker of Success Of distal Revascularisation  
(The RAMSOR study) 
 
I am writing with regards to your patient ___________________________________, who 
has agreed to take part in the above named study, being conducted in the Vascular 
Department at Selly Oak Hospital. 
 
It is an observational study of all patients undergoing treatment for chronic critical limb 
ischaemia of the lower limb, to assess tissue perfusion and vessel reactivity before and after 
treatment and see if this correlates with the anatomical extent of revascularisation.  This will 
predominantly be measured using Laser Doppler studies (non-invasive measurements) on 
three separate occasions, over a six week period.   
 
Your patient has been given information on the study and is happy to proceed.  Their 
participation will not affect their treatment in any way. 
 
If you would like any further information on the study please feel free to contact me. 
 
Kind Regards, 
 
Miss Anna Nicolson  
 
(MBChB MRCSEd) 
Vascular Research Fellow to Mr M. Simms 
 
 
Version0.2 (29th November) 
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